BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med 2017;195:557-82. [PMID: 28128970 DOI: 10.1164/rccm.201701-0218PP] [Cited by in Crossref: 1248] [Cited by in F6Publishing: 788] [Article Influence: 249.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Maitinuer A, Lian Z, Li Y, Ding W, Wang W, Wu C, Yang X. Home based pulmonary tele-rehabilitation under telemedicine system for COPD: a cohort study. BMC Pulm Med 2022;22. [DOI: 10.1186/s12890-022-02077-w] [Reference Citation Analysis]
2 Chouinard G, Roy P, Blais M, Lippens A, Pelletier É, Roy E, Marcoux M, Ugalde PA, Rheault J, Pigeon M, Nicodème F, Lacasse Y, Maltais F. Exercise testing and postoperative complications after minimally invasive lung resection: A cohort study. Front Physiol 2022;13:951460. [DOI: 10.3389/fphys.2022.951460] [Reference Citation Analysis]
3 Huang D, He D, Gong L, Yao R, Wang W, Yang L, Zhang Z, He Q, Wu Z, Shi Y, Liang Z. A prediction model for hospital mortality in patients with severe community-acquired pneumonia and chronic obstructive pulmonary disease. Respir Res 2022;23. [DOI: 10.1186/s12931-022-02181-9] [Reference Citation Analysis]
4 Trudzinski FC, Presotto MA, Buck E, Herth FJF, Ries M. Orphan drug development in alpha-1 antitypsin deficiency. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-19707-2] [Reference Citation Analysis]
5 Sullivan DR, Iyer AS, Enguidanos S, Cox CE, Farquhar M, Janssen DJA, Lindell KO, Mularski RA, Smallwood N, Turnbull AE, Wilkinson AM, Courtright KR, Maddocks M, Mcpherson ML, Thornton JD, Campbell ML, Fasolino TK, Fogelman PM, Gershon L, Gershon T, Hartog C, Luther J, Meier DE, Nelson JE, Rabinowitz E, Rushton CH, Sloan DH, Kross EK, Reinke LF. Palliative Care Early in the Care Continuum among Patients with Serious Respiratory Illness: An Official ATS/AAHPM/HPNA/SWHPN Policy Statement. Am J Respir Crit Care Med 2022;206:e44-69. [DOI: 10.1164/rccm.202207-1262st] [Reference Citation Analysis]
6 Gu Y, Sun Z, Sun Y, Wen Y, Guan X, Jiang D, Cheng C, Gu H. A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease. Front Pharmacol 2022;13:892526. [DOI: 10.3389/fphar.2022.892526] [Reference Citation Analysis]
7 Han MK, Ye W, Wang D, White E, Arjomandi M, Barjaktarevic IZ, Brown SA, Buhr RG, Comellas AP, Cooper CB, Criner GJ, Dransfield MT, Drescher F, Folz RJ, Hansel NN, Kaner RJ, Kanner RE, Krishnan JA, Lazarus SC, Maddipati V, Martinez FJ, Mathews A, Meldrum C, McEvoy C, Nyunoya T, Rogers L, Stringer WW, Wendt CH, Wise RA, Wisniewski SR, Sciurba FC, Woodruff PG; RETHINC Study Group. Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function. N Engl J Med 2022. [PMID: 36066078 DOI: 10.1056/NEJMoa2204752] [Reference Citation Analysis]
8 Huang X, Yin W, Shen M, Wang X, Ren T, Wang L, Liu M, Guo Y. Contributions of Emphysema and Functional Small Airway Disease on Intrapulmonary Vascular Volume in COPD. Int J Chron Obstruct Pulmon Dis 2022;17:1951-61. [PMID: 36045693 DOI: 10.2147/COPD.S368974] [Reference Citation Analysis]
9 Wei D, Wang Q, Liu S, Tan X, Chen L, Tu R, Liu Q, Jia Y, Liu S. . COPD 2022;Volume 17:2053-65. [DOI: 10.2147/copd.s373834] [Reference Citation Analysis]
10 Yan R, Duong M, Tse LA, Yin L, Rangarajan S, Yusuf S, Hou Y, Xu Z, Li J, Li W. Regional differences in the contribution of smoking, dietary and cooking behaviours to airflow obstruction in China: A population-based case-control study. Respirology 2022. [PMID: 35999170 DOI: 10.1111/resp.14347] [Reference Citation Analysis]
11 Bergs I, Just KS, Müller A, Stingl JC, Dreher M. Emergency Department Visits Due to Dyspnea: Association with Inhalation Therapy in COPD and Cases with Adverse Drug Reactions. Int J Chron Obstruct Pulmon Dis 2022;17:1827-34. [PMID: 35983166 DOI: 10.2147/COPD.S367062] [Reference Citation Analysis]
12 Meng Q, Wang J, Cui J, Li B, Wu S, Yun J, Aschner M, Wang C, Zhang L, Li X, Chen R. Prediction of COPD acute exacerbation in response to air pollution using exosomal circRNA profile and Machine learning. Environ Int 2022;168:107469. [PMID: 36041244 DOI: 10.1016/j.envint.2022.107469] [Reference Citation Analysis]
13 Tudorache E, Fira-Mladinescu O, Traila D, Marc M, Rajnoveanu RM, Tofolean DE, Fildan AP. Endothelial dysfunction: The possible link between cardiovascular comorbidities and phenomenon of inflammaging from COPD. Medicine (Baltimore) 2022;101:e30078. [PMID: 35984178 DOI: 10.1097/MD.0000000000030078] [Reference Citation Analysis]
14 Hamada Y, Nakatani E, Nagahama T, Nagai K, Nagayama K, Tomita Y, Sekiya K, Taniguchi M, Fukutomi Y. Identification of asthma cases in Japan using health insurance claims data: Positive and negative predictive values of proposed discrimination criteria: A single-center study. Allergol Int 2022:S1323-8930(22)00079-X. [PMID: 35965192 DOI: 10.1016/j.alit.2022.07.001] [Reference Citation Analysis]
15 Peng JC, Gong WW, Wu Y, Yan TY, Jiang XY. Development and validation of a prognostic nomogram among patients with acute exacerbation of chronic obstructive pulmonary disease in intensive care unit. BMC Pulm Med 2022;22:306. [PMID: 35945553 DOI: 10.1186/s12890-022-02100-0] [Reference Citation Analysis]
16 Finamore P, Lattanzi G, Pedone C, Poci S, Alma A, Scarlata S, Fontana DO, Khazrai YM, Incalzi RA. Energy expenditure and intake in COPD: The extent of unnoticed unbalance by predicting REE. Respir Med 2022;201:106951. [PMID: 35963031 DOI: 10.1016/j.rmed.2022.106951] [Reference Citation Analysis]
17 Xiang X, Huang L, Fang Y, Cai S, Zhang M. Physical activity and chronic obstructive pulmonary disease: a scoping review. BMC Pulm Med 2022;22:301. [PMID: 35932050 DOI: 10.1186/s12890-022-02099-4] [Reference Citation Analysis]
18 Ouyang Y, Liu J, Wen S, Xu Y, Zhang Z, Pi Y, Chen D, Su Z, Liang Z, Wang Y, Guo L. Association between chronic obstructive pulmonary disease and periodontitis: The common role of innate immune cells? Cytokine 2022;158:155982. [PMID: 35932499 DOI: 10.1016/j.cyto.2022.155982] [Reference Citation Analysis]
19 Bhatt SP, Bodduluri S, Nakhmani A, Kim YI, Reinhardt JM, Hoffman EA, Motahari A, Wilson CG, Humphries SM, Regan EA, DeMeo DL. Sex Differences in Airways at Chest CT: Results from the COPDGene Cohort. Radiology 2022;:212985. [PMID: 35916677 DOI: 10.1148/radiol.212985] [Reference Citation Analysis]
20 Feng Z, Zhang L, Yu H, Su X, Shuai T, Zhu L, Chen D, Liu J. . COPD 2022;Volume 17:1987-99. [DOI: 10.2147/copd.s375107] [Reference Citation Analysis]
21 Schultz K, Koczulla AR. [Pulmonary Rehabilitation in Patients with Chronic Obstructive Airway Diseases]. Dtsch Med Wochenschr 2022;147:961-73. [PMID: 35915882 DOI: 10.1055/a-1854-7286] [Reference Citation Analysis]
22 Bains D, Chahal A, Shaphe MA, Kashoo FZ, Ali T, Alghadir AH, Khan M, Bernardo-filho M. Effects of Muscle Energy Technique and Joint Manipulation on Pulmonary Functions, Mobility, Disease Exacerbations, and Health-Related Quality of Life in Chronic Obstructive Pulmonary Disease Patients: A Quasiexperimental Study. BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/5528724] [Reference Citation Analysis]
23 Wucherpfennig L, Triphan SM, Weinheimer O, Eichinger M, Wege S, Eberhardt R, Puderbach MU, Kauczor HU, Heussel CP, Heussel G, Wielpütz MO. Reproducibility of pulmonary magnetic resonance angiography in adults with muco-obstructive pulmonary disease. Acta Radiol 2022;:2841851221111486. [PMID: 35876445 DOI: 10.1177/02841851221111486] [Reference Citation Analysis]
24 Zeng S, Bai H, Zou M, Huang T. Effects of Roflumilast on Patients with Chronic Obstructive Pulmonary Disease Treated with Inhaled Corticosteroid/Long-Acting β2 Agonist: A Meta-analysis. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/8101099] [Reference Citation Analysis]
25 Wang W, Yang Q, Xun Q, Ye X. Study on the Management of the Health Status of Patients with Stable Chronic Obstructive Pulmonary Disease Treated with Double Bronchodilator. Evid Based Complement Alternat Med 2022;2022:1183436. [PMID: 35855824 DOI: 10.1155/2022/1183436] [Reference Citation Analysis]
26 Collinsworth AW, Masica AL, Kudyakov R, Bayer V, Millard MW, Shaikh A. Retrospective observational study of asthma and chronic obstructive pulmonary disease prevalence and associated healthcare resource utilization in a large, integrated healthcare system. Baylor University Medical Center Proceedings. [DOI: 10.1080/08998280.2022.2096370] [Reference Citation Analysis]
27 García AR, Piccari L. Emerging phenotypes of pulmonary hypertension associated with COPD a field guide. Curr Opin Pulm Med 2022. [PMID: 35838373 DOI: 10.1097/MCP.0000000000000890] [Reference Citation Analysis]
28 Huang D, Su L, He C, Chen L, Huang D, Peng J, Yang F, Cao Y, Luo X. Pristimerin alleviates cigarette smoke-induced inflammation in chronic obstructive pulmonary disease via inhibiting NF-κB pathway. Biochem Cell Biol 2022. [PMID: 35833632 DOI: 10.1139/bcb-2021-0251] [Reference Citation Analysis]
29 Wada S, Matsuoka S, Mimura H. Inspiratory and expiratory CT analyses of the diaphragmatic crus in chronic obstructive pulmonary disease. Jpn J Radiol 2022. [PMID: 35821376 DOI: 10.1007/s11604-022-01314-w] [Reference Citation Analysis]
30 Çolak Y, Ingebrigtsen TS, Nordestgaard BG, Marott JL, Lange P, Vestbo J, Afzal S. Plasma immunoglobulin E and risk of exacerbation and mortality in chronic obstructive pulmonary disease: A contemporary population-based cohort. Ann Allergy Asthma Immunol 2022:S1081-1206(22)00582-8. [PMID: 35835293 DOI: 10.1016/j.anai.2022.06.028] [Reference Citation Analysis]
31 Nay MA, Planquette B, Perrin C, Clément J, Plantier L, Sève A, Druelle S, Morrier M, Lainé JB, Colombain L, Corvaisier G, Bizien N, Pouget-Abadie X, Bigot A, Bernard L, Nyamankolly E, Fossat G, Boulain T. Does awake prone positioning prevent the use of mechanical respiratory support or death in COVID-19 patients on standard oxygen therapy hospitalised in general wards? A multicentre randomised controlled trial: the PROVID-19 protocol. BMJ Open 2022;12:e060320. [PMID: 35803621 DOI: 10.1136/bmjopen-2021-060320] [Reference Citation Analysis]
32 Hou J, Wang X, Su C, Ma W, Zheng X, Ge X, Duan X. Reduced frequencies of Foxp3+GARP+ regulatory T cells in COPD patients are associated with multi-organ loss of tissue phenotype. Respir Res 2022;23:176. [PMID: 35780120 DOI: 10.1186/s12931-022-02099-2] [Reference Citation Analysis]
33 Du Y, Sidorenkov G, Groen HJM, Heuvelmans MA, Vliegenthart R, Dorrius MD, Timens W, de Bock GH. Airflow Limitation Increases Lung Cancer Risk in Smokers: The Lifelines Cohort Study. Cancer Epidemiol Biomarkers Prev 2022;31:1442-9. [PMID: 35534234 DOI: 10.1158/1055-9965.EPI-21-1365] [Reference Citation Analysis]
34 Palma G, Sorice GP, Genchi VA, Giordano F, Caccioppoli C, D’oria R, Marrano N, Biondi G, Giorgino F, Perrini S. Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity. IJMS 2022;23:7349. [DOI: 10.3390/ijms23137349] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Patel M, Chowdhury J, Zhao H, Lu X, Roth S, Giovacchini CX, Wahidi MM, Criner G. Meta-analysis and Systematic Review of Bronchoscopic Lung Volume Reduction Through Endobronchial Valves in Severe Emphysema. J Bronchology Interv Pulmonol 2022;29:224-37. [PMID: 35698281 DOI: 10.1097/LBR.0000000000000872] [Reference Citation Analysis]
36 Chen X, Kang F, Lai J, Deng X, Guo X, Liu S. Comparative effectiveness of phlegm-heat clearing Chinese medicine injections for AECOPD: A systematic review and network meta-analysis. J Ethnopharmacol 2022;292:115043. [PMID: 35124185 DOI: 10.1016/j.jep.2022.115043] [Reference Citation Analysis]
37 Lin C, Bahmed K, Kosmider B. Impaired Alveolar Re-Epithelialization in Pulmonary Emphysema. Cells 2022;11:2055. [DOI: 10.3390/cells11132055] [Reference Citation Analysis]
38 Zhang J, Xu N, Zheng D. Effect of High-Quality Nursing Care on Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure: An Observational Cohort Study. Appl Bionics Biomech 2022;2022:9440899. [PMID: 35733447 DOI: 10.1155/2022/9440899] [Reference Citation Analysis]
39 Wu D, Zhao X, Huang D, Dai Z, Chen M, Li D, Wu B. Outcomes associated with comorbid anxiety and depression among patients with stable COPD: A patient registry study in China. J Affect Disord 2022:S0165-0327(22)00719-4. [PMID: 35760193 DOI: 10.1016/j.jad.2022.06.059] [Reference Citation Analysis]
40 Kilaru SC, Bansal AG, Naik VS, Lopez M, Gogtay JA. A review of the efficacy and safety of fluticasone propionate/formoterol fixed-dose combination. Expert Rev Respir Med 2022;:1-12. [PMID: 35727177 DOI: 10.1080/17476348.2022.2089117] [Reference Citation Analysis]
41 Marin-Oto M, Sanz-Rubio D, Santamaría-Martos F, Benitez I, Simon AL, Forner M, Cubero P, Gil A, Sanchez-de-laTorre M, Barbe F, Marin JM. Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea. Respir Res 2022;23:163. [PMID: 35729539 DOI: 10.1186/s12931-022-02092-9] [Reference Citation Analysis]
42 Rivas M, Gupta G, Costanzo L, Ahmed H, Wyman AE, Geraghty P. Senescence: Pathogenic Driver in Chronic Obstructive Pulmonary Disease. Medicina (Kaunas) 2022;58:817. [PMID: 35744080 DOI: 10.3390/medicina58060817] [Reference Citation Analysis]
43 Pace E, Cerveri I, Lacedonia D, Paone G, Sanduzzi Zamparelli A, Sorbo R, Allegretti M, Lanata L, Scaglione F. Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action. Pharmaceutics 2022;14:1261. [PMID: 35745833 DOI: 10.3390/pharmaceutics14061261] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Doldi P, Steffen J, Orban M, Theiss H, Sadoni S, Hagl C, Massberg S, Hausleiter J, Deseive S, Braun D. Clinical Outcome Following Transcatheter Aortic Valve Implantation in Patients With Chronic Obstructive Pulmonary Disease. JACC Cardiovasc Interv 2022;15:1188-90. [PMID: 35680203 DOI: 10.1016/j.jcin.2022.03.017] [Reference Citation Analysis]
45 Ashrafizadeh M, Zarrabi A, Mostafavi E, Aref AR, Sethi G, Wang L, Tergaonkar V. Non-coding RNA-based regulation of inflammation. Semin Immunol 2022;:101606. [PMID: 35691882 DOI: 10.1016/j.smim.2022.101606] [Reference Citation Analysis]
46 Li T, Chen J. Research Trends on Pulmonary Rehabilitation: A Bibliometric Analysis From 2011 to 2020. Front Med 2022;9:887793. [DOI: 10.3389/fmed.2022.887793] [Reference Citation Analysis]
47 Baugh A, Buhr RG, Quibrera P, Barjaktarevic I, Barr RG, Bowler R, Han MK, Kaufman JD, Koch AL, Krishnan J, Labaki W, Martinez FJ, Mkorombindo T, Namen A, Ortega V, Paine R, Peters SP, Schotland H, Sundar K, Zeidler MR, Hansel NN, Woodruff PG, Thakur N. Risk of COPD exacerbation is increased by poor sleep quality and modified by social adversity. Sleep 2022:zsac107. [PMID: 35665826 DOI: 10.1093/sleep/zsac107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Qiao X, Hou G, Kang J, Wang Q, Yin Y. CT Attenuation and Cross-Sectional Area of the Pectoralis Are Associated With Clinical Characteristics in Chronic Obstructive Pulmonary Disease Patients. Front Physiol 2022;13:833796. [DOI: 10.3389/fphys.2022.833796] [Reference Citation Analysis]
49 De Bontridder S, Corhay JL, Haenebalcke C, Fievet F, Etienne I, Vanderhelst E. Correlation of symptoms and physical activity level in chronic obstructive pulmonary disease patients: results from the observational SPACE study. Acta Clin Belg 2022;77:671-8. [PMID: 34252000 DOI: 10.1080/17843286.2021.1950419] [Reference Citation Analysis]
50 Shah SA, Nwaru BI, Sheikh A, Simpson CR, Kotz D. Development and validation of a multivariable mortality risk prediction model for COPD in primary care. NPJ Prim Care Respir Med 2022;32:21. [PMID: 35641524 DOI: 10.1038/s41533-022-00280-0] [Reference Citation Analysis]
51 Shin SH, Kim DK, Kim S, Shin TR, Jung K, Yoo KH, Hwang K, Park HY, Jo YS; on behalf of the KOCOSS Cohort. Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease. JPM 2022;12:916. [DOI: 10.3390/jpm12060916] [Reference Citation Analysis]
52 Hou R, Miao F, Jin D, Duan Q, Yin C, Feng Q, Wang T. General Anesthesia for Patients With Chronic Obstructive Pulmonary Disease and Postoperative Respiratory Failure: A Retrospective Analysis of 120 Patients. Front Physiol 2022;13:842784. [DOI: 10.3389/fphys.2022.842784] [Reference Citation Analysis]
53 Rahman HH, Niemann D, Munson-McGee SH. Urinary metals, arsenic, and polycyclic aromatic hydrocarbon exposure and risk of chronic bronchitis in the US adult population. Environ Sci Pollut Res Int 2022. [PMID: 35624372 DOI: 10.1007/s11356-022-20982-9] [Reference Citation Analysis]
54 Assaf EA, Badarneh A, Saifan A, Al-yateem N. Chronic obstructive pulmonary disease patients' quality of life and its related factors: A cross-sectional study of the Jordanian population. F1000Res 2022;11:581. [DOI: 10.12688/f1000research.121783.1] [Reference Citation Analysis]
55 Trudzinski FC, Jörres RA, Alter P, Walter J, Watz H, Koch A, John M, Lommatzsch M, Vogelmeier CF, Kauczor HU, Welte T, Behr J, Tufman A, Bals R, Herth FJF, Kahnert K; COSYCONET Study Group. Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET. Sci Rep 2022;12:8790. [PMID: 35610473 DOI: 10.1038/s41598-022-12828-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 D'Amato M, Iadarola P, Viglio S. Proteomic Analysis of Human Sputum for the Diagnosis of Lung Disorders: Where Are We Today? Int J Mol Sci 2022;23:5692. [PMID: 35628501 DOI: 10.3390/ijms23105692] [Reference Citation Analysis]
57 Zhang X, Ding K, Miao X, Wang J, Hu B, Shen J, Hu X, Xu Y, Yu B, Tu T, Lin A, Chen X, Huang Y. Associations between bone mineral density and chronic obstructive pulmonary disease. J Int Med Res 2022;50:3000605221094644. [PMID: 35579181 DOI: 10.1177/03000605221094644] [Reference Citation Analysis]
58 He AWJ, Ngai SPC, Cheung K, Lau BWM, Sánchez-vidaña D, Pang MYC. Impacts of Cigarette Smoke (CS) on Muscle Derangement in Rodents—A Systematic Review. Toxics 2022;10:262. [DOI: 10.3390/toxics10050262] [Reference Citation Analysis]
59 Pincikova T, Parrot T, Hjelte L, Högman M, Lisspers K, Ställberg B, Janson C, Malinovschi A, Sandberg JK. MAIT cell counts are associated with the risk of hospitalization in COPD. Respir Res 2022;23:127. [PMID: 35585629 DOI: 10.1186/s12931-022-02045-2] [Reference Citation Analysis]
60 Aldhahir AM, Alqahtani JS, Alghamdi SM, Alqarni AA, Khormi SK, Alwafi H, Samannodi M, Siraj RA, Alhotye M, Naser AY, Hakamy A. Physicians’ Attitudes, Beliefs and Barriers to a Pulmonary Rehabilitation for COPD Patients in Saudi Arabia: A Cross-Sectional Study. Healthcare 2022;10:904. [DOI: 10.3390/healthcare10050904] [Reference Citation Analysis]
61 Kaasgaard M, Rasmussen DB, Løkke A, Vuust P, Hilberg O, Bodtger U. Physiological changes related to 10 weeks of singing for lung health in patients with COPD. BMJ Open Respir Res 2022;9:e001206. [PMID: 35545297 DOI: 10.1136/bmjresp-2022-001206] [Reference Citation Analysis]
62 Song CY, Liu X, Wang YQ, Cao HP, Yang Z, Ma RC, Yin YY, Xie J. Effects of home-based telehealth on the physical condition and psychological status of patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis. Int J Nurs Pract 2022;:e13062. [PMID: 35545098 DOI: 10.1111/ijn.13062] [Reference Citation Analysis]
63 Xu W, Wu J, Feng Y, Zhu J, Cui R. Clinical significance of serum HMGB1 in COPD and correlation with severity of airflow restriction and immune function. Revista Romana de Medicina de Laborator 2022;30:173-81. [DOI: 10.2478/rrlm-2022-0013] [Reference Citation Analysis]
64 Choi YA, Lee JS, Kim YH. Association between physical activity and dynapenia in older adults with COPD: a nationwide survey. Sci Rep 2022;12:7480. [PMID: 35523837 DOI: 10.1038/s41598-022-11504-1] [Reference Citation Analysis]
65 Tang L, Zhong X, Gong H, Tuerxun M, Ma T, Ren J, Xie C, Zheng A, Abudureheman Z, Abudukadeer A, Aini P, Yilamujiang S, Li L. Analysis of the association of ANO3/MUC15, COL4A4, RRBP1, and KLK1 polymorphisms with COPD susceptibility in the Kashi population. BMC Pulm Med 2022;22:178. [PMID: 35513865 DOI: 10.1186/s12890-022-01975-3] [Reference Citation Analysis]
66 Neri T, Celi A, Tinè M, Bernardinello N, Cosio MG, Saetta M, Nieri D, Bazzan E. The Emerging Role of Extracellular Vesicles Detected in Different Biological Fluids in COPD. Int J Mol Sci 2022;23:5136. [PMID: 35563528 DOI: 10.3390/ijms23095136] [Reference Citation Analysis]
67 Zinellu A, Zinellu E, Pau MC, Fois AG, Mellino S, Piras B, Scano V, Fois SS, Mangoni AA, Carru C, Pirina P. A systematic review and meta-analysis of homocysteine concentrations in chronic obstructive pulmonary disease. Clin Exp Med 2022. [PMID: 35513742 DOI: 10.1007/s10238-022-00833-0] [Reference Citation Analysis]
68 Chen H, Oliver BG, Pant A, Olivera A, Poronnik P, Pollock CA, Saad S. Effects of air pollution on human health - Mechanistic evidence suggested by in vitro and in vivo modelling. Environ Res 2022;:113378. [PMID: 35525290 DOI: 10.1016/j.envres.2022.113378] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Abdelaleem NA, Ahmed MK, Mohamed MN, Bayoumi HA. Lung health after tuberculosis: clinical and functional assessment in post-pulmonary tuberculosis Egyptian patients. Egypt J Bronchol 2022;16. [DOI: 10.1186/s43168-022-00123-z] [Reference Citation Analysis]
70 Pellicori P, Cleland JG, Clark AL. Chronic Obstructive Pulmonary Disease and Heart Failure. Cardiology Clinics 2022;40:171-82. [DOI: 10.1016/j.ccl.2021.12.005] [Reference Citation Analysis]
71 Mitra A, Rahmawati L, Lee HP, Kim SA, Han C, Hyun SH, Cho JY. Korean red ginseng water extract inhibits cadmium-induced lung injury via suppressing MAPK/ERK1/2/AP-1 pathway. Journal of Ginseng Research 2022. [DOI: 10.1016/j.jgr.2022.04.003] [Reference Citation Analysis]
72 Zhang L, Wang X, Zhang Y, Chen W. Efficacy and Safety of Single Inhaler Triple Therapy Versus Separate Triple Therapy in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis. Clinical Therapeutics 2022. [DOI: 10.1016/j.clinthera.2022.04.004] [Reference Citation Analysis]
73 Yang IA, Jenkins CR, Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. The Lancet Respiratory Medicine 2022;10:497-511. [DOI: 10.1016/s2213-2600(21)00506-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
74 Yang H, Wang Z, Xiao S, Dai C, Wen X, Wu F, Peng J, Tian H, Zhou Y, Ran P. Association Between Serum Uric Acid and Lung Function in People with and without Chronic Obstructive Pulmonary Disease. COPD 2022;Volume 17:1069-80. [DOI: 10.2147/copd.s356797] [Reference Citation Analysis]
75 Fan L, Sun D, Yang J, Shi X, Shen F, Chen K, Yang J. Association Between Serum Sodium and Long-Term Mortality in Critically Ill Patients with Comorbid Chronic Obstructive Pulmonary Disease: Analysis from the MIMIC-IV Database. COPD 2022;Volume 17:1143-55. [DOI: 10.2147/copd.s353741] [Reference Citation Analysis]
76 Yang T, Cai B, Cao B, Kang J, Wen F, Chen Y, Jian W, Shang H, Wang C. Severity distribution and treatment of chronic obstructive pulmonary disease in China: baseline results of an observational study. Respir Res 2022;23:106. [PMID: 35488337 DOI: 10.1186/s12931-022-02021-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Zhang X, Wang Y, He X, Sun Z, Shi X. Diagnosis of Chronic Obstructive Pulmonary Disease and Regulatory Mechanism of miR-149-3p on Alveolar Inflammatory Factors and Expression of Surfactant Proteins A (SP-A) and D (SP-D) on Lung Surface Mediated by Wnt Pathway. Comput Intell Neurosci 2022;2022:7205016. [PMID: 35463266 DOI: 10.1155/2022/7205016] [Reference Citation Analysis]
78 Hyodo K, Masuko H, Oshima H, Shigemasa R, Kitazawa H, Kanazawa J, Iijima H, Ishikawa H, Kodama T, Nomura A, Kagohashi K, Satoh H, Saito T, Sakamoto T, Hizawa N. Common exacerbation-prone phenotypes across asthma and chronic obstructive pulmonary disease (COPD). PLoS One 2022;17:e0264397. [PMID: 35312711 DOI: 10.1371/journal.pone.0264397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Hawthorne G, Richardson M, Greening NJ, Esliger D, Briggs-Price S, Chaplin EJ, Clinch L, Steiner MC, Singh SJ, Orme MW. A proof of concept for continuous, non-invasive, free-living vital signs monitoring to predict readmission following an acute exacerbation of COPD: a prospective cohort study. Respir Res 2022;23:102. [PMID: 35473718 DOI: 10.1186/s12931-022-02018-5] [Reference Citation Analysis]
80 Tang T, Dou B, Zha HX, Tao LS, Gu ZJ, Liu KY, Xie WP. Factors Related to Activation in Chinese Patients With Chronic Obstructive Pulmonary Disease: A Cross-Sectional Survey Study. J Nurs Res 2022. [PMID: 35471203 DOI: 10.1097/jnr.0000000000000491] [Reference Citation Analysis]
81 Man K, Liu J, Phan KM, Wang K, Lee JY, Sun X, Story M, Saha D, Liao J, Sadat H, Yang Y. Dimensionality-Dependent Mechanical Stretch Regulation of Cell Behavior. ACS Appl Mater Interfaces 2022;14:17081-92. [PMID: 35380801 DOI: 10.1021/acsami.2c01266] [Reference Citation Analysis]
82 Just IA, Fries D, Loewe S, Falk V, Cesarovic N, Kemper D, Edelmann F, Feuerstein A, Haufe FL, Xiloyannis M, Riener R, Schoenrath F. Movement therapy in lung transplantation candidates assisted by a lightweight wearable robot. Assist Technol 2022. [PMID: 35438604 DOI: 10.1080/10400435.2022.2067914] [Reference Citation Analysis]
83 Kako J, Kobayashi M, Kajiwara K, Kimura Y, Oosono Y, Takegata M, Nakano K, Matsuda Y, Nakamura N, Kawashima N, Hirano Y, Kitae M, Yamaguchi K, Iwamoto H, Hattori N, Sawatari H, Shiono S, Ogino H, Nishioka Y, Amano K, Yorke J. Validity and Reliability of the Japanese Version of the Dyspnea-12 Questionnaire in Patients with Lung Cancer. J Pain Symptom Manage 2022:S0885-3924(22)00691-1. [PMID: 35452793 DOI: 10.1016/j.jpainsymman.2022.04.171] [Reference Citation Analysis]
84 Tanaka KI, Shiota S, Sakakibara O, Shimoda M, Takafuji A, Takabatake M, Kadota Y, Kawakami T, Suzuki S, Kawahara M. Exacerbation of Elastase-Induced Emphysema via Increased Oxidative Stress in Metallothionein-Knockout Mice. Biomolecules 2022;12:583. [DOI: 10.3390/biom12040583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
85 Liao S, Chen J, Zhang L, Zhang J, Sun P, Ou-yang Y. Effects of SOCS1-overexpressing dendritic cells on Th17- and Treg-related cytokines in COPD mice. BMC Pulm Med 2022;22. [DOI: 10.1186/s12890-022-01931-1] [Reference Citation Analysis]
86 Gaynor-Sodeifi K, Lewthwaite H, Jenkins AR, Fernandes Belo L, Koch E, Mujaddid A, Raffoul D, Tracey L, Jensen D. The Association between Fat-Free Mass and Exercise Test Outcomes in People with Chronic Obstructive Pulmonary Disease: A Systematic Review. COPD 2022;19:182-205. [PMID: 35410561 DOI: 10.1080/15412555.2022.2049737] [Reference Citation Analysis]
87 de Fays C, Carlier FM, Gohy S, Pilette C. Secretory Immunoglobulin A Immunity in Chronic Obstructive Respiratory Diseases. Cells 2022;11:1324. [DOI: 10.3390/cells11081324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
88 Guiot J, Henket M, Frix A, Gester F, Thys M, Giltay L, Desir C, Moermans C, Njock M, Meunier P, Corhay J, Louis R. Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ? Respir Res 2022;23. [DOI: 10.1186/s12931-022-02006-9] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
89 Hu T, Liu X, Liu Y. Usefulness of Glucose to Lymphocyte Ratio to Predict in-Hospital Mortality in Patients with AECOPD Admitted to the Intensive Care Unit. COPD 2022;19:158-65. [PMID: 35392756 DOI: 10.1080/15412555.2022.2052272] [Reference Citation Analysis]
90 Wang D, Fan G, Wu S, Yang T, Xu J, Yang L, Zhao J, Zhang X, Bai C, Kang J, Ran P, Shen H, Wen F, Huang K, Chen Y, Sun T, Shan G, Lin Y, Xu G, Wang R, Shi Z, Xu Y, Ye X, Song Y, Wang Q, Zhou Y, Li W, Ding L, Wan C, Yao W, Guo Y, Xiao F, Lu Y, Peng X, Zhang B, Xiao D, Wang Z, Bu X, Zhang H, Zhang X, An L, Zhang S, Zhu J, Cao Z, Zhan Q, Yang Y, Liang L, Dai H, Cao B, He J, Wang C; China Pulmonary Health (CPH) Study Group. Development and Validation of a Screening Questionnaire of COPD from a Large Epidemiological Study in China. COPD 2022;19:118-24. [PMID: 35385369 DOI: 10.1080/15412555.2022.2042504] [Reference Citation Analysis]
91 Shlomi D, Cohen J, Alon A, Oberman B, Katz I. Duplicate Prescription Rates of Long-Acting Bronchodilator Inhalers. J Aerosol Med Pulm Drug Deliv 2022. [PMID: 35384737 DOI: 10.1089/jamp.2021.0065] [Reference Citation Analysis]
92 Puah SH, Goh CY, Chan CL, Teoh AKJ, Zhang H, Shen Z, Neo LP. Mobile device: a useful tool to teach inhaler devices to healthcare professionals. BMC Med Educ 2022;22. [DOI: 10.1186/s12909-022-03302-0] [Reference Citation Analysis]
93 Qin J, Wang G, Han D. Benefits of LAMA in patients with asthma-COPD overlap: A systematic review and meta-analysis. Clinical Immunology 2022;237:108986. [DOI: 10.1016/j.clim.2022.108986] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
94 Sanders KJC, Wierts R, van Marken Lichtenbelt WD, de Vos-Geelen J, Plasqui G, Kelders MCJM, Schrauwen-Hinderling VB, Bucerius J, Dingemans AC, Mottaghy FM, Schols AMWJ. Brown adipose tissue activation is not related to hypermetabolism in emphysematous chronic obstructive pulmonary disease patients. J Cachexia Sarcopenia Muscle 2022;13:1329-38. [PMID: 35166050 DOI: 10.1002/jcsm.12881] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Wang GD, Li Q, Han YT, Zhang T. A prospective study on clinical effect and immune regulation on cytokines secreted by Th cells of aerosolized Traditional Chinese Medicine on elderly patients with AECOPD. Phytomedicine Plus 2022. [DOI: 10.1016/j.phyplu.2022.100282] [Reference Citation Analysis]
96 Sulku J, Janson C, Melhus H, Ställberg B, Bröms K, Högman M, Lisspers K, Malinovschi A, Nielsen EI. Changes in critical inhaler technique errors in inhaled COPD treatment – A one-year follow-up study in Sweden. Respiratory Medicine 2022. [DOI: 10.1016/j.rmed.2022.106849] [Reference Citation Analysis]
97 Çolak Y, Nordestgaard BG, Vestbo J, Afzal S, Lange P. Potential clinical implications of targeted spirometry for detection of COPD: A contemporary population-based cohort study. Respiratory Medicine 2022. [DOI: 10.1016/j.rmed.2022.106852] [Reference Citation Analysis]
98 Yan T, Liang XQ, Wang GJ, Wang T, Li WO, Liu Y, Wu LY, Yu KY, Zhu SN, Wang DX, Sessler DI. Prophylactic Penehyclidine Inhalation for Prevention of Postoperative Pulmonary Complications in High-risk Patients: A Double-blind Randomized Trial. Anesthesiology 2022;136:551-66. [PMID: 35226725 DOI: 10.1097/ALN.0000000000004159] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Larcombe AN, Iosifidis T, Foong RE, Berry LJ, Stumbles PA, Strickland DH, Sly PD, Kicic A. Exacerbation of chronic cigarette-smoke induced lung disease by rhinovirus in mice. Respiratory Physiology & Neurobiology 2022;298:103846. [DOI: 10.1016/j.resp.2022.103846] [Reference Citation Analysis]
100 Nyberg A, Lundell S, Pesola U, Audulv Å, Wadell K. Evaluation of a Digital COPD Education Program for Healthcare Professionals in Long-Term Care – A Mixed Methods Study. COPD 2022;Volume 17:905-18. [DOI: 10.2147/copd.s353187] [Reference Citation Analysis]
101 Murata K, Fujita N, Takahashi R. Ninjinyoeito ameliorated cigarette smoke extract-induced apoptosis and inflammation through JNK signaling inhibition in human lung fibroblasts. BMC Complement Med Ther 2022;22:96. [PMID: 35361188 DOI: 10.1186/s12906-022-03574-5] [Reference Citation Analysis]
102 Kadushkin AG, Tahanovich AD, Movchan LV, Dziadzichkina VV, Levandovskaya OV, Shman TV. Nortriptyline overcomes corticosteroid resistance in NK and NKT-like cells from peripheral blood of patients with chronic obstructive pulmonary disease. RRP 2022;8:59-70. [DOI: 10.3897/rrpharmacology.8.75467] [Reference Citation Analysis]
103 Li CL, Lin MH, Tsai YC, Tseng CW, Chang CL, Shen LS, Kuo HC, Liu SF. The Impact of the Age, Dyspnoea, and Airflow Obstruction (ADO) Index on the Medical Burden of Chronic Obstructive Pulmonary Disease (COPD). J Clin Med 2022;11:1893. [PMID: 35407503 DOI: 10.3390/jcm11071893] [Reference Citation Analysis]
104 Lin L, Song Q, Cheng W, Liu C, Zhao YY, Duan JX, Li J, Liu D, Li X, Chen Y, Cai S, Chen P. Comparation of predictive value of CAT and change in CAT in the short term for future exacerbation of chronic obstructive pulmonary disease. Ann Med 2022;54:875-85. [PMID: 35341416 DOI: 10.1080/07853890.2022.2055134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Chen Y, Chen L, Tsao C, Chen Y, Huang C. Effects of a Pedometer-Based Walking Program in Patients with COPD—A Pilot Study. Medicina 2022;58:490. [DOI: 10.3390/medicina58040490] [Reference Citation Analysis]
106 De Luca SN, Brassington K, Chan SMH, Dobric A, Mou K, Seow HJ, Vlahos R. Ebselen prevents cigarette smoke-induced cognitive dysfunction in mice by preserving hippocampal synaptophysin expression. J Neuroinflammation 2022;19. [DOI: 10.1186/s12974-022-02432-y] [Reference Citation Analysis]
107 He G, Dong T, Yang Z, Branstad A, Huang L, Jiang Z. Point-of-care COPD diagnostics: biomarkers, sampling, paper-based analytical devices, and perspectives. Analyst 2022;147:1273-93. [PMID: 35113085 DOI: 10.1039/d1an01702k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Quint J, Montonen J, Singh D, Wachtel H, Attick S, Palli S, Frazer M, Willey V, Giessel G. New insights into the optimal management of COPD: Extracts from CHEST 2021 annual meeting (October 17-20, 2021). Expert Rev Respir Med 2022. [PMID: 35325585 DOI: 10.1080/17476348.2022.2056022] [Reference Citation Analysis]
109 Yang Z, Kwok MK, Schooling CM. Do deaths from competing risks influence COPD patterns in China and high socio-demographic index countries?: a cross-sectional analysis of summary statistics from the Global Burden of Disease Study 2017. BMJ Open 2022;12:e050080. [PMID: 35321891 DOI: 10.1136/bmjopen-2021-050080] [Reference Citation Analysis]
110 Hoffmann C, Maglakelidze M, von Schneidemesser E, Witt C, Hoffmann P, Butler T. Asthma and COPD exacerbation in relation to outdoor air pollution in the metropolitan area of Berlin, Germany. Respir Res 2022;23. [DOI: 10.1186/s12931-022-01983-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
111 Lundell S, Toots A, Sönnerfors P, Halvarsson A, Wadell K. Participatory methods in a digital setting: experiences from the co-creation of an eHealth tool for people with chronic obstructive pulmonary disease. BMC Med Inform Decis Mak 2022;22:68. [PMID: 35303895 DOI: 10.1186/s12911-022-01806-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Polat Ö, Şalk İ, Doğan ÖT. Determination of COPD severity from chest CT images using deep transfer learning network. Multimed Tools Appl 2022;81:21903-17. [DOI: 10.1007/s11042-022-12801-7] [Reference Citation Analysis]
113 Oberholzer L, Mølmen KS, Hammarström D, Falch GS, Meinild Lundby A, Rønnestad BR, Ellefsen S, Lundby C. Resistance exercise training increases skeletal muscle mitochondrial respiration in chronic obstructive pulmonary disease. JCSM Rapid Communications. [DOI: 10.1002/rco2.58] [Reference Citation Analysis]
114 Andreen N, Andersson LM, Sundell N, Gustavsson L, Westin J. Mortality of COVID-19 is associated with comorbidity in patients with chronic obstructive pulmonary disease. Infect Dis (Lond) 2022;:1-6. [PMID: 35287524 DOI: 10.1080/23744235.2022.2050422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Liu YH, Chen Y, Wang QH, Wang LR, Jiang L, Yang Y, Chen X, Li Y, Cen Y, Xu C, Zhu J, Li W, Wang YR, Zhang LL, Liu J, Xu ZQ, Wang YJ. One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study. JAMA Neurol 2022. [PMID: 35258587 DOI: 10.1001/jamaneurol.2022.0461] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 18.0] [Reference Citation Analysis]
116 Ding F, Han L, Fu Q, Fan X, Tang R, Lv C, Xue Y, Tian X, Zhang M. IL-17 Aggravates Pseudomonas aeruginosa Airway Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Front Immunol 2021;12:811803. [PMID: 35095906 DOI: 10.3389/fimmu.2021.811803] [Reference Citation Analysis]
117 Guo X, Lin Y, Lin Y, Zhong Y, Yu H, Huang Y, Yang J, Cai Y, Liu F, Li Y, Zhang QQ, Dai J. PM2.5 induces pulmonary microvascular injury in COPD via METTL16-mediated m6A modification. Environ Pollut 2022;303:119115. [PMID: 35259473 DOI: 10.1016/j.envpol.2022.119115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
118 Ding Q, Li J, Xu S, Gao Y, Guo Y, Xie B, Li H, Wei X. Different Smoking Statuses on Survival and Emphysema in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. COPD 2022;Volume 17:505-15. [DOI: 10.2147/copd.s346456] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
119 Ghimire S, Lamichhane A, Basnet A, Pandey S, Poudel N, Shrestha B, Pathak S, Mahato G, Shrestha RK. Guideline based knowledge and practice of physicians in the management of COPD in a low- to middle-income country. Clin Respir J 2022;16:190-9. [PMID: 35023608 DOI: 10.1111/crj.13468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Cruthirds CL, Deutz NE, Harrykissoon R, Zachria AJ, Engelen MP. A low postabsorptive whole body protein balance is associated with markers of poor daily physical functioning in Chronic Obstructive Pulmonary Disease. Clinical Nutrition 2022. [DOI: 10.1016/j.clnu.2022.02.018] [Reference Citation Analysis]
121 Peng Y, Cheng W, Duan J, Zhao Y, Zhou Z, Zhou A, Deng M, Peng H, Ouyang R, Chen Y, Chen P. Prohibitin Protects Pulmonary Microvascular Endothelial Cells Against Cigarette Smoke Extract-Induced Cell Apoptosis and Inflammation. COPD 2022;Volume 17:653-65. [DOI: 10.2147/copd.s345058] [Reference Citation Analysis]
122 Lin J, Xue Y, Su W, Zhang Z, Wei Q, Huang T. Identification of Dysregulated Mechanisms and Candidate Gene Markers in Chronic Obstructive Pulmonary Disease. COPD 2022;Volume 17:475-87. [DOI: 10.2147/copd.s349694] [Reference Citation Analysis]
123 Jung YJ, Kim EJ, Heo JY, Choi YH, Kim DJ, Ha KH. Short-Term Air Pollution Exposure and Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea: A National Time-Stratified Case-Crossover Study. Int J Environ Res Public Health 2022;19:2823. [PMID: 35270512 DOI: 10.3390/ijerph19052823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
124 Cen J, Weng L. Comparison of peak expiratory Flow(PEF) and COPD assessment test (CAT) to assess COPD exacerbation requiring hospitalization: A prospective observational study. Chron Respir Dis 2022;19:14799731221081859. [PMID: 35209726 DOI: 10.1177/14799731221081859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Li L, Huang H, Song J, Yu Y, Jia Y, Wang Y, Dang X, Huang L, Liu X. Network Meta-Analysis of the Effects of Different Types of Traditional Chinese Exercises on Pulmonary Function, Endurance Capacity and Quality of Life in Patients With COPD. Front Med (Lausanne) 2022;9:806025. [PMID: 35186994 DOI: 10.3389/fmed.2022.806025] [Reference Citation Analysis]
126 Kotlyarov S. Analysis of differentially expressed genes and signaling pathways involved in atherosclerosis and chronic obstructive pulmonary disease. Biomol Concepts 2022;13:34-54. [PMID: 35189051 DOI: 10.1515/bmc-2022-0001] [Reference Citation Analysis]
127 Kiani FZ, Ahmadi A. The Prevalence of Metabolic Syndrome, Scoring, and Comparison in People With and Without COPD: Evidence from Shahrekord PERSIAN Cohort Study. Metab Syndr Relat Disord 2022. [PMID: 35180365 DOI: 10.1089/met.2021.0060] [Reference Citation Analysis]
128 Jasemi SV, Khazaei H, Momtaz S, Farzaei MH, Echeverría J. Natural products in the treatment of pulmonary emphysema: Therapeutic effects and mechanisms of action. Phytomedicine 2022;99:153988. [PMID: 35217434 DOI: 10.1016/j.phymed.2022.153988] [Reference Citation Analysis]
129 Fei Q, Weng X, Liu K, Liu S, Chen J, Guo X, Jing C. The Relationship between Metal Exposure and Chronic Obstructive Pulmonary Disease in the General US Population: NHANES 2015–2016. IJERPH 2022;19:2085. [DOI: 10.3390/ijerph19042085] [Reference Citation Analysis]
130 Wang H, Zhong Y, Li N, Yu M, Zhu L, Wang L, Chen F, Xu Y, Liu J, Huang H. Transcriptomic analysis and validation reveal the pathogenesis and a novel biomarker of acute exacerbation of chronic obstructive pulmonary disease. Respir Res 2022;23. [DOI: 10.1186/s12931-022-01950-w] [Reference Citation Analysis]
131 Hanrahan C, Broderick J, O’connor TM, Mcveigh JG. Behaviour change and physical activity interventions for physical activity engagement in community dwelling adults with chronic obstructive pulmonary disease: protocol for a systematic review. HRB Open Res 2021;4:110. [DOI: 10.12688/hrbopenres.13399.2] [Reference Citation Analysis]
132 Sin S, Lim MN, Kim J, Bak SH, Kim WJ. Association between plasma sRAGE and emphysema according to the genotypes of AGER gene. BMC Pulm Med 2022;22:58. [PMID: 35144588 DOI: 10.1186/s12890-022-01848-9] [Reference Citation Analysis]
133 Yang L, Li M, Shu J, Yang Y, Huang Q. A Risk Prediction Model for Prolonged Length of Stay in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective Study of 225 Patients in a Single Center in Kunming, China. Med Sci Monit 2022;28:e934392. [PMID: 35136009 DOI: 10.12659/MSM.934392] [Reference Citation Analysis]
134 Yu C, Zhang L. Methylprednisolone up-regulates annexin A1 (ANXA1) to inhibit the inflammation, apoptosis and oxidative stress of cigarette smoke extract (CSE)-induced bronchial epithelial cells, a chronic obstructive pulmonary disease in vitro model, through the formyl peptide receptor 2 (FPR2) receptors and the adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) pathway. Bioengineered 2022;13:4028-38. [PMID: 35129068 DOI: 10.1080/21655979.2022.2031769] [Reference Citation Analysis]
135 Xu J, Li L, Ren J, Zhong X, Xie C, Zheng A, Abudukadier A, Tuerxun M, Zhang S, Tang L, Hairoula D, Zou X. Whole-Exome Sequencing Implicates the USP34 rs777591A > G Intron Variant in Chronic Obstructive Pulmonary Disease in a Kashi Cohort. Front Cell Dev Biol 2022;9:792027. [DOI: 10.3389/fcell.2021.792027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Zhong CCW, Wong CHL, Cheung WKW, Yeoh E, Hung CT, Yip BHK, Wong ELY, Wong SYS, Chung VCH. Effectiveness of Peri-Discharge Complex Interventions for Reducing 30-Day Readmissions among COPD Patients: Overview of Systematic Reviews and Network Meta-Analysis. Int J Integr Care 2022;22:7. [DOI: 10.5334/ijic.6018] [Reference Citation Analysis]
137 Taniguchi A, Oda N, Morichika D, Senoo S, Itano J, Fujii U, Guo L, Sunami R, Kiura K, Maeda Y, Miyahara N. Protective effects of neuropeptide Y against elastase-induced pulmonary emphysema. Am J Physiol Lung Cell Mol Physiol 2022. [PMID: 35107033 DOI: 10.1152/ajplung.00353.2020] [Reference Citation Analysis]
138 Wen-Ting LI, Chang-Wei WU, De-Jian B, Wei S. Arterial partial pressure of oxygen and procalcitonin levels correlate with pulmonary artery systolic pressure in patients with active pulmonary tuberculosis. Int J Infect Dis 2022:S1201-9712(22)00070-4. [PMID: 35121127 DOI: 10.1016/j.ijid.2022.01.060] [Reference Citation Analysis]
139 Nogueira Gomes T, Camelo Pereira M, Smith SC, Melgar TA. Lung Herniation Associated With Crack Cocaine Use: An Uncommon Cause of Chest Pain. Cureus. [DOI: 10.7759/cureus.21801] [Reference Citation Analysis]
140 Price DB, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Barille S, Nudo E, Carter V, Skinner D, Vella R, Georges G. Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone. COPD 2022;Volume 17:355-70. [DOI: 10.2147/copd.s342357] [Reference Citation Analysis]
141 Kanouté T, Aurélien S, Daniela M, Denis C, Frédéric C. Prevalence of a decreased FEV3/FEV6 ratio in symptomatic smokers with preserved lung function. Respiratory Medicine and Research 2022. [DOI: 10.1016/j.resmer.2022.100891] [Reference Citation Analysis]
142 Alfano P, Cuttitta G, Audino P, Fazio G, La Grutta S, Marcantonio S, Snamid Palermo Cooperative Group, Bucchieri S. Relationship between Multimorbidity and Quality of Life in a Primary Care Setting: The Mediating Role of Dyspnea. J Clin Med 2022;11:656. [PMID: 35160105 DOI: 10.3390/jcm11030656] [Reference Citation Analysis]
143 Kahnert K, Andreas S, Kellerer C, Lutter JI, Lucke T, Yildirim Ö, Lehmann M, Seissler J, Behr J, Frankenberger M, Bals R, Watz H, Welte T, Trudzinski FC, Vogelmeier CF, Alter P, Jörres RA; COSYCONET Study Group. Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment. Sci Rep 2022;12:1435. [PMID: 35082306 DOI: 10.1038/s41598-022-05276-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Wu F, Fan H, Liu J, Li H, Zeng W, Zheng S, Tian H, Deng Z, Zheng Y, Zhao N, Hu G, Zhou Y, Ran P. Association Between Non-obstructive Chronic Bronchitis and Incident Chronic Obstructive Pulmonary Disease and All-Cause Mortality: A Systematic Review and Meta-Analysis. Front Med 2022;8:805192. [DOI: 10.3389/fmed.2021.805192] [Reference Citation Analysis]
145 Giordano L, Gregory AD, Pérez Verdaguer M, Ware SA, Harvey H, Devallance E, Brzoska T, Sundd P, Zhang Y, Sciurba FC, Shapiro SD, Kaufman BA. Extracellular Release of Mitochondrial DNA: Triggered by Cigarette Smoke and Detected in COPD. Cells 2022;11:369. [DOI: 10.3390/cells11030369] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
146 Lee SW, Park JJ, Lyu YR, Lee EJ, Kim SY, Kang W, Son JW, Jung IC, Park YC. The effect of lung-conduction exercise in chronic obstructive pulmonary disease: Randomized, assessor-blind, multicenter pilot trial. Medicine (Baltimore) 2022;101:e28629. [PMID: 35060543 DOI: 10.1097/MD.0000000000028629] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
147 Schick MA, Schlegel N. Clinical Implication of Phosphodiesterase-4-Inhibition. Int J Mol Sci 2022;23:1209. [PMID: 35163131 DOI: 10.3390/ijms23031209] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
148 Wang C, Feng D, Dong S, He R, Fan B. Dysregulated circulating microRNA‐126 in chronic obstructive pulmonary disease: linkage with acute exacerbation risk, severity degree, and inflammatory cytokines. Clinical Laboratory Analysis. [DOI: 10.1002/jcla.24204] [Reference Citation Analysis]
149 Maniscalco M, Paris D, Cuomo P, Fuschillo S, Ambrosino P, Tramice A, Palomba L, Motta A. Metabolomics of COPD Pulmonary Rehabilitation Outcomes via Exhaled Breath Condensate. Cells 2022;11:344. [DOI: 10.3390/cells11030344] [Reference Citation Analysis]
150 Paolucci T, Pezzi L, Bellomo RG, Spacone A, Giannandrea N, Di Matteo A, Prosperi P, Bernetti A, Mangone M, Agostini F, Saggini R. Tailored patient self-management and supervised, home-based, pulmonary rehabilitation for mild and moderate chronic obstructive pulmonary disease. J Phys Ther Sci 2022;34:49-59. [PMID: 35035080 DOI: 10.1589/jpts.34.49] [Reference Citation Analysis]
151 Chen CYJ, Yew MS, Abisheganaden JA, Xu H. Predictors of Influenza PCR Positivity in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2022;17:25-32. [PMID: 35023911 DOI: 10.2147/COPD.S338757] [Reference Citation Analysis]
152 Yang H, He S, Chen F, Liang L, Pan J. Efficacy and safety of nitrate supplementation on exercise tolerance in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e28578. [PMID: 35029233 DOI: 10.1097/MD.0000000000028578] [Reference Citation Analysis]
153 Dai Z, Zeng H, Cui Y, Chen P, Chen Y. Subgroup analysis reveals higher reliability of the new comprehensive evaluation of Global Initiative for Chronic Obstructive Lung Disease 2019. Sci Rep 2022;12:757. [PMID: 35031681 DOI: 10.1038/s41598-021-04756-w] [Reference Citation Analysis]
154 Muramatsu S, Sato K, Yamashiro T, Doi K. Quantitative measurements of emphysema in ultra-high resolution computed tomography using model-based iterative reconstruction in comparison to that using hybrid iterative reconstruction. Phys Eng Sci Med 2022. [PMID: 35023075 DOI: 10.1007/s13246-021-01091-2] [Reference Citation Analysis]
155 Ho T, Nichols M, Nair G, Radford K, Kjarsgaard M, Huang C, Bhalla A, Lavigne N, Mukherjee M, Surette M, Macri J, Nair P. Iron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease. Respir Res 2022;23:8. [PMID: 35022042 DOI: 10.1186/s12931-022-01929-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Ogata H, Katahira K, Enokizu-ogawa A, Jingushi Y, Ishimatsu A, Taguchi K, Nogami H, Aso H, Moriwaki A, Yoshida M. The association between transfer coefficient of the lung and the risk of exacerbation in asthma-COPD overlap: an observational cohort study. BMC Pulm Med 2022;22. [DOI: 10.1186/s12890-021-01815-w] [Reference Citation Analysis]
157 Koulouris N, Dimakou K, Gourgoulianis K, Tzanakis N, Rapti A, Gaga M, Georgatou N, Steiropoulos P, Karachristos C, Gogali A, Kalafatakis K, Kostikas K. Self-perceived quality of sleep among COPD patients in Greece: the SLEPICO study. Sci Rep 2022;12:540. [PMID: 35017591 DOI: 10.1038/s41598-021-04610-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
158 Yu X, Jiang HY, Zhang CX, Jin ZH, Gao L, Wang RD, Fang JP, Su Y, Xi JN, Fang BY. The Role of the Diaphragm in Postural Stability and Visceral Function in Parkinson's Disease. Front Aging Neurosci 2021;13:785020. [PMID: 35002681 DOI: 10.3389/fnagi.2021.785020] [Reference Citation Analysis]
159 Skurikhin E, Pershina O, Zhukova M, Widera D, Pan E, Pakhomova A, Krupin V, Ermakova N, Skurikhina V, Sandrikina L, Morozov S, Kubatiev A, Dygai A. Spiperone Stimulates Regeneration in Pulmonary Endothelium Damaged by Cigarette Smoke and Lipopolysaccharide. Int J Chron Obstruct Pulmon Dis 2021;16:3575-91. [PMID: 35002229 DOI: 10.2147/COPD.S336410] [Reference Citation Analysis]
160 Mendes Xavier D, Lanza Galvão E, Aliane Fonseca A, de Souza GM, Pereira Lima V. Effects of Home-Based Pulmonary Rehabilitation on Dyspnea, Exercise Capacity, Quality of Life and Impact of the Disease in COPD Patients: A Systematic Review. COPD 2022;:1-29. [PMID: 35000507 DOI: 10.1080/15412555.2021.2020234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Zhou J, Zhang J, Zhou M, Hang J, Zhang M, Han F, Zhu H. The role of long-acting muscarinic antagonist/long-acting β agonist fixed-dose combination treatment for chronic obstructive pulmonary disease in China: a narrative review. J Thorac Dis 2021;13:6453-67. [PMID: 34992824 DOI: 10.21037/jtd-21-961] [Reference Citation Analysis]
162 Zhang D, Zhang H, Li X, Lei S, Wang L, Guo W, Li J. Pulmonary Rehabilitation Programmes Within Three Days of Hospitalization for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Int J Chron Obstruct Pulmon Dis 2021;16:3525-38. [PMID: 34992360 DOI: 10.2147/COPD.S338074] [Reference Citation Analysis]
163 Wu F, Jiang C, Zhou Y, Zheng Y, Tian H, Li H, Deng Z, Zhao N, Chen H, Ran P. Association of Total Airway Count on Computed Tomography with Pulmonary Function Decline in Early-Stage COPD: A Population-Based Prospective Cohort Study. Int J Chron Obstruct Pulmon Dis 2021;16:3437-48. [PMID: 34984001 DOI: 10.2147/COPD.S339029] [Reference Citation Analysis]
164 Fan Z, Zhou B, Liu Y, Sun W, Fang Y, Lu H, Chen D, Lu K, Wu X, Xiao T, Xie W, Bian Q. Optimization and Application of an Efficient and Stable Inhalation Exposure System for Rodents. AAPS PharmSciTech 2022;23:50. [PMID: 34993683 DOI: 10.1208/s12249-021-02191-8] [Reference Citation Analysis]
165 Zhang P, Chen B, Lou H, Zhu Y, Chen P, Dong Z, Zhu X, Li T, Lou P. Predictors and outcomes of obstructive sleep apnea in patients with chronic obstructive pulmonary disease in China. BMC Pulm Med 2022;22:16. [PMID: 34983482 DOI: 10.1186/s12890-021-01780-4] [Reference Citation Analysis]
166 Li W, Song Y, Xiang Q, Wang X, Wei X, Fan T. Effect of different conditioning methods of traditional Chinese health exercise on lung function in healthy middle-aged and elderly people: study protocol for a randomized controlled trial. Trials 2022;23:8. [PMID: 34980233 DOI: 10.1186/s13063-021-05980-5] [Reference Citation Analysis]
167 Wang L, Fei J, Wang X, Xie G, Cao P, Zhang C, Zhao H, Fu L, Cao W. Environmental cadmium positively correlates with autophagy and apoptosis in chronic obstructive pulmonary disease patients. Atmospheric Pollution Research 2022;13:101275. [DOI: 10.1016/j.apr.2021.101275] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Won Y, Lee H. A proposal of spirometry reference equations for Korean workers. Ann Occup Environ Med 2022;34:e14. [DOI: 10.35371/aoem.2022.34.e14] [Reference Citation Analysis]
169 Yoshimatsu Y, Tobino K, Nishizawa S, Yoshimine K, Oku Y. Interferential Current Stimulation for Swallowing Disorders in Chronic Obstructive Pulmonary Disease: A Preliminary Study. PRM 2022;7:n/a. [DOI: 10.2490/prm.20220007] [Reference Citation Analysis]
170 Savadjiev P, Gallix B, Rezanejad M, Bhatnagar S, Semionov A, Siddiqi K, Forghani R, Reinhold C, Eidelman DH, Dandurand RJ. Improved Detection of Chronic Obstructive Pulmonary Disease at Chest CT Using the Mean Curvature of Isophotes. Radiol Artif Intell 2022;4:e210105. [PMID: 35146436 DOI: 10.1148/ryai.210105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Messous S, Trabelsi I, Bel Haj Ali K, Abdelghani A, Ben Daya Y, Razgallah R, Grissa MH, Beltaief K, Mezgar Z, Belguith A, Bouida W, Boukef R, Boubaker H, Msolli MA, Sekma A, Nouira S. Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial. Ther Adv Respir Dis 2022;16:17534666221099729. [PMID: 35657073 DOI: 10.1177/17534666221099729] [Reference Citation Analysis]
172 Yu A, Ding W, Lin W, Cai J, Huang W. Application of pulmonary rehabilitation in patients with pulmonary embolism (Review). Exp Ther Med 2022;23:96. [PMID: 34976138 DOI: 10.3892/etm.2021.11019] [Reference Citation Analysis]
173 Moreira A, Müller M, Costa PF, Kohl Y. Advanced In Vitro Lung Models for Drug and Toxicity Screening: The Promising Role of Induced Pluripotent Stem Cells. Adv Biol (Weinh) 2021;:e2101139. [PMID: 34962104 DOI: 10.1002/adbi.202101139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
174 Alqahtani JS, Al Rajeh AM, Aldhahir AM, Aldabayan YS, Hurst JR, Mandal S. The clinical utility of forced oscillation technique during hospitalisation in patients with exacerbation of COPD. ERJ Open Res 2021;7:00448-2021. [PMID: 34938802 DOI: 10.1183/23120541.00448-2021] [Reference Citation Analysis]
175 Li Q, Sun J, Cao Y, Liu B, Zhao Z, Hu L, Zhang H, Kong Q, Wu J, Dong J. Icaritin inhibited cigarette smoke extract-induced CD8+ T cell chemotaxis enhancement by targeting the CXCL10/CXCR3 axis and TGF-β/Smad2 signaling. Phytomedicine 2021;96:153907. [PMID: 35026517 DOI: 10.1016/j.phymed.2021.153907] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Qin M, Guo A, Li F, Zhang F, Bi M, Zhang Y, Zhu W. Liquiritigenin enhances cyclic adenosine monophosphate production to mitigate inflammation in dendritic cells. Int J Immunopathol Pharmacol 2021;35:20587384211038098. [PMID: 34939873 DOI: 10.1177/20587384211038098] [Reference Citation Analysis]
177 Egoshi S, Horie J, Nakagawa A, Matsunaga Y, Hayashi S. Walking distance in incremental shuttle walking test as a predictor of physical activity in patients diagnosed with low-risk chronic obstructive pulmonary disease. SAGE Open Med 2021;9:20503121211064716. [PMID: 34917386 DOI: 10.1177/20503121211064716] [Reference Citation Analysis]
178 Baker JM, Hammond M, Dungwa J, Shah R, Montero-Fernandez A, Higham A, Lea S, Singh D. Red Blood Cell-Derived Iron Alters Macrophage Function in COPD. Biomedicines 2021;9:1939. [PMID: 34944755 DOI: 10.3390/biomedicines9121939] [Reference Citation Analysis]
179 Takahashi K, Tashiro H, Tajiri R, Takamori A, Uchida M, Kato G, Kurihara Y, Sadamatsu H, Kinoshita T, Yoshida M, Kawaguchi A, Kimura S, Sueoka-Aragane N, Kawayama T; Saga-naïve COPD Physical Activity Evaluation (SCOPE) Study Investigator Group. Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Naïve Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2021;16:3297-307. [PMID: 34908832 DOI: 10.2147/COPD.S338560] [Reference Citation Analysis]
180 Fang H, Zhang M, Zhao C, Yao X, Wang H, Xia H, Yu M. Characteristics of length of stay and cardiovascular pharmacotherapy advice among chronic obstructive pulmonary disease patients. Sci Prog 2021;104:368504211066003. [PMID: 34907809 DOI: 10.1177/00368504211066003] [Reference Citation Analysis]
181 He Q, Zhang M, Feng C. The role of pentraxin3 in plasma and bronchoalveolar lavage fluid in COPD patients with invasive pulmonary aspergillosis. BMC Pulm Med 2021;21:414. [PMID: 34915889 DOI: 10.1186/s12890-021-01793-z] [Reference Citation Analysis]
182 Gao W, Gao L, Yang F, Li Z. Circulating JNK pathway-associated phosphatase: A novel biomarker correlates with Th17 cells, acute exacerbation risk, and severity in chronic obstructive pulmonary disease patients. J Clin Lab Anal 2021;:e24153. [PMID: 34918391 DOI: 10.1002/jcla.24153] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
183 Liu X, Lu X, Hu Z. N-Acetylcysteine (NAC) Inhibits Synthesis of IL-18 in Macrophage by Suppressing NLRP3 Expression to Reduce the Production of IFN-γ from NK Cells. Comput Math Methods Med 2021;2021:7596343. [PMID: 34899969 DOI: 10.1155/2021/7596343] [Reference Citation Analysis]
184 Ali L, Wallström S, Fors A, Barenfeld E, Fredholm E, Fu M, Goudarzi M, Gyllensten H, Lindström Kjellberg I, Swedberg K, Vanfleteren LEGW, Ekman I. Effects of Person-Centered Care Using a Digital Platform and Structured Telephone Support for People With Chronic Obstructive Pulmonary Disease and Chronic Heart Failure: Randomized Controlled Trial. J Med Internet Res 2021;23:e26794. [PMID: 34898447 DOI: 10.2196/26794] [Reference Citation Analysis]
185 Chen X, Luan M, Liu J, Yao Y, Li X, Wang T, Zhang H, Han Y, Lu X, Chen W, Hu X, Zheng M, Qiu X, Zhu T. Risk factors in air pollution exposome contributing to higher levels of TNFα in COPD patients. Environ Int 2021;159:107034. [PMID: 34906887 DOI: 10.1016/j.envint.2021.107034] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Sato R, Hasegawa D, Nishida K, Takahashi K, Schleicher M, Chaisson N. Prevalence of pulmonary embolism in patients with acute exacerbations of COPD: A systematic review and meta-analysis. Am J Emerg Med 2021;50:606-17. [PMID: 34879475 DOI: 10.1016/j.ajem.2021.09.041] [Reference Citation Analysis]
187 Abe Y, Suzuki M, Shima H, Shiraishi Y, Tanabe N, Sato S, Shimizu K, Kimura H, Makita H, Hirai T, Konno S, Nishimura M. Annual Body Weight Change and Prognosis in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2021;16:3243-53. [PMID: 34876811 DOI: 10.2147/COPD.S338908] [Reference Citation Analysis]
188 Ajimizu H, Ozasa H, Sato S, Funazo T, Sakamori Y, Nomizo T, Kuninaga K, Ogimoto T, Hosoya K, Yamazoe M, Tsuji T, Yoshida H, Itotani R, Ueno K, Kim YH, Muro S, Hirai T. Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer. Sci Rep 2021;11:23677. [PMID: 34880386 DOI: 10.1038/s41598-021-03139-5] [Reference Citation Analysis]
189 Hao W, Lin F, Shi H, Guan Z, Jiang Y. Long non-coding RNA OIP5-AS1 regulates smoke-related chronic obstructive pulmonary disease via targeting micro RNA -410-3p/IL-13. Bioengineered 2021;12:11664-76. [PMID: 34872453 DOI: 10.1080/21655979.2021.2000199] [Reference Citation Analysis]
190 Smith MC, Ashdown HF, Sheppard JP, Butler CC, Bankhead C. Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a retrospective cohort study in the Clinical Practice Research Datalink. BMJ Open 2021;11:e050757. [PMID: 34876426 DOI: 10.1136/bmjopen-2021-050757] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
191 Liu B, Zan S, Luo W. Safety evaluation of revefenacin at the approved dose in patients with chronic obstructive pulmonary disease: A meta-analysis. Heart Lung 2021;52:52-60. [PMID: 34875569 DOI: 10.1016/j.hrtlng.2021.11.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
192 Kim W, Moll M, Qiao D, Hobbs BD, Shrine N, Sakornsakolpat P, Tobin MD, Dudbridge F, Wain LV, Ladd-Acosta C, Chatterjee N, Silverman EK, Cho MH, Beaty TH. Interaction of Cigarette Smoking and Polygenic Risk Score on Reduced Lung Function. JAMA Netw Open 2021;4:e2139525. [PMID: 34913977 DOI: 10.1001/jamanetworkopen.2021.39525] [Reference Citation Analysis]
193 Pavitt MJ, Lewis A, Buttery SC, Fernandez BO, Mikus-Lelinska M, Banya WAS, Feelisch M, Polkey MI, Hopkinson NS. Dietary nitrate supplementation to enhance exercise capacity in hypoxic COPD: EDEN-OX, a double-blind, placebo-controlled, randomised cross-over study. Thorax 2021:thoraxjnl-2021-217147. [PMID: 34853156 DOI: 10.1136/thoraxjnl-2021-217147] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
194 Wang Y, Yin X, Xie M, Wang Q, Wang W, Yi W, Yu J. Asymptomatic Patients with Airflow Limitation are at Higher Risk of Postoperative Pulmonary Complications After Lung Surgeries: An Ambispective Cohort Study. COPD 2021;Volume 16:3465-75. [DOI: 10.2147/copd.s338758] [Reference Citation Analysis]
195 Ruzieh M, Baugh AD, Al Jebbawi L, Edwards ES, Jia KQ, Dransfield MT, Foy AJ. Beta-blocker use in patients with chronic obstructive pulmonary disease: A systematic review: A systematic review of βB in COPD. Trends Cardiovasc Med 2021:S1050-1738(21)00139-0. [PMID: 34856338 DOI: 10.1016/j.tcm.2021.11.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
196 Cardoso J, Ferreira AJ, Guimarães M, Oliveira AS, Simão P, Sucena M. Treatable Traits in COPD - A Proposed Approach. Int J Chron Obstruct Pulmon Dis 2021;16:3167-82. [PMID: 34824530 DOI: 10.2147/COPD.S330817] [Reference Citation Analysis]
197 Aldhahir AM, Alghamdi SM, Alqahtani JS, Alqahtani KA, Al Rajah AM, Alkhathlan BS, Singh SJ, Mandal S, Hurst JR. Pulmonary rehabilitation for COPD: A narrative review and call for further implementation in Saudi Arabia. Ann Thorac Med 2021;16:299-305. [PMID: 34820017 DOI: 10.4103/atm.atm_639_20] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
198 Chen L, Chen L, Zheng H, Wu S, Wang S. The association of blood urea nitrogen levels upon emergency admission with mortality in acute exacerbation of chronic obstructive pulmonary disease. Chron Respir Dis 2021;18:14799731211060051. [PMID: 34806456 DOI: 10.1177/14799731211060051] [Reference Citation Analysis]
199 Carlson SA, Wheaton AG, Liu Y, Moore LV, Eke PI, Croft JB, Greenlund KJ, Thomas CW. Associations of self-reported chronic obstructive pulmonary disease with indicators of economic instability and stress - 16 states, 2017. Chronic Illn 2021;:17423953211059144. [PMID: 34812655 DOI: 10.1177/17423953211059144] [Reference Citation Analysis]
200 Lee MK, Kim SB, Shin B. Differences in the clinical characteristics of chronic pulmonary aspergillosis according to spirometric impairment. PLoS One 2021;16:e0260274. [PMID: 34807947 DOI: 10.1371/journal.pone.0260274] [Reference Citation Analysis]
201 de-Miguel-Diez J, Jimenez-Garcia R, Hernandez-Barrera V, de-Miguel-Yanes JM, Carabantes-Alarcon D, Lopez-de-Andres A. Assessing the Impact of Gender and COPD on the Incidence and Mortality of Hospital-Acquired Pneumonia. A Retrospective Cohort Study Using the Spanish National Discharge Database (2016-2019). J Clin Med 2021;10:5453. [PMID: 34830733 DOI: 10.3390/jcm10225453] [Reference Citation Analysis]
202 Park S, Kim SW, Rhee CK, Kim K, Kim WJ, Yoo KH, Lee CY, Kim DK, Park YB, Jung KS, Lee JH. Effect of low protein intake on acute exacerbations in mild to moderate chronic obstructive pulmonary disease: data from the 2007-2012 KNHANES. J Thorac Dis 2021;13:5592-603. [PMID: 34795910 DOI: 10.21037/jtd-20-3433] [Reference Citation Analysis]
203 Wang Y, Su T, Feng S, Chen J, Tian X, Zhu L. Evaluation of the cross-sectional area of small pulmonary vessels in the diagnosis of chronic obstructive pulmonary disease by quantitative computed tomography: A case-control study. Medicine (Baltimore) 2021;100:e27622. [PMID: 34797285 DOI: 10.1097/MD.0000000000027622] [Reference Citation Analysis]
204 Oca MM, Varela MVL, Menezes AMB, Wehrmeister FC, Ramirez L, Miravitlles M. Respiratory symptoms (COPD Assessment Test and modified Medical Research Council dyspnea scores) and GOLD-ABCD COPD classification: the LASSYC study. J Bras Pneumol 2021;47:e20210156. [PMID: 34787288 DOI: 10.36416/1806-3756/e20210156] [Reference Citation Analysis]
205 Lackey L, Coria A, Ghosh AJ, Grayeski P, Hatfield A, Shankar V, Platig J, Xu Z, Ramos SBV, Silverman EK, Ortega VE, Cho MH, Hersh CP, Hobbs BD, Castaldi P, Laederach A. Alternative poly-adenylation modulates α1-antitrypsin expression in chronic obstructive pulmonary disease. PLoS Genet 2021;17:e1009912. [PMID: 34784346 DOI: 10.1371/journal.pgen.1009912] [Reference Citation Analysis]
206 McDowell G, Sumowski M, Toellner H, Karok S, O'Dwyer C, Hornsby J, Lowe DJ, Carlin CM. Assistive technologies for home NIV in patients with COPD: feasibility and positive experience with remote-monitoring and volume-assured auto-EPAP NIV mode. BMJ Open Respir Res 2021;8:e000828. [PMID: 34782327 DOI: 10.1136/bmjresp-2020-000828] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
207 Chen H, Zhang X, Luo J, Dong X, Jiang X. The association between periodontitis and lung function: results from NHANES 2009-2012. J Periodontol 2021. [PMID: 34787900 DOI: 10.1002/JPER.21-0399] [Reference Citation Analysis]
208 Otake S, Chubachi S, Nakayama S, Sakurai K, Irie H, Hashiguchi M, Itabashi Y, Yamada Y, Jinzaki M, Murata M, Nakamura H, Asano K, Fukunaga K. Clinical Utility of the Electrocardiographic P-Wave Axis in Patients with Chronic Obstructive Pulmonary Disease. Respiration 2021;:1-8. [PMID: 34784604 DOI: 10.1159/000519668] [Reference Citation Analysis]
209 Kim EK, Kim MA, Lee JS, Lee SM, Lim S, Park J, Kim JH, Oh YM, Lee SD, Lee SH, Lee JH; KOLD Study Group. Clinical Impact of the Bronchiectasis with Chronic Bronchitis Symptoms in COPD: Analysis of a Longitudinal Cohort. Int J Chron Obstruct Pulmon Dis 2021;16:2997-3008. [PMID: 34754185 DOI: 10.2147/COPD.S332299] [Reference Citation Analysis]
210 Sarwar F, Alam K, Chow CW, Saeed M, Malik RN. Pulmonary Dysfunction Augmenting Bacterial Aerosols in Leather Tanneries of Punjab, Pakistan. Int J Chron Obstruct Pulmon Dis 2021;16:2925-37. [PMID: 34737557 DOI: 10.2147/COPD.S328129] [Reference Citation Analysis]
211 Kadushkin AG, Tahanovich AD, Movchan LV, Kolesnikova TS, Khadasouskaya EV, Shman TV. The Effect of Glucocorticoids in Combination with Azithromycin or Theophylline on Cytokine Production by NK and NKT-Like Blood Cells of Patients with Chronic Obstructive Pulmonary Disease. Biochem Moscow Suppl Ser B 2021;15:337-44. [DOI: 10.1134/s1990750821040053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Men WJ, Cheng LY, Chen MY, Zhang XY, Zhang Y, Zhou K. Study on pharmacokinetics of eight active compounds from Bufei-Huoxue Capsule based on UHPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2021;1184:122974. [PMID: 34655890 DOI: 10.1016/j.jchromb.2021.122974] [Reference Citation Analysis]
213 Njoroge MW, Mjojo P, Chirwa C, Rylance S, Nightingale R, Gordon SB, Mortimer K, Burney P, Balmes J, Rylance J, Obasi A, Niessen LW, Devereux G; IMPALA consortium. Changing lung function and associated health-related quality-of-life: A five-year cohort study of Malawian adults. EClinicalMedicine 2021;41:101166. [PMID: 34712931 DOI: 10.1016/j.eclinm.2021.101166] [Reference Citation Analysis]
214 Zinellu E, Zinellu A, Pau MC, Piras B, Fois AG, Mellino S, Carru C, Mangoni AA, Pirina P. Glutathione Peroxidase in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis. Antioxidants (Basel) 2021;10:1745. [PMID: 34829616 DOI: 10.3390/antiox10111745] [Reference Citation Analysis]
215 Ali HAEM, Al-adl AS. Neurophysiological biomarkers of peripheral nervous system affection in patients with stable chronic obstructive pulmonary disease (COPD). Egypt J Neurol Psychiatry Neurosurg 2021;57. [DOI: 10.1186/s41983-021-00400-6] [Reference Citation Analysis]
216 Ram S, Han MK. X-ray dark field imaging: a tool for early diagnosis of emphysema in chronic obstructive pulmonary disease? Lancet Digit Health 2021;3:e691-2. [PMID: 34711374 DOI: 10.1016/S2589-7500(21)00230-2] [Reference Citation Analysis]
217 Nieri D, Daniele M, Lombardi S, Bazzan E, Santerini S, De Cusatis G, Vagaggini B, Cosio MG, Saetta M, Paggiaro P, Celi A, Neri T. Circulating Extracellular Vesicles Are Associated with Disease Severity and Interleukin-6 Levels in COPD: A Pilot Study. J Clin Med 2021;10:5014. [PMID: 34768536 DOI: 10.3390/jcm10215014] [Reference Citation Analysis]
218 Ding Q, Wei X, Li J, Gao YZ, Xu SD, Yu N, Mi JY, Mi BB, Guo YM. Role of the Emphysema Index Combined with the Chronic Obstructive Pulmonary Disease Assessment Test Score in the Evaluation of Chronic Obstructive Pulmonary Disease. Can Respir J 2021;2021:9996305. [PMID: 34691315 DOI: 10.1155/2021/9996305] [Reference Citation Analysis]
219 Tomaich A, Klatt S, Nagy MW. Narrative Literature Review Guided Approach of Inhaled Corticosteroid de-escalation in Chronic Obstructive Pulmonary Disease. J Pharm Pract 2021;:8971900211053771. [PMID: 34697964 DOI: 10.1177/08971900211053771] [Reference Citation Analysis]
220 Xiang L, Meng X. Emerging cellular and molecular interactions between the lung microbiota and lung diseases. Crit Rev Microbiol 2021;:1-34. [PMID: 34693852 DOI: 10.1080/1040841X.2021.1992345] [Reference Citation Analysis]
221 Fujioka N, Kitabatake M, Ouji-Sageshima N, Ibaraki T, Kumamoto M, Fujita Y, Hontsu S, Yamauchi M, Yoshikawa M, Muro S, Ito T. Human Adipose-Derived Mesenchymal Stem Cells Ameliorate Elastase-Induced Emphysema in Mice by Mesenchymal-Epithelial Transition. Int J Chron Obstruct Pulmon Dis 2021;16:2783-93. [PMID: 34675503 DOI: 10.2147/COPD.S324952] [Reference Citation Analysis]
222 O'Sullivan KJ, Power V, Linnane B, McGrath D, Fogarty H, Ryan M, White R, Noonan C, Mulloy E, O'Sullivan LW, Dunne CP. An initial evaluation of the safety of a disposable oscillating positive expiratory pressure device in patients with chronic obstructive pulmonary disease: a sort-term pilot study. BMC Pulm Med 2021;21:326. [PMID: 34666748 DOI: 10.1186/s12890-021-01689-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
223 Bukhari I, Ashfaq M, Nisa BU, Ahmed A, Waseem H, Yasir M. Comparison of the Effects of Beclomethasone Dipropionate and Budesonide in the Treatment of Children with Mild, Persistent Asthma. Cureus 2021;13:e17943. [PMID: 34660132 DOI: 10.7759/cureus.17943] [Reference Citation Analysis]
224 Yu S, Zhang C, Yan Z, Fang Q, Gao X. Tiotropium Bromide Attenuates Mucus Hypersecretion in Patients with Stable Chronic Obstructive Pulmonary Disease. Comput Math Methods Med 2021;2021:1341644. [PMID: 34650619 DOI: 10.1155/2021/1341644] [Reference Citation Analysis]
225 Jiang YL, Fei J, Cao P, Zhang C, Tang MM, Cheng JY, Zhao H, Fu L. Serum cadmium positively correlates with inflammatory cytokines in patients with chronic obstructive pulmonary disease. Environ Toxicol 2022;37:151-60. [PMID: 34652871 DOI: 10.1002/tox.23386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
226 Chen L, Chen S. Prediction of readmission in patients with acute exacerbation of chronic obstructive pulmonary disease within one year after treatment and discharge. BMC Pulm Med 2021;21:320. [PMID: 34654406 DOI: 10.1186/s12890-021-01692-3] [Reference Citation Analysis]
227 Fathinavid A, Ghobadi MZ, Najafi A, Masoudi-Nejad A. Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis. BMC Genom Data 2021;22:41. [PMID: 34635059 DOI: 10.1186/s12863-021-00986-z] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
228 Araya J, Kuwano K. Cellular senescence-an aging hallmark in chronic obstructive pulmonary disease pathogenesis. Respir Investig 2021:S2212-5345(21)00158-1. [PMID: 34649812 DOI: 10.1016/j.resinv.2021.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
229 Cheng W, Duan J, Zhou A, Zhao Y, Yi R, Liu Y, Deng D, Li X, Zeng Y, Peng Y, Song Q, Lin L, Yang M, Chen P. Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study. Front Pharmacol 2021;12:753653. [PMID: 34621178 DOI: 10.3389/fphar.2021.753653] [Reference Citation Analysis]
230 Ladeira I, Oliveira P, Gomes J, Lima R, Guimarães M. Can static hyperinflation predict exercise capacity in COPD? Pulmonology 2021:S2531-0437(21)00188-4. [PMID: 34629326 DOI: 10.1016/j.pulmoe.2021.08.011] [Reference Citation Analysis]
231 Dobric A, De Luca SN, Spencer SJ, Bozinovski S, Saling MM, McDonald CF, Vlahos R. Novel pharmacological strategies to treat cognitive dysfunction in chronic obstructive pulmonary disease. Pharmacol Ther 2021;:108017. [PMID: 34626675 DOI: 10.1016/j.pharmthera.2021.108017] [Reference Citation Analysis]
232 Chu SH, Wan ES, Cho MH, Goryachev S, Gainer V, Linneman J, Scotty EJ, Hebbring SJ, Murphy S, Lasky-Su J, Weiss ST, Smoller JW, Karlson E. An independently validated, portable algorithm for the rapid identification of COPD patients using electronic health records. Sci Rep 2021;11:19959. [PMID: 34620889 DOI: 10.1038/s41598-021-98719-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
233 Peng Y, Duan J, Li X, Zeng Y, Zhou Z, Deng M, Ouyang R, Chen Y, Cai S, Chen P. Adherence to Inhaled Therapy in Patients with COPD Associated to Pneumoconiosis. Int J Chron Obstruct Pulmon Dis 2021;16:2697-706. [PMID: 34611398 DOI: 10.2147/COPD.S327686] [Reference Citation Analysis]
234 Kupeli A, Bulut E, Unver E, Danisan G. The relationship between vertebral deformities and thoracic arthropathy with back pain in Chronic Obstructive Pulmonary Disease. Int J Clin Pract 2021;:e14953. [PMID: 34610196 DOI: 10.1111/ijcp.14953] [Reference Citation Analysis]
235 Sun L, Xu A, Li M, Xia X, Li P, Han R, Fei G, Zhou S, Wang R. Effect of Methylation Status of lncRNA-MALAT1 and MicroRNA-146a on Pulmonary Function and Expression Level of COX2 in Patients With Chronic Obstructive Pulmonary Disease. Front Cell Dev Biol 2021;9:667624. [PMID: 34604205 DOI: 10.3389/fcell.2021.667624] [Reference Citation Analysis]
236 Goolam Mahomed T, Peters RPH, Allam M, Ismail A, Mtshali S, Goolam Mahomed A, Ueckermann V, Kock MM, Ehlers MM. Lung microbiome of stable and exacerbated COPD patients in Tshwane, South Africa. Sci Rep 2021;11:19758. [PMID: 34611216 DOI: 10.1038/s41598-021-99127-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
237 Stöber A, Lutter JI, Schwarzkopf L, Kirsch F, Schramm A, Vogelmeier CF, Leidl R. Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data. Int J Chron Obstruct Pulmon Dis 2021;16:2637-51. [PMID: 34588773 DOI: 10.2147/COPD.S313711] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 García-Fernández A, Sancenón F, Martínez-Máñez R. Mesoporous silica nanoparticles for pulmonary drug delivery. Adv Drug Deliv Rev 2021;177:113953. [PMID: 34474094 DOI: 10.1016/j.addr.2021.113953] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
239 Marcos PJ, Otero González I, Pernas Ónega Y, Delgado-roel M, Montero-martínez C. Prevalence of Clinical COPD Phenotypes in Patients Who Are Candidates for Lung Transplantation, Complications and Post-Transplant Survival. Open Respiratory Archives 2021;3:100133. [DOI: 10.1016/j.opresp.2021.100133] [Reference Citation Analysis]
240 Hanrahan C, Broderick J, O’connor TM, Mcveigh JG. Behaviour change and physical activity interventions for physical activity engagement in community dwelling adults with chronic obstructive pulmonary disease: protocol for a systematic review. HRB Open Res 2021;4:110. [DOI: 10.12688/hrbopenres.13399.1] [Reference Citation Analysis]
241 Weiden MD, Singh A, Goldfarb DG, Putman B, Zeig-Owens R, Schwartz T, Cohen HW, Prezant DJ. Serum Th-2 cytokines and FEV1 decline in WTC-exposed firefighters: A 19-year longitudinal study. Am J Ind Med 2021;64:845-52. [PMID: 34288008 DOI: 10.1002/ajim.23276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
242 Lavorini F, Chudek J, Gálffy G, Pallarés-Sanmartin A, Pelkonen AS, Rytilä P, Syk J, Szilasi M, Tamási L, Xanthopoulos A, Haahtela T. Switching to the Dry-Powder Inhaler Easyhaler®: A Narrative Review of the Evidence. Pulm Ther 2021;7:409-27. [PMID: 34581994 DOI: 10.1007/s41030-021-00174-5] [Reference Citation Analysis]
243 Egervall K, Rosso A, Elmståhl S. Association between cardiovascular disease- and inflammation-related serum biomarkers and poor lung function in elderly. Clin Proteomics 2021;18:23. [PMID: 34583636 DOI: 10.1186/s12014-021-09329-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
244 Strong J, Weems L, Burgon T, Branch J, Martin J, Paculdo D, Tamondong-Lachica D, Cruz J, Peabody J. Initiative to Improve Evidence-Based Chronic Obstructive Pulmonary Disease Hospitalist Care Using a Novel On-Line Gamification Patient Simulation Tool: A Prospective Study. Healthcare (Basel) 2021;9:1267. [PMID: 34682947 DOI: 10.3390/healthcare9101267] [Reference Citation Analysis]
245 Shah CH, Reed RM, Liang Y, Zafari Z. Association between lung function and future risks of diabetes, asthma, myocardial infarction, hypertension and all-cause mortality. ERJ Open Res 2021;7:00178-2021. [PMID: 34549046 DOI: 10.1183/23120541.00178-2021] [Reference Citation Analysis]
246 Zhang Y, Ren L, Sun J, Han F, Guo X. Increased Serum Soluble Interleukin-2 Receptor Associated with Severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2021;16:2561-73. [PMID: 34522094 DOI: 10.2147/COPD.S321904] [Reference Citation Analysis]
247 van Riel SE, Klipstein-Grobusch K, Barth RE, Grobbee DE, Feldman C, Shaddock E, Stacey SL, Venter WDF, Vos AG. Predictors of impaired pulmonary function in people living with HIV in an urban African setting. South Afr J HIV Med 2021;22:1252. [PMID: 34522426 DOI: 10.4102/sajhivmed.v22i1.1252] [Reference Citation Analysis]
248 Ting MJ, Tsai YH, Chuang SP, Wang PH, Cheng SL. Is PM2.5 associated with emergency department visits for mechanical ventilation in acute exacerbation of chronic obstructive pulmonary disease? Am J Emerg Med 2021;50:566-73. [PMID: 34583244 DOI: 10.1016/j.ajem.2021.09.024] [Reference Citation Analysis]
249 Kraemer R, Smith HJ, Gardin F, Barandun J, Minder S, Kern L, Brutsche MH. Bronchodilator Response in Patients with COPD, Asthma-COPD-Overlap (ACO) and Asthma, Evaluated by Plethysmographic and Spirometric z-Score Target Parameters. Int J Chron Obstruct Pulmon Dis 2021;16:2487-500. [PMID: 34511893 DOI: 10.2147/COPD.S319220] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
250 Meteran H, Sivapalan P, Stæhr Jensen JU. Treatment Response Biomarkers in Asthma and COPD. Diagnostics (Basel) 2021;11:1668. [PMID: 34574009 DOI: 10.3390/diagnostics11091668] [Reference Citation Analysis]
251 Kellerer C, Jörres RA, Schneider A, Alter P, Kauczor HU, Jobst B, Biederer J, Bals R, Watz H, Behr J, Kauffmann-Guerrero D, Lutter J, Hapfelmeier A, Magnussen H, Trudzinski FC, Welte T, Vogelmeier CF, Kahnert K. Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET. Respir Res 2021;22:242. [PMID: 34503520 DOI: 10.1186/s12931-021-01837-2] [Reference Citation Analysis]
252 Janjua S, Pike KC, Carr R, Coles A, Fortescue R, Batavia M. Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev 2021;9:CD013381. [PMID: 34496032 DOI: 10.1002/14651858.CD013381.pub2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
253 Heo J, Moon DH, Hong Y, Bak SH, Kim J, Park JH, Oh BD, Kim YS, Kim WJ. Word Embedding Reveals Cyfra 21-1 as a Biomarker for Chronic Obstructive Pulmonary Disease. J Korean Med Sci 2021;36:e224. [PMID: 34490754 DOI: 10.3346/jkms.2021.36.e224] [Reference Citation Analysis]
254 Robinson SA, Cooper JA Jr, Goldstein RL, Polak M, Cruz Rivera PN, Gagnon DR, Samuelson A, Moore S, Kadri R, Richardson CR, Moy ML. A randomised trial of a web-based physical activity self-management intervention in COPD. ERJ Open Res 2021;7:00158-2021. [PMID: 34476247 DOI: 10.1183/23120541.00158-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
255 Kelly N, Winning L, Irwin C, Lundy FT, Linden D, McGarvey L, Linden GJ, El Karim IA. Periodontal status and chronic obstructive pulmonary disease (COPD) exacerbations: a systematic review. BMC Oral Health 2021;21:425. [PMID: 34479518 DOI: 10.1186/s12903-021-01757-z] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
256 Papp-Zipernovszky O, Csabai M, Schulz PJ, Varga JT. Does Health Literacy Reinforce Disease Knowledge Gain? A Prospective Observational Study of Hungarian COPD Patients. J Clin Med 2021;10:3990. [PMID: 34501438 DOI: 10.3390/jcm10173990] [Reference Citation Analysis]
257 Artzy-Schnirman A, Arber Raviv S, Doppelt Flikshtain O, Shklover J, Korin N, Gross A, Mizrahi B, Schroeder A, Sznitman J. Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics. Adv Drug Deliv Rev 2021;176:113901. [PMID: 34331989 DOI: 10.1016/j.addr.2021.113901] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
258 Xie W, Dumas O, Varraso R, Boggs KM, Camargo CA Jr, Stokes AC. Association of Occupational Exposure to Inhaled Agents in Operating Rooms With Incidence of Chronic Obstructive Pulmonary Disease Among US Female Nurses. JAMA Netw Open 2021;4:e2125749. [PMID: 34542617 DOI: 10.1001/jamanetworkopen.2021.25749] [Reference Citation Analysis]
259 Bhattarai B, Walpola R, Khan S, Mey A. Factors associated with medication adherence among people living with COPD: Pharmacists' perspectives. Exploratory Research in Clinical and Social Pharmacy 2021;3:100049. [DOI: 10.1016/j.rcsop.2021.100049] [Reference Citation Analysis]
260 Ancel J, Belgacemi R, Diabasana Z, Perotin JM, Bonnomet A, Dewolf M, Launois C, Mulette P, Deslée G, Polette M, Dormoy V. Impaired Ciliary Beat Frequency and Ciliogenesis Alteration during Airway Epithelial Cell Differentiation in COPD. Diagnostics (Basel) 2021;11:1579. [PMID: 34573921 DOI: 10.3390/diagnostics11091579] [Reference Citation Analysis]
261 Ragland MF, Strand M, Baraghoshi D, Young KA, Kinney GL, Austin E, Hokanson JE, Regan E, Crapo J, Silverman EK, Make B; COPDGene Investigators. 10 Year Follow-up of Lung Function, Respiratory Symptoms, and Functional Capacity in the COPDGene Study. Ann Am Thorac Soc 2021. [PMID: 34461026 DOI: 10.1513/AnnalsATS.202007-873OC] [Reference Citation Analysis]
262 Beghé B, Cerri S, Fabbri LM, Marchioni A. COPD, Pulmonary Fibrosis and ILAs in Aging Smokers: The Paradox of Striking Different Responses to the Major Risk Factors. Int J Mol Sci 2021;22:9292. [PMID: 34502194 DOI: 10.3390/ijms22179292] [Reference Citation Analysis]
263 Henoch I, Ekberg-Jansson A, Löfdahl CG, Strang P. Benefits, for patients with late stage chronic obstructive pulmonary disease, of being cared for in specialized palliative care compared to hospital. A nationwide register study. BMC Palliat Care 2021;20:130. [PMID: 34429078 DOI: 10.1186/s12904-021-00826-y] [Reference Citation Analysis]
264 Lewis BW, Ford ML, Rogers LK, Britt RD Jr. Oxidative Stress Promotes Corticosteroid Insensitivity in Asthma and COPD. Antioxidants (Basel) 2021;10:1335. [PMID: 34572965 DOI: 10.3390/antiox10091335] [Reference Citation Analysis]
265 Liu S, Zhou Y, Zou W, Tan X, Ran P. Prevalence and characteristics of chronic obstructive pulmonary disease in China with a diagnostic criterion of FEV1/FVC less than the lower limit of normal-a reanalysis of Chinese epidemiological survey of COPD (CESCOPD) study. J Thorac Dis 2021;13:4043-53. [PMID: 34422334 DOI: 10.21037/jtd-21-95] [Reference Citation Analysis]
266 Halner A, Beer S, Pullinger R, Bafadhel M, Russell REK. Predicting treatment outcomes following an exacerbation of airways disease. PLoS One 2021;16:e0254425. [PMID: 34415919 DOI: 10.1371/journal.pone.0254425] [Reference Citation Analysis]
267 Booke H, Dalchow C, Booke M. Almost complete airway occlusion due to an internal laryngocele. Oxf Med Case Reports 2021;2021:omab067. [PMID: 34408890 DOI: 10.1093/omcr/omab067] [Reference Citation Analysis]
268 Huang YT, Wencker M, Driehuys B. Imaging in alpha-1 antitrypsin deficiency: a window into the disease. Ther Adv Chronic Dis 2021;12_suppl:20406223211024523. [PMID: 34408834 DOI: 10.1177/20406223211024523] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
269 Jahanian F, Khatir IG, Ahidashti HA, Amirifard S. The Effect of Intravenous Magnesium Sulphate as an Adjuvant in the Treatment of Acute Exacerbations of COPD in the Emergency Department: A Double-Blind Randomized Clinical Trial. Ethiop J Health Sci 2021;31:267-74. [PMID: 34158778 DOI: 10.4314/ejhs.v31i2.9] [Reference Citation Analysis]
270 Lytras T, Beckmeyer-Borowko A, Kogevinas M, Kromhout H, Carsin AE, Antó JM, Bentouhami H, Weyler J, Heinrich J, Nowak D, Urrutia I, Martínez-Moratalla J, Gullón JA, Pereira Vega A, Raherison Semjen C, Pin I, Demoly P, Leynaert B, Villani S, Gislason T, Svanes Ø, Holm M, Forsberg B, Norbäck D, Mehta AJ, Keidel D, Vernez D, Benke G, Jõgi R, Torén K, Sigsgaard T, Schlünssen V, Olivieri M, Blanc PD, Watkins J, Bono R, Squillacioti G, Buist AS, Vermeulen R, Jarvis D, Probst-Hensch N, Zock JP. Cumulative Occupational Exposures and Lung-Function Decline in Two Large General-Population Cohorts. Ann Am Thorac Soc 2021;18:238-46. [PMID: 33090904 DOI: 10.1513/AnnalsATS.202002-113OC] [Reference Citation Analysis]
271 Huber MB, Schneider N, Kirsch F, Schwarzkopf L, Schramm A, Leidl R. Long-term weight gain in obese COPD patients participating in a disease management program: a risk factor for reduced health-related quality of life. Respir Res 2021;22:226. [PMID: 34391434 DOI: 10.1186/s12931-021-01787-9] [Reference Citation Analysis]
272 Adler D, Bailly S, Soccal PM, Janssens JP, Sapène M, Grillet Y, Stach B, Tamisier R, Pépin JL. Symptomatic response to CPAP in obstructive sleep apnea versus COPD- obstructive sleep apnea overlap syndrome: Insights from a large national registry. PLoS One 2021;16:e0256230. [PMID: 34383866 DOI: 10.1371/journal.pone.0256230] [Reference Citation Analysis]
273 Fuller JM, Barenfeld E, Ekman I. Why do patients struggle with their medicines?-A phenomenological hermeneutical study of how patients experience medicines in their everyday lives. PLoS One 2021;16:e0255478. [PMID: 34358258 DOI: 10.1371/journal.pone.0255478] [Reference Citation Analysis]
274 Chen L, Chen L, Zheng H, Wu S, Wang S. Emergency admission parameters for predicting in-hospital mortality in patients with acute exacerbations of chronic obstructive pulmonary disease with hypercapnic respiratory failure. BMC Pulm Med 2021;21:258. [PMID: 34362328 DOI: 10.1186/s12890-021-01624-1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
275 Yi M, Jiang D, Jia Y, Xu W, Wang H, Li Y, Zhang Z, Wang J, Chen O. Impact of Caregiving Burden on Quality of Life of Caregivers of COPD Patients: The Chain Mediating Role of Social Support and Negative Coping Styles. Int J Chron Obstruct Pulmon Dis 2021;16:2245-55. [PMID: 34376977 DOI: 10.2147/COPD.S311772] [Reference Citation Analysis]
276 Daynes E, Greening N, Owers-Bradley J, Singh SJ, Siddiqui S. The validity of shortened multiple-breath washout testing using sulfur hexafluoride in the assessment of patients with COPD. ERJ Open Res 2021;7:00379-2020. [PMID: 34350284 DOI: 10.1183/23120541.00379-2020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
277 Nnate DA, Barber D, Abaraogu UO. Discharge Plan to Promote Patient Safety and Shared Decision Making by a Multidisciplinary Team of Healthcare Professionals in a Respiratory Unit. Nurs Rep 2021;11:590-9. [PMID: 34968334 DOI: 10.3390/nursrep11030056] [Reference Citation Analysis]
278 Hognon L, Heraud N, Varray A, Torre K. Adaptive Capacities and Complexity of Heart Rate Variability in Patients With Chronic Obstructive Pulmonary Disease Throughout Pulmonary Rehabilitation. Front Physiol 2021;12:669722. [PMID: 34393810 DOI: 10.3389/fphys.2021.669722] [Reference Citation Analysis]
279 Peng JC, Wu T, Wu X, Yan P, Kang YX, Liu Y, Zhang NY, Liu Q, Wang HS, Deng YH, Wang M, Luo XQ, Duan SB. Development of mortality prediction model in the elderly hospitalized AKI patients. Sci Rep 2021;11:15157. [PMID: 34312443 DOI: 10.1038/s41598-021-94271-9] [Reference Citation Analysis]
280 Ju Y, Ma X, Li H, Liu S, Liya A, Guo X. Relationship between Air Pollution and Hospital Admissions for Chronic Obstructive Pulmonary Disease in Changchun, China: A Season-Stratified Case-Cross Study. Can Respir J 2021;2021:3240785. [PMID: 34326908 DOI: 10.1155/2021/3240785] [Reference Citation Analysis]
281 Qiao D, Hu C, Li Q, Fan J. Circ-RBMS1 Knockdown Alleviates CSE-Induced Apoptosis, Inflammation and Oxidative Stress via Up-Regulating FBXO11 Through miR-197-3p in 16HBE Cells. Int J Chron Obstruct Pulmon Dis 2021;16:2105-18. [PMID: 34295155 DOI: 10.2147/COPD.S311222] [Reference Citation Analysis]
282 Zhang Y, Meng X, Shen Y, Xie J, Yu X, Wang Q, Wang L. The Reliability and Validity of the Brief ICF Core Set in Patients with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2021;16:2077-87. [PMID: 34290501 DOI: 10.2147/COPD.S306410] [Reference Citation Analysis]
283 Wu X, Wang C, Li H, Meng H, Jie J, Fu M, Bai Y, Li G, Wei W, Feng Y, Li M, Guan X, He M, Zhang X, Guo H. Circulating white blood cells and lung function impairment: the observational studies and Mendelian randomization analysis. Ann Med 2021;53:1118-28. [PMID: 34259107 DOI: 10.1080/07853890.2021.1948603] [Reference Citation Analysis]
284 MacDonald MI, Osadnik CR, Bulfin L, Leahy E, Leong P, Shafuddin E, Hamza K, King PT, Bardin PG. MULTI-PHACET: multidimensional clinical phenotyping of hospitalised acute COPD exacerbations. ERJ Open Res 2021;7:00198-2021. [PMID: 34262973 DOI: 10.1183/23120541.00198-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
285 Tzanakis N, Koulouris N, Dimakou K, Gourgoulianis K, Kosmas E, Chasapidou G, Konstantinidis A, Kyriakopoulos C, Kontakiotis T, Rapti A, Gaga M, Kalafatakis K, Kostikas K. Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study. BMC Pulm Med 2021;21:216. [PMID: 34243744 DOI: 10.1186/s12890-021-01576-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
286 Muro S, Ishida M, Horie Y, Takeuchi W, Nakagawa S, Ban H, Nakagawa T, Kitamura T. Machine Learning Methods for the Diagnosis of Chronic Obstructive Pulmonary Disease in Healthy Subjects: Retrospective Observational Cohort Study. JMIR Med Inform 2021;9:e24796. [PMID: 34255684 DOI: 10.2196/24796] [Reference Citation Analysis]
287 Volpato E, Toniolo S, Pagnini F, Banfi P. The Relationship Between Anxiety, Depression and Treatment Adherence in Chronic Obstructive Pulmonary Disease: A Systematic Review. Int J Chron Obstruct Pulmon Dis 2021;16:2001-21. [PMID: 34262270 DOI: 10.2147/COPD.S313841] [Reference Citation Analysis]
288 Aldhahir AM, Rajeh AMA, Aldabayan YS, Drammeh S, Subbu V, Alqahtani JS, Hurst JR, Mandal S. Nutritional supplementation during pulmonary rehabilitation in COPD: A systematic review. Chron Respir Dis 2020;17:1479973120904953. [PMID: 32054293 DOI: 10.1177/1479973120904953] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
289 Sugarman J, Weatherald J. Management of Pulmonary Hypertension Due to Chronic Lung Disease. Methodist Debakey Cardiovasc J 2021;17:124-33. [PMID: 34326932 DOI: 10.14797/ZKUT3813] [Reference Citation Analysis]
290 Bai S, Ye R, Wang C, Sun P, Wang D, Yue Y, Wang H, Wu S, Yu M, Xi S, Zhao L. Identification of Proteomic Signatures in Chronic Obstructive Pulmonary Disease Emphysematous Phenotype. Front Mol Biosci 2021;8:650604. [PMID: 34277700 DOI: 10.3389/fmolb.2021.650604] [Reference Citation Analysis]
291 Amado CA, Pérez-García C, Tamayo Fernández B, Agüero-Calvo J, Muñoz-Cacho P, Golpe R. Information Needs in COPD After an Educational Programme: Influence in Exacerbations and Admissions. Int J Chron Obstruct Pulmon Dis 2020;15:2663-71. [PMID: 33149564 DOI: 10.2147/COPD.S275002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
292 Dunand A, Beysard N, Maudet L, Carron PN, Dami F, Piquilloud L, Caillet-Bois D, Pasquier M. Management of respiratory distress following prehospital implementation of noninvasive ventilation in a physician-staffed emergency medical service: a single-center retrospective study. Scand J Trauma Resusc Emerg Med 2021;29:85. [PMID: 34187538 DOI: 10.1186/s13049-021-00900-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
293 Cheng SL, Lin CH. COPD Guidelines in the Asia-Pacific Regions: Similarities and Differences. Diagnostics (Basel) 2021;11:1153. [PMID: 34202503 DOI: 10.3390/diagnostics11071153] [Reference Citation Analysis]
294 Carlier FM, de Fays C, Pilette C. Epithelial Barrier Dysfunction in Chronic Respiratory Diseases. Front Physiol 2021;12:691227. [PMID: 34248677 DOI: 10.3389/fphys.2021.691227] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
295 Dransfield MT, Garner JL, Bhatt SP, Slebos DJ, Klooster K, Sciurba FC, Shah PL, Marchetti NT, Sue RD, Wright S, Rivas-Perez H, Wiese TA, Wahidi MM, Goulart de Oliveira H, Armstrong B, Radhakrishnan S, Shargill NS, Criner GJ; LIBERATE Study Group:. Effect of Zephyr Endobronchial Valves on Dyspnea, Activity Levels, and Quality of Life at One Year. Results from a Randomized Clinical Trial. Ann Am Thorac Soc 2020;17:829-38. [PMID: 32223724 DOI: 10.1513/AnnalsATS.201909-666OC] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
296 Hanafi NS, Agarwal D, Chippagiri S, Brakema EA, Pinnock H, Sheikh A, Liew SM, Ng CW, Isaac R, Chinna K, Wong LP, Hussein N, Abu Bakar AI, Pang YK, Juvekar S, Khoo EM. Chronic respiratory disease surveys in adults in low- and middle-income countries: A systematic scoping review of methodological approaches and outcomes. J Glob Health 2021;11:04026. [PMID: 34221357 DOI: 10.7189/jogh.11.04026] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
297 Gonzalez-Garcia M, Barrero M, Maldonado D. Exercise Capacity, Ventilatory Response, and Gas Exchange in COPD Patients With Mild to Severe Obstruction Residing at High Altitude. Front Physiol 2021;12:668144. [PMID: 34220533 DOI: 10.3389/fphys.2021.668144] [Reference Citation Analysis]
298 Xu X, Milea D, Navarro Rojas AA, Braganza A, Holbrook T, Marett B, Young R, Scott RJ, Gribben B. A Real-World Analysis of Treatment Patterns and Clinical Characteristics Among Patients with COPD Who Initiated Multiple-Inhaler Triple Therapy in New Zealand. Int J Chron Obstruct Pulmon Dis 2021;16:1835-50. [PMID: 34177262 DOI: 10.2147/COPD.S295183] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
299 Tamaki K, Sakihara E, Miyata H, Hirahara N, Kirichek O, Tawara R, Akiyama S, Katsumata M, Haruya M, Ishii T, Simard EP, Miller BE, Tal-Singer R, Kaise T. Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) Study. Int J Chron Obstruct Pulmon Dis 2021;16:1771-82. [PMID: 34168439 DOI: 10.2147/COPD.S302259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
300 Tran MC, Nguyen V, Bruce R, Crockett DC, Formenti F, Phan PA, Payne SJ, Farmery AD. Simulation-based optimisation to quantify heterogeneity of specific ventilation and perfusion in the lung by the Inspired Sinewave Test. Sci Rep 2021;11:12627. [PMID: 34135419 DOI: 10.1038/s41598-021-92062-w] [Reference Citation Analysis]
301 Cheng SL. Comparison of Effectiveness Using Different Dual Bronchodilator Agents in Chronic Obstructive Pulmonary Disease Treatment. J Clin Med 2021;10:2649. [PMID: 34208599 DOI: 10.3390/jcm10122649] [Reference Citation Analysis]
302 Morasert T, Jantarapootirat M, Phinyo P, Patumanond J. Prognostic indicators for in-hospital mortality in COPD with acute exacerbation in Thailand: a retrospective cohort study. BMJ Open Respir Res 2020;7:e000488. [PMID: 32467292 DOI: 10.1136/bmjresp-2019-000488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
303 Toren K, Schiöler L, Lindberg A, Andersson A, Behndig AF, Bergström G, Blomberg A, Caidahl K, Engvall J, Eriksson M, Hamrefors V, Janson C, Kylhammar D, Lindberg E, Lindén A, Malinovschi A, Persson HL, Sandelin M, Eriksson Ström J, Tanash HA, Vikgren J, Östgren CJ, Wollmer P, Sköld CM. Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers: a cross-sectional study. BMJ Open Respir Res 2020;7:e000600. [PMID: 32759170 DOI: 10.1136/bmjresp-2020-000600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
304 Mapel DW, Roberts MH, Sama S, Bobbili PJ, Cheng WY, Duh MS, Nguyen C, Thompson-Leduc P, Van Dyke MK, Rothnie KJ, Sundaresan D, Certa JM, Whiting TS, Brown JL, Roblin DW. Development and Validation of a Healthcare Utilization-Based Algorithm to Identify Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2021;16:1687-98. [PMID: 34135580 DOI: 10.2147/COPD.S302241] [Reference Citation Analysis]
305 Li M, Cheng K, Ku K, Li J, Hu H, Ung COL. Factors Influencing the Length of Hospital Stay Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in Macao Population: A Retrospective Study of Inpatient Health Record. Int J Chron Obstruct Pulmon Dis 2021;16:1677-85. [PMID: 34135579 DOI: 10.2147/COPD.S307164] [Reference Citation Analysis]
306 Chan SMH, Bernardo I, Mastronardo C, Mou K, De Luca SN, Seow HJ, Dobric A, Brassington K, Selemidis S, Bozinovski S, Vlahos R. Apocynin prevents cigarette smoking-induced loss of skeletal muscle mass and function in mice by preserving proteostatic signalling. Br J Pharmacol 2021;178:3049-66. [PMID: 33817783 DOI: 10.1111/bph.15482] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
307 Hartman JE, Slebos DJ. Lung volume reduction in real clinical practice. ERJ Open Res 2021;7:00258-2021. [PMID: 34109245 DOI: 10.1183/23120541.00258-2021] [Reference Citation Analysis]
308 Lee EG, Rhee CK. Epidemiology, burden, and policy of chronic obstructive pulmonary disease in South Korea: a narrative review. J Thorac Dis 2021;13:3888-97. [PMID: 34277078 DOI: 10.21037/jtd-20-2100] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
309 Liu W, Liu Y, Li X. Impact of Exercise Capacity Upon Respiratory Functions, Perception of Dyspnea, and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2021;16:1529-34. [PMID: 34103910 DOI: 10.2147/COPD.S311221] [Reference Citation Analysis]
310 Rasch-Halvorsen Ø, Hassel E, Brumpton BM, Jenssen H, Spruit MA, Langhammer A, Steinshamn S. Lung function and peak oxygen uptake in chronic obstructive pulmonary disease phenotypes with and without emphysema. PLoS One 2021;16:e0252386. [PMID: 34043708 DOI: 10.1371/journal.pone.0252386] [Reference Citation Analysis]
311 Sugiya R, Higashimoto Y, Shiraishi M, Tamura T, Kimura T, Chiba Y, Nishiyama O, Arizono S, Fukuda K, Tohda Y. Decreased Tongue Strength is Related to Skeletal Muscle Mass in COPD Patients. Dysphagia 2021. [PMID: 34036401 DOI: 10.1007/s00455-021-10314-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
312 Li P, Wang T, Chen M, Chen J, Shen Y, Chen L. RAGE-mediated functional DNA methylated modification contributes to cigarette smoke-induced airway inflammation in mice. Biosci Rep 2021;41:BSR20210308. [PMID: 34017996 DOI: 10.1042/BSR20210308] [Reference Citation Analysis]
313 Mohamed Amine M, Selma M, Adel S, Khaoula BHA, Mohamed Hassene K, Imen T, Ahmed A, Nadia BB, Yosra BD, Rabie R, Mohamed Habib G, Kaouthar B, Mehdi M, Asma B, Wahid B, Riadh B, Hamdi B, Semir N; GREAT Network. 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial. PLoS One 2021;16:e0251716. [PMID: 34015041 DOI: 10.1371/journal.pone.0251716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
314 Song Q, Zhao YY, Zeng YQ, Liu C, Cheng W, Deng MH, Li X, Ma LB, Chen Y, Cai S, Chen P. The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients. Int J Chron Obstruct Pulmon Dis 2021;16:1401-12. [PMID: 34040367 DOI: 10.2147/COPD.S309267] [Reference Citation Analysis]
315 Goffin JR, Corriveau S, Tang GH, Pond GR. Management and outcomes of patients with chronic obstructive lung disease and lung cancer in a public healthcare system. PLoS One 2021;16:e0251886. [PMID: 33999942 DOI: 10.1371/journal.pone.0251886] [Reference Citation Analysis]
316 Hedhli A, Slim A, Ouahchi Y, Mjid M, Koumenji J, Cheikh Rouhou S, Toujani S, Dhahri B. Maximal Voluntary Breath-Holding Tele-Inspiratory Test in Patients with Chronic Obstructive Pulmonary Disease. Am J Mens Health 2021;15:15579883211015857. [PMID: 33993797 DOI: 10.1177/15579883211015857] [Reference Citation Analysis]
317 Gao K, Chen X, Li X, Zhang H, Luan M, Yao Y, Xu Y, Wang T, Han Y, Xue T, Wang J, Zheng M, Qiu X, Zhu T. Susceptibility of patients with chronic obstructive pulmonary disease to heart rate difference associated with the short-term exposure to metals in ambient fine particles: A panel study in Beijing, China. Sci China Life Sci 2021. [PMID: 34008166 DOI: 10.1007/s11427-020-1912-4] [Reference Citation Analysis]
318 Zheng ZG, Sun WZ, Hu JY, Jie ZJ, Xu JF, Cao J, Song YL, Wang CH, Wang J, Zhao H, Guo ZL, Zhong NS. Hydrogen/oxygen therapy for the treatment of an acute exacerbation of chronic obstructive pulmonary disease: results of a multicenter, randomized, double-blind, parallel-group controlled trial. Respir Res 2021;22:149. [PMID: 33985501 DOI: 10.1186/s12931-021-01740-w] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
319 Roessler FK, Benedikter BJ, Schmeck B, Bar N. Novel computational analysis of large transcriptome datasets identifies sets of genes distinguishing chronic obstructive pulmonary disease from healthy lung samples. Sci Rep 2021;11:10258. [PMID: 33986404 DOI: 10.1038/s41598-021-89762-8] [Reference Citation Analysis]
320 Jang JG, Ahn JH, Jin HJ. Incidence and Prognostic Factors of Respiratory Viral Infections in Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2021;16:1265-73. [PMID: 33994783 DOI: 10.2147/COPD.S306916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
321 Mummy DG, Coleman EM, Wang Z, Bier EA, Lu J, Driehuys B, Huang YC. Regional Gas Exchange Measured by 129 Xe Magnetic Resonance Imaging Before and After Combination Bronchodilators Treatment in Chronic Obstructive Pulmonary Disease. J Magn Reson Imaging 2021;54:964-74. [PMID: 33960534 DOI: 10.1002/jmri.27662] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
322 Bai S, Zhao L. Imbalance Between Injury and Defense in the COPD Emphysematous Phenotype. Front Med (Lausanne) 2021;8:653332. [PMID: 34026786 DOI: 10.3389/fmed.2021.653332] [Reference Citation Analysis]
323 Mizumoto J, Shimizu T. Unforgettable in every way. J Gen Fam Med 2021;22:197-201. [PMID: 34221793 DOI: 10.1002/jgf2.442] [Reference Citation Analysis]
324 Rao Y, Le Y, Xiong J, Pei Y, Sun Y. NK Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease. Front Immunol 2021;12:666045. [PMID: 34017339 DOI: 10.3389/fimmu.2021.666045] [Reference Citation Analysis]
325 Kim W, Prokopenko D, Sakornsakolpat P, Hobbs BD, Lutz SM, Hokanson JE, Wain LV, Melbourne CA, Shrine N, Tobin MD, Silverman EK, Cho MH, Beaty TH. Genome-Wide Gene-by-Smoking Interaction Study of Chronic Obstructive Pulmonary Disease. Am J Epidemiol 2021;190:875-85. [PMID: 33106845 DOI: 10.1093/aje/kwaa227] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
326 Zeng X, Liu X, Bao H. Sulforaphane suppresses lipopolysaccharide- and Pam3CysSerLys4-mediated inflammation in chronic obstructive pulmonary disease via toll-like receptors. FEBS Open Bio 2021;11:1313-21. [PMID: 33590951 DOI: 10.1002/2211-5463.13118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
327 McNeill JN, Lau ES, Zern EK, Nayor M, Malhotra R, Liu EE, Bhat RR, Brooks LC, Farrell R, Sbarbaro JA, Schoenike MW, Medoff BD, Lewis GD, Ho JE. Association of obesity-related inflammatory pathways with lung function and exercise capacity. Respir Med 2021;183:106434. [PMID: 33964816 DOI: 10.1016/j.rmed.2021.106434] [Reference Citation Analysis]
328 Zinellu E, Zinellu A, Fois AG, Pau MC, Scano V, Piras B, Carru C, Pirina P. Oxidative Stress Biomarkers in Chronic Obstructive Pulmonary Disease Exacerbations: A Systematic Review. Antioxidants (Basel) 2021;10:710. [PMID: 33946941 DOI: 10.3390/antiox10050710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
329 Chen KY, Wu SM, Tseng CH, Lee KY, Lin YH, Liu HY, Chien LN. Combination therapies with thiazolidinediones are associated with a lower risk of acute exacerbations in new-onset COPD patients with advanced diabetic mellitus: a cohort-based case-control study. BMC Pulm Med 2021;21:141. [PMID: 33926423 DOI: 10.1186/s12890-021-01505-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
330 Zhou Y, Wang M, Yang W, Li J, Li J, Hu Y, Wang W, Che C, Qi H. Environmental and Genetic Factors in the Pathogenesis of COPD in the Road-Working Population. Dis Markers 2021;2021:9953234. [PMID: 34012494 DOI: 10.1155/2021/9953234] [Reference Citation Analysis]
331 Brat K, Svoboda M, Zatloukal J, Plutinsky M, Volakova E, Popelkova P, Novotna B, Dvorak T, Koblizek V. The Relation Between Clinical Phenotypes, GOLD Groups/Stages and Mortality in COPD Patients - A Prospective Multicenter Study. Int J Chron Obstruct Pulmon Dis 2021;16:1171-82. [PMID: 33953554 DOI: 10.2147/COPD.S297087] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
332 Moll M, Jackson VE, Yu B, Grove ML, London SJ, Gharib SA, Bartz TM, Sitlani CM, Dupuis J, O'Connor GT, Xu H, Cassano PA, Patchen BK, Kim WJ, Park J, Kim KH, Han B, Barr RG, Manichaikul A, Nguyen JN, Rich SS, Lahousse L, Terzikhan N, Brusselle G, Sakornsakolpat P, Liu J, Benway CJ, Hall IP, Tobin MD, Wain LV, Silverman EK, Cho MH, Hobbs BD. A systematic analysis of protein-altering exonic variants in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2021;321:L130-43. [PMID: 33909500 DOI: 10.1152/ajplung.00009.2021] [Reference Citation Analysis]
333 Martinez FJ, Thomashow B, Sapir T, Simone L, Carter J, Han M. Does Evaluation and Management of COPD Follow Therapeutic Strategy Recommendations? Chronic Obstr Pulm Dis 2021;8:230-42. [PMID: 33610138 DOI: 10.15326/jcopdf.2020.0175] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
334 Zhang WZ, Hoffman KL, Schiffer KT, Oromendia C, Rice MC, Barjaktarevic I, Peters SP, Putcha N, Bowler RP, Wells JM, Couper DJ, Labaki WW, Curtis JL, Han MK, Paine R 3rd, Woodruff PG, Criner GJ, Hansel NN, Diaz I, Ballman KV, Nakahira K, Choi ME, Martinez FJ, Choi AMK, Cloonan SM. Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort. Respir Res 2021;22:126. [PMID: 33902556 DOI: 10.1186/s12931-021-01707-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
335 Wang Z, Liang W, Ma C, Wang J, Gao X, Wei L. Macrophages Inhibit Ciliary Protein Levels by Secreting BMP-2 Leading to Airway Epithelial Remodeling Under Cigarette Smoke Exposure. Front Mol Biosci 2021;8:663987. [PMID: 33981724 DOI: 10.3389/fmolb.2021.663987] [Reference Citation Analysis]
336 Huang YT, Chen CC, Ho YN, Tsai MT, Tsai CM, Chuang PC, Cheng FJ. Short-Term Effects of Particulate Matter and Its Constituents on Emergency Room Visits for Chronic Obstructive Pulmonary Disease: A Time-Stratified Case-Crossover Study in an Urban Area. Int J Environ Res Public Health 2021;18:4400. [PMID: 33919089 DOI: 10.3390/ijerph18094400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
337 Li T, He X, Luo L, Zeng H, Ren S, Chen Y. F-Box Protein FBXW17-Mediated Proteasomal Degradation of Protein Methyltransferase PRMT6 Exaggerates CSE-Induced Lung Epithelial Inflammation and Apoptosis. Front Cell Dev Biol 2021;9:599020. [PMID: 33959602 DOI: 10.3389/fcell.2021.599020] [Reference Citation Analysis]
338 Milea D, Yeo SH, Nam Y, Navarro Rojas AA, Shantakumar S, Beale J, Marett B, Young RP, Scott RJ, Gribben B. Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and Evolution Using the HealthStat Database. Int J Chron Obstruct Pulmon Dis 2021;16:1075-91. [PMID: 33907394 DOI: 10.2147/COPD.S290887] [Reference Citation Analysis]
339 Baloira A, Abad A, Fuster A, García Rivero JL, García-Sidro P, Márquez-Martín E, Palop M, Soler N, Velasco JL, González-Torralba F. Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion. Int J Chron Obstruct Pulmon Dis 2021;16:1021-33. [PMID: 33907390 DOI: 10.2147/COPD.S297980] [Reference Citation Analysis]
340 Celli BR, Anderson JA, Cowans NJ, Crim C, Hartley BF, Martinez FJ, Morris AN, Quasny H, Yates J, Vestbo J, Calverley PMA. Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review. Am J Respir Crit Care Med 2021;203:689-98. [PMID: 32966751 DOI: 10.1164/rccm.202005-1854OC] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
341 Yu W, Ye T, Ding J, Huang Y, Peng Y, Xia Q, Cuntai Z. miR-4456/CCL3/CCR5 Pathway in the Pathogenesis of Tight Junction Impairment in Chronic Obstructive Pulmonary Disease. Front Pharmacol 2021;12:551839. [PMID: 33953665 DOI: 10.3389/fphar.2021.551839] [Reference Citation Analysis]
342 Gonzalez-Montesinos JL, Fernandez-Santos JR, Vaz-Pardal C, Ponce-Gonzalez JG, Marin-Galindo A, Arnedillo A. Effects of a Rehabilitation Programme Using a Nasal Inspiratory Restriction Device in COPD. Int J Environ Res Public Health 2021;18:4207. [PMID: 33921105 DOI: 10.3390/ijerph18084207] [Reference Citation Analysis]
343 Lutter JI, Jörres RA, Trudzinski FC, Alter P, Kellerer C, Watz H, Welte T, Bals R, Kauffmann-Guerrero D, Behr J, Holle R, F Vogelmeier C, Kahnert K; COSYCONET study group. Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort - Determinants and Consequences. Int J Chron Obstruct Pulmon Dis 2021;16:987-98. [PMID: 33883892 DOI: 10.2147/COPD.S304532] [Reference Citation Analysis]
344 Lee JW, Chun W, Lee HJ, Min JH, Kim SM, Seo JY, Ahn KS, Oh SR. The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases. Cells 2021;10:897. [PMID: 33919784 DOI: 10.3390/cells10040897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
345 Wang M, Liu Y, Zhang Y, Zhang L. LncRNA LOC729178 acts as a sponge of miR-144-3p to mitigate cigarette smoke extract-induced inflammatory injury via regulating PHLPP2 in 16HBE cells. J Mol Histol 2021;52:437-47. [PMID: 33847879 DOI: 10.1007/s10735-021-09972-2] [Reference Citation Analysis]
346 Luo J, Zhang D, Tang W, Dou LY, Sun Y. Impact of Frailty on the Risk of Exacerbations and All-Cause Mortality in Elderly Patients with Stable Chronic Obstructive Pulmonary Disease. Clin Interv Aging 2021;16:593-601. [PMID: 33880018 DOI: 10.2147/CIA.S303852] [Reference Citation Analysis]
347 Liu K, Yu X, Cui X, Su Y, Sun L, Yang J, Han W. Effects of Proprioceptive Neuromuscular Facilitation Stretching Combined with Aerobic Training on Pulmonary Function in COPD Patients: A Randomized Controlled Trial. Int J Chron Obstruct Pulmon Dis 2021;16:969-77. [PMID: 33880021 DOI: 10.2147/COPD.S300569] [Reference Citation Analysis]
348 Hallit S, Zeidan RK, Saade S, Hajj A, Hallit R, Akel M, Yahchouchy C, Kheir N, Iskandar K, Sacre H, Salameh P. Knowledge, Attitude and Practice of Lebanese Community Pharmacists toward Chronic Obstructive Pulmonary Disease. J Epidemiol Glob Health 2020;10:86-95. [PMID: 32175715 DOI: 10.2991/jegh.k.191215.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
349 Lu HH, Zeng HH, Chen Y. Early chronic obstructive pulmonary disease: A new perspective. Chronic Dis Transl Med 2021;7:79-87. [PMID: 34136767 DOI: 10.1016/j.cdtm.2021.02.003] [Reference Citation Analysis]
350 Qiu W, Kang N, Wu Y, Cai Y, Xiao L, Ge H, Zhu H. Mucosal Associated Invariant T Cells Were Activated and Polarized Toward Th17 in Chronic Obstructive Pulmonary Disease. Front Immunol 2021;12:640455. [PMID: 33868270 DOI: 10.3389/fimmu.2021.640455] [Reference Citation Analysis]
351 Hashimoto N, Wakahara K, Sakamoto K. The Importance of Appropriate Diagnosis in the Practical Management of Chronic Obstructive Pulmonary Disease. Diagnostics (Basel) 2021;11:618. [PMID: 33808229 DOI: 10.3390/diagnostics11040618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
352 Roest S, Struijk C, Constantinescu AA, Caliskan K, Plasmeijer EI, Boersma E, Brugts JJ, Manintveld OC. Influence of renal insufficiency pre-heart transplantation on malignancy risk post-heart transplantation. ESC Heart Fail 2021;8:2172-82. [PMID: 33779076 DOI: 10.1002/ehf2.13309] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
353 Jang YO, Kim OH, Kim SJ, Lee SH, Yun S, Lim SE, Yoo HJ, Shin Y, Lee SW. High-fiber diets attenuate emphysema development via modulation of gut microbiota and metabolism. Sci Rep 2021;11:7008. [PMID: 33772084 DOI: 10.1038/s41598-021-86404-x] [Cited by in F6Publishing: 19] [Reference Citation Analysis]
354 Huang Y, Wang J, Shen J, Ma J, Miao X, Ding K, Jiang B, Hu B, Fu F, Huang L, Cao M, Zhang X. Relationship of Red Cell Index with the Severity of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2021;16:825-34. [PMID: 33814906 DOI: 10.2147/COPD.S292666] [Reference Citation Analysis]
355 Zhao X, Wu Y. Correlations of Silent Information Regulator of Transcription 1 (SIRT1) Expression, Inflammatory Factors, and Oxidative Stress with Pulmonary Function in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD). Med Sci Monit 2021;27:e929046. [PMID: 33762567 DOI: 10.12659/MSM.929046] [Reference Citation Analysis]
356 Kiani FZ, Ahmadi A, Babadi AS, Rouhi H. Profile and preliminary results of Iranian sub cohort chronic obstructive pulmonary disease (COPD) in Shahrekord PERSIAN cohort in southwest Iran. BMC Pulm Med 2021;21:105. [PMID: 33765987 DOI: 10.1186/s12890-021-01469-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
357 Balasuriya GK, Mohsenipour M, Brassington K, Dobric A, De Luca SN, Mou K, Seow HJ, Lee CYQ, Herath M, Chan SMH, Vlahos R, Hill-Yardin EL. Ebselen prevents cigarette smoke-induced gastrointestinal dysfunction in mice. Clin Sci (Lond) 2020;134:2943-57. [PMID: 33125061 DOI: 10.1042/CS20200886] [Reference Citation Analysis]
358 Yang CY, Li SW, Chin CY, Hsu CW, Lee CC, Yeh YM, Wu KA. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state. J Transl Med 2021;19:121. [PMID: 33757530 DOI: 10.1186/s12967-021-02788-4] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
359 Sriboonreung T, Leelarungrayub J, Yankai A, Puntumetakul R. Correlation and Predicted Equations of MIP/MEP from the Pulmonary Function, Demographics and Anthropometrics in Healthy Thai Participants aged 19 to 50 Years. Clin Med Insights Circ Respir Pulm Med 2021;15:11795484211004494. [PMID: 33814938 DOI: 10.1177/11795484211004494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
360 He S, Sun S, Lu J, Chen L, Mei X, Li L, Zeng Z, Zhong M, Xie L. The effects of the miR-21/SMAD7/TGF-β pathway on Th17 cell differentiation in COPD. Sci Rep 2021;11:6338. [PMID: 33739023 DOI: 10.1038/s41598-021-85637-0] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
361 Apessos I, Voulgaris A, Agrafiotis M, Andreadis D, Steiropoulos P. Effect of periodontal therapy on COPD outcomes: a systematic review. BMC Pulm Med 2021;21:92. [PMID: 33736634 DOI: 10.1186/s12890-021-01429-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
362 Li L, Zhong X, Zheng A, JianKun C, Budukadeer AA, Aini P, Tuerxun M, Yasen M, Ma T, Ren J, Semaiti R, Xie C, Li F, Rexiati M, Tang L, Abudurexiti G, Zheng D, Li JQ. Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in Kashi Region, Northwestern China. Int J Chron Obstruct Pulmon Dis 2021;16:655-63. [PMID: 33758502 DOI: 10.2147/COPD.S289620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
363 Athlin Å, Giezeman M, Hasselgren M, Montgomery S, Lisspers K, Ställberg B, Janson C, Sundh J. Prediction of Mortality Using Different COPD Risk Assessments - A 12-Year Follow-Up. Int J Chron Obstruct Pulmon Dis 2021;16:665-75. [PMID: 33758503 DOI: 10.2147/COPD.S282694] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
364 Patterson F, Brewer B, Blair R, Grandner MA, Hoopes E, Ma G, Criner GJ, Satti A. An exploration of clinical, behavioral, and community factors associated with sleep duration and efficiency among middle-aged Black/African American smokers. Sleep Health 2021;7:397-407. [PMID: 33741321 DOI: 10.1016/j.sleh.2021.01.006] [Reference Citation Analysis]
365 Siddharthan T, Pollard SL, Jackson P, Robertson NM, Wosu AC, Rahman N, Padalkar R, Sekitoleko I, Namazzi E, Alupo P, Hurst JR, Kalyesubula R, Dowdy D, Wise R, Barnes PJ, Checkley W, Kirenga B. Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial. Trials 2021;22:213. [PMID: 33726828 DOI: 10.1186/s13063-021-05163-2] [Reference Citation Analysis]
366 Su J, Ye Q, Zhang D, Zhou J, Tao R, Ding Z, Lu G, Liu J, Xu F. Joint association of cigarette smoking and PM2.5 with COPD among urban and rural adults in regional China. BMC Pulm Med 2021;21:87. [PMID: 33722217 DOI: 10.1186/s12890-021-01465-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
367 Blervaque L, Préfaut C, Forthin H, Maffre F, Bourrelier M, Héraud N, Catteau M, Pomiès P, Jaffuel D, Molinari N, Hayot M, Gouzi F. Efficacy of a long-term pulmonary rehabilitation maintenance program for COPD patients in a real-life setting: a 5-year cohort study. Respir Res 2021;22:79. [PMID: 33691702 DOI: 10.1186/s12931-021-01674-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
368 Liu H, Cui N, Li Y. Review on the correlation between chronic obstructive pulmonary disease and eosinophil in peripheral blood. Eur J Inflamm 2021;19:205873922199818. [DOI: 10.1177/2058739221998183] [Reference Citation Analysis]
369 Huang YJ, Kao S, Kao LT, Chian CF, Chung CH, Chien WC, Wang KY. Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids. Int J Chron Obstruct Pulmon Dis 2021;16:591-602. [PMID: 33716501 DOI: 10.2147/COPD.S292026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
370 Jordan A, Sivapalan P, Jensen JU. Does inhaled corticosteroid use affect the risk of 
COVID-19-related death? Breathe (Sheff) 2021;17:200275. [PMID: 34295392 DOI: 10.1183/20734735.0275-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
371 Cao Y, Xing Z, Long H, Huang Y, Zeng P, Janssens JP, Guo Y. Predictors of mortality in COPD exacerbation cases presenting to the respiratory intensive care unit. Respir Res 2021;22:77. [PMID: 33663493 DOI: 10.1186/s12931-021-01657-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
372 Lin F, Nie S, Zhao R, Cao M, Yuan W, Li Y, Tan C, Xu B, Wang H. Intercept of minute ventilation versus carbon dioxide output relationship as an index of ventilatory inefficiency in chronic obstructive pulmonary disease. J Thorac Dis 2021;13:1553-63. [PMID: 33841947 DOI: 10.21037/jtd-20-2725] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
373 Kang HS, Bak SH, Oh HY, Lim MN, Cha YK, Yoon HJ, Kim WJ. Computed tomography-based visual assessment of chronic obstructive pulmonary disease: comparison with pulmonary function test and quantitative computed tomography. J Thorac Dis 2021;13:1495-506. [PMID: 33841942 DOI: 10.21037/jtd-20-3041] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
374 Dai J, He Y, Maneenil K, Liu H, Liu M, Guo Q, Bennett AC, Stoddard SM, Wampfler JA, Jiang G, Yang P. Timing of chronic obstructive pulmonary disease diagnosis in lung cancer prognosis: a clinical and genomic-based study. Transl Lung Cancer Res 2021;10:1209-20. [PMID: 33889503 DOI: 10.21037/tlcr-20-1017] [Reference Citation Analysis]
375 Wang Y, Li Z, Li FS. Development and Assessment of Prediction Models for the Development of COPD in a Typical Rural Area in Northwest China. Int J Chron Obstruct Pulmon Dis 2021;16:477-86. [PMID: 33664570 DOI: 10.2147/COPD.S297380] [Reference Citation Analysis]
376 Jaen-Moreno MJ, Feu N, Del Pozo GI, Gómez C, Carrión L, Chauca GM, Guler I, Montiel FJ, Sánchez MD, Alcalá JA, Gutierrez-Rojas L, Molina V, Bobes J, Balanzá-Martínez V, Ruiz-Rull C, Sarramea F. Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking. Eur Psychiatry 2021;64:e22. [PMID: 33632347 DOI: 10.1192/j.eurpsy.2021.12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
377 Ma N, Qi Y, Liang X, Bai J, Deng J, Li M, He Z. Compare the Effect of Inhaled Corticosteroids and Systemic Corticosteroids on Sputum Microbiome of AECOPD. Front Med (Lausanne) 2021;8:637246. [PMID: 33718410 DOI: 10.3389/fmed.2021.637246] [Reference Citation Analysis]
378 Jiang L, Sun YQ, Langhammer A, Brumpton BM, Chen Y, Nilsen TI, Leivseth L, Wahl SGF, Mai XM. Asthma and asthma symptom control in relation to incidence of lung cancer in the HUNT study. Sci Rep 2021;11:4539. [PMID: 33633205 DOI: 10.1038/s41598-021-84012-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
379 Bruce RM, Phan PA, Rigolli M, Tran MC, Pacpaco E, Rahman NM, Farmery AD. Assessment of Ventilatory Heterogeneity in Chronic Obstructive Pulmonary Disease Using the Inspired Sinewave Test. Int J Chron Obstruct Pulmon Dis 2021;16:401-13. [PMID: 33654391 DOI: 10.2147/COPD.S264360] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
380 Atik D, Cander B, Dikmetaş C, Dogan S, Çaltekin İ, Albayrak L, Gökçen E, Bulut B. EVALUATION OF THE RELATIONSHIP BETWEEN D VITAMIN LEVEL IN COPD PATIENTS WITH ACUTE RESPIRATORY FAILURE. International Journal of Health Services Research and Policy. [DOI: 10.33457/ijhsrp.814906] [Reference Citation Analysis]
381 Yang N, Singhera GK, Yan YX, Pieper MP, Leung JM, Sin DD, Dorscheid DR. Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells. Respir Res 2021;22:65. [PMID: 33622325 DOI: 10.1186/s12931-021-01659-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
382 Waeijen-Smit K, Houben-Wilke S, DiGiandomenico A, Gehrmann U, Franssen FME. Unmet needs in the management of exacerbations of chronic obstructive pulmonary disease. Intern Emerg Med 2021;16:559-69. [PMID: 33616876 DOI: 10.1007/s11739-020-02612-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
383 Tu YH, Guo Y, Ji S, Shen JL, Fei GH. The Influenza A Virus H3N2 Triggers the Hypersusceptibility of Airway Inflammatory Response via Activating the lncRNA TUG1/miR-145-5p/NF-κB Pathway in COPD. Front Pharmacol 2021;12:604590. [PMID: 33841139 DOI: 10.3389/fphar.2021.604590] [Reference Citation Analysis]
384 Guo B, Wang Y, Pei L, Yu Y, Liu F, Zhang D, Wang X, Su Y, Zhang D, Zhang B, Guo H. Determining the effects of socioeconomic and environmental determinants on chronic obstructive pulmonary disease (COPD) mortality using geographically and temporally weighted regression model across Xi'an during 2014-2016. Sci Total Environ 2021;756:143869. [PMID: 33280870 DOI: 10.1016/j.scitotenv.2020.143869] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
385 Chen W, Sadatsafavi M, FitzGerald JM, Lynd LD, Sin DD. Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis. Respir Res 2021;22:59. [PMID: 33602241 DOI: 10.1186/s12931-021-01656-5] [Reference Citation Analysis]
386 Fujikura K, Albini A, Barr RG, Parikh M, Kern J, Hoffman E, Hiura GT, Bluemke DA, Carr J, Lima JAC, Michos ED, Gomes AS, Prince MR. Aortic enlargement in chronic obstructive pulmonary disease (COPD) and emphysema: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD study. Int J Cardiol 2021;331:214-20. [PMID: 33587941 DOI: 10.1016/j.ijcard.2021.02.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
387 Kang J, Lee JS, Lee SW, Lee JB, Oh YM. Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV1 level: a patient-level pooled analysis of phase-3 randomized clinical trials. Respir Res 2021;22:55. [PMID: 33579288 DOI: 10.1186/s12931-021-01648-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
388 Leung C, Bourbeau J, Sin DD, Aaron SD, FitzGerald JM, Maltais F, Marciniuk DD, O'Donnell D, Hernandez P, Chapman KR, Walker B, Road JD, Zheng L, Zou C, Hogg JC, Tan WC; CanCOLD Collaborative Research Group. The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study. Int J Chron Obstruct Pulmon Dis 2021;16:305-20. [PMID: 33603357 DOI: 10.2147/COPD.S285338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
389 Bodduluri S, Kizhakke Puliyakote A, Nakhmani A, Charbonnier JP, Reinhardt JM, Bhatt SP. Computed Tomography-based Airway Surface Area-to-Volume Ratio for Phenotyping Airway Remodeling in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2021;203:185-91. [PMID: 32755486 DOI: 10.1164/rccm.202004-0951OC] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
390 Sulku J, Bröms K, Högman M, Janson C, Lisspers K, Malinovschi A, Melhus H, Ställberg B, Nielsen EI. Critical inhaler technique errors in Swedish patients with COPD: a cross-sectional study analysing video-recorded demonstrations. NPJ Prim Care Respir Med 2021;31:5. [PMID: 33563979 DOI: 10.1038/s41533-021-00218-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
391 Tahery N, Zarea K, Cheraghi M, Hatamzadeh N, Farhadi M, Dobaradarn S, Mohammadi MJ. Chronic Obstructive Pulmonary Disease (COPD) and Air Pollution: A Review. Jundishapur J Chronic Dis Care 2021;10. [DOI: 10.5812/jjcdc.110273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
392 Perumal SD. Renewed vision on pulmonary rehabilitation service delivery for chronic obstructive pulmonary disease management beyond COVID-19. Chronic Dis Transl Med 2021;7:107-16. [PMID: 34136770 DOI: 10.1016/j.cdtm.2021.01.003] [Reference Citation Analysis]
393 Xiong J, Zhou L, Tian J, Yang X, Li Y, Jin R, Le Y, Rao Y, Sun Y. Cigarette Smoke-Induced Lymphoid Neogenesis in COPD Involves IL-17/RANKL Pathway. Front Immunol 2020;11:588522. [PMID: 33613513 DOI: 10.3389/fimmu.2020.588522] [Reference Citation Analysis]
394 Huang Y, Ma J, Jiang B, Yang N, Fu F, Chen X, Liu C, Miao X, Mao H, Zheng R, Wang J, Ding K, Zhang X. Effect of nutritional risk on cognitive function in patients with chronic obstructive pulmonary disease. J Int Med Res 2021;49:300060521990127. [PMID: 33535842 DOI: 10.1177/0300060521990127] [Reference Citation Analysis]
395 Dogu E, Albayrak YE, Tuncay E. Length of hospital stay prediction with an integrated approach of statistical-based fuzzy cognitive maps and artificial neural networks. Med Biol Eng Comput 2021;59:483-96. [PMID: 33544271 DOI: 10.1007/s11517-021-02327-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
396 Yao C, Wang L, Shi F, Chen R, Li B, Liu W, Feng M, Li S. Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure. Int J Med Sci 2021;18:1592-9. [PMID: 33746575 DOI: 10.7150/ijms.52405] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
397 Mammen MJ, Charbek E, Alexander PE, Nici L, Aaron SD. Reply to Vozoris: Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details. Am J Respir Crit Care Med 2021;203:267-9. [PMID: 33022179 DOI: 10.1164/rccm.202009-3605LE] [Reference Citation Analysis]
398 Shin HJ, Kim TO, Kim YI, Kim SH, Kim HK, Kim YH, Byun MK, Jung KS, Yoo KH, Lee JS, Lim SC; KOCOSS Cohort Study Group. The paradoxical response to short-acting bronchodilator administration in patients with chronic obstructive pulmonary disease. J Thorac Dis 2021;13:511-20. [PMID: 33717524 DOI: 10.21037/jtd-20-985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
399 Lee MK, Kim SB, Lee JH, Lee SJ, Kim SH, Lee WY, Yong SJ, Lee JH, Shin B. Association between airflow limitation and prognosis in patients with chronic pulmonary aspergillosis. J Thorac Dis 2021;13:681-8. [PMID: 33717541 DOI: 10.21037/jtd-20-1815] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
400 Firdausi NL, Artanti KD, Li C. Analysis of Risk Factors Affecting The Occurrence of Chronic Obstructive Pulmonary Disease in Indonesia. JBE 2021;9:18. [DOI: 10.20473/jbe.v9i12021.18-25] [Reference Citation Analysis]
401 Xu Y, Thakur A, Zhang Y, Foged C. Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects. Pharmaceutics 2021;13:177. [PMID: 33525500 DOI: 10.3390/pharmaceutics13020177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
402 Norful AA, de Jacq K, Liu J, Ye S, Khadka S, Poghosyan L. The impact of nurse practitioner and physician assistant workforce supply on Medicaid-related emergency department visits and hospitalizations. J Am Assoc Nurse Pract 2021. [PMID: 33534285 DOI: 10.1097/JXX.0000000000000542] [Reference Citation Analysis]
403 Singla S, Gong M, Riley C, Sciurba F, Batmanghelich K. Improving clinical disease subtyping and future events prediction through a chest CT-based deep learning approach. Med Phys 2021;48:1168-81. [PMID: 33340116 DOI: 10.1002/mp.14673] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
404 Yang Y, Jin X, Jiao X, Li J, Liang L, Ma Y, Liu R, Li Z. Advances in Pharmacological Actions and Mechanisms of Flavonoids from Traditional Chinese Medicine in Treating Chronic Obstructive Pulmonary Disease. Evid Based Complement Alternat Med 2020;2020:8871105. [PMID: 33488753 DOI: 10.1155/2020/8871105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
405 Kato T, Kasai T, Suda S, Sato A, Ishiwata S, Yatsu S, Matsumoto H, Shitara J, Shimizu M, Murata A, Kagiyama N, Hiki M, Matsue Y, Naito R, Takagi A, Daida H. Prognostic effects of arterial carbon dioxide levels in patients hospitalized into the cardiac intensive care unit for acute heart failure. Eur Heart J Acute Cardiovasc Care 2021;10:497-502. [PMID: 34192746 DOI: 10.1093/ehjacc/zuab001] [Reference Citation Analysis]
406 Cvejic L, Guiney N, Nicholson T, Lau KK, Finlay P, Hamza K, Osadnik C, Leong P, MacDonald M, King PT, Bardin PG. Aspiration and severe exacerbations in COPD: a prospective study. ERJ Open Res 2021;7:00735-2020. [PMID: 33532466 DOI: 10.1183/23120541.00735-2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
407 Treekitkarnmongkol W, Hassane M, Sinjab A, Chang K, Hara K, Rahal Z, Zhang J, Lu W, Sivakumar S, McDowell TL, Kantrowitz J, Zhou J, Lang W, Xu L, Ochieng JK, Nunomura-Nakamura S, Deng S, Behrens C, Raso MG, Fukuoka J, Reuben A, Ostrin EJ, Parra E, Solis LM, Spira AE, McAllister F, Cascone T, Wistuba II, Moghaddam SJ, Scheet PA, Fujimoto J, Kadara H. Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma Development. Am J Respir Crit Care Med 2021;203:90-101. [PMID: 32730093 DOI: 10.1164/rccm.202004-1079OC] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
408 Li LC, Han YY, Zhang ZH, Zhou WC, Fang HM, Qu J, Kan LD. Chronic Obstructive Pulmonary Disease Treatment and Pharmacist-Led Medication Management. Drug Des Devel Ther 2021;15:111-24. [PMID: 33469264 DOI: 10.2147/DDDT.S286315] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
409 Zhang Y, Tedrow J, Nouraie M, Li X, Chandra D, Bon J, Kass DJ, Fuhrman CR, Leader JK, Duncan SR, Kaminski N, Sciurba FC. Elevated plasma level of Pentraxin 3 is associated with emphysema and mortality in smokers. Thorax 2021;76:335-42. [PMID: 33479043 DOI: 10.1136/thoraxjnl-2020-215356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
410 Koda K, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T. Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease. Sci Rep 2021;11:1682. [PMID: 33462365 DOI: 10.1038/s41598-021-81313-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
411 Siu DCH, So CT, Lau CWL, Hui EHM, Fung A, Chan TM, Chan FSF, Chan CKF, Chen WPW, Cheung SHM, Chan KPY, Poon P, Cheung M, Chan C, Tse J, Fung V, Fong KNK. The Manchester Respiratory Activities of Daily Living Questionnaire: Reliability and Validity of the Chinese Version with Pictorial Enhancement. Int J Chron Obstruct Pulmon Dis 2021;16:91-100. [PMID: 33488072 DOI: 10.2147/COPD.S283769] [Reference Citation Analysis]
412 Kiani FZ, Ahmadi A. Prevalence of different comorbidities in chronic obstructive pulmonary disease among Shahrekord PERSIAN cohort study in southwest Iran. Sci Rep 2021;11:1548. [PMID: 33452286 DOI: 10.1038/s41598-020-79707-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
413 Wada H, Ikeda A, Maruyama K, Yamagishi K, Barnes PJ, Tanigawa T, Tamakoshi A, Iso H. Low BMI and weight loss aggravate COPD mortality in men, findings from a large prospective cohort: the JACC study. Sci Rep 2021;11:1531. [PMID: 33452329 DOI: 10.1038/s41598-020-79860-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
414 Zinellu E, Fois AG, Sotgiu E, Mellino S, Mangoni AA, Carru C, Zinellu A, Pirina P. Serum Albumin Concentrations in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. J Clin Med 2021;10:E269. [PMID: 33450916 DOI: 10.3390/jcm10020269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
415 Islam R, Hossain MT, Chakma N, Khanom A, Mazumder T, Islam MT. Prevalence, risk factors, and interventions for chronic obstructive pulmonary disease in South Asia: a scoping review protocol. Syst Rev 2021;10:20. [PMID: 33423676 DOI: 10.1186/s13643-020-01556-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
416 Pastor L, Vera E, Marin JM, Sanz-Rubio D. Extracellular Vesicles from Airway Secretions: New Insights in Lung Diseases. Int J Mol Sci 2021;22:E583. [PMID: 33430153 DOI: 10.3390/ijms22020583] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
417 Liu X, Wang J, Luo H, Xu C, Chen X, Zhang R. MiR-218 Inhibits CSE-Induced Apoptosis and Inflammation in BEAS-2B by Targeting BRD4. Int J Chron Obstruct Pulmon Dis 2020;15:3407-16. [PMID: 33408470 DOI: 10.2147/COPD.S278553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
418 Wageck B, Cox NS, McDonald CF, Burge AT, Mahal A, Hill CJ, Lee AL, Moore R, Nicolson C, O'Halloran P, Lahham A, Gillies R, Holland AE. The Impact of COPD Exacerbations in the Year Following Pulmonary Rehabilitation: Secondary Analysis of a Randomised Controlled Trial. Int J Chron Obstruct Pulmon Dis 2020;15:3423-31. [PMID: 33408472 DOI: 10.2147/COPD.S271094] [Reference Citation Analysis]
419 Kim CY, Kim BK, Kim YJ, Lee SH, Kim YS, Kim JH. Longitudinal Evaluation of the Relationship Between Low Socioeconomic Status and Incidence of Chronic Obstructive Pulmonary Disease: Korean Genome and Epidemiology Study (KoGES). Int J Chron Obstruct Pulmon Dis 2020;15:3447-54. [PMID: 33447022 DOI: 10.2147/COPD.S276639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
420 Li H, Xin H, Yu J, Yu H, Zhang J, Wang W, Peng D. Abnormal intrinsic functional hubs and connectivity in stable patients with COPD: a resting-state MRI study. Brain Imaging Behav 2020;14:573-85. [PMID: 31187474 DOI: 10.1007/s11682-019-00130-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
421 Pannu AK, Kumar M, Singh P, Shaji A, Ghosh A, Behera A, Sharda SC, Bhatia M, Singla N, Dhibar DP, Singh MP, Sharma N, Saroch A. Severe Acute Respiratory Infection Surveillance during the Initial Phase of the COVID-19 Outbreak in North India: A Comparison of COVID-19 to Other SARI Causes. Indian J Crit Care Med 2021;25:761-7. [PMID: 34316169 DOI: 10.5005/jp-journals-10071-23882] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
422 Priya N, Isaac BTJ, Thangakunam B, Christopher DJ. Effect of home-based pulmonary rehabilitation on health-related quality of life, lung function, exercise tolerance, and dyspnea in chronic obstructive pulmonary disorder patients in a tertiary care center in South India. Lung India 2021;38:211-5. [PMID: 33942743 DOI: 10.4103/lungindia.lungindia_895_20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
423 Du Y, Li Q, Sidorenkov G, Vonder M, Cai J, de Bock GH, Guan Y, Xia Y, Zhou X, Zhang D, Rook M, Vliegenthart R, Heuvelmans MA, Dorrius MD, van Ooijen PMA, Groen HJM, van der Harst P, Xiao Y, Ye Z, Xie X, Wang W, Oudkerk M, Fan L, Liu S. Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai: Rationale and Design of a Population-based Comparative Study. Acad Radiol 2021;28:36-45. [PMID: 32151538 DOI: 10.1016/j.acra.2020.01.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
424 Nattusami L, Hadda V, Khilnani GC, Madan K, Mittal S, Tiwari P, Mohan A, Khan MA, Guleria R. Co-existing obstructive sleep apnea among patients with chronic obstructive pulmonary disease. Lung India 2021;38:12-7. [PMID: 33402632 DOI: 10.4103/lungindia.lungindia_169_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
425 Yawn BP, Han M, Make BM, Mannino D, Brown RW, Meldrum C, Murray S, Spino C, Bronicki JS, Leidy N, Tapp H, Dolor RJ, Joo M, Knox L, Zittleman L, Thomashow BM, Martinez FJ. Protocol Summary of the COPD Assessment in Primary Care To Identify Undiagnosed Respiratory Disease and Exacerbation Risk (CAPTURE) Validation in Primary Care Study. Chronic Obstr Pulm Dis 2021;8. [PMID: 33156981 DOI: 10.15326/jcopdf.2020.0155] [Reference Citation Analysis]
426 Kim JS, Thomashow MA, Yip NH, Burkart KM, Lo Cascio CM, Shimbo D, Barr RG. Randomization to Omega-3 Fatty Acid Supplementation and Endothelial Function in COPD: The COD-Fish Randomized Controlled Trial. Chronic Obstr Pulm Dis 2021;8. [PMID: 33150779 DOI: 10.15326/jcopdf.8.1.2020.0132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
427 Gillenwater LA, Pratte KA, Hobbs BD, Cho MH, Zhuang Y, Halper-Stromberg E, Cruickshank-Quinn C, Reisdorph N, Petrache I, Labaki WW, O'Neal WK, Ortega VE, Jones DP, Uppal K, Jacobson S, Michelotti G, Wendt CH, Kechris KJ, Bowler RP. Plasma Metabolomic Signatures of Chronic Obstructive Pulmonary Disease and the Impact of Genetic Variants on Phenotype-Driven Modules. Netw Syst Med 2020;3:159-81. [PMID: 33987620 DOI: 10.1089/nsm.2020.0009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
428 Fu PK, Wei YF, Sheu CC, Wang CY, Hsu CK, Chen CM, Chen WC, Yang KY. Effect of Tiotropium Soft Mist Inhalers on Dynamic Changes in Lung Mechanics of Patients with Chronic Obstructive Pulmonary Disease Receiving Mechanical Ventilation: A Prospective Pilot Study. Pharmaceutics 2020;13:51. [PMID: 33396552 DOI: 10.3390/pharmaceutics13010051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
429 Seedahmed MI, Baugh AD, Kempker JA. Higher serum vitamin D levels are associated with decreased odds of obstructive lung disease in the general population: an NHANES analysis (2007-2008 to 2009-2010). BMJ Open Respir Res 2020;7:e000798. [PMID: 33384287 DOI: 10.1136/bmjresp-2020-000798] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
430 Tan J, Li L, Huang X, Yang C, Liang X, Zhao Y, Xie J, Chen R, Wang D, Xie S. Associations between gastro-oesophageal reflux disease and a range of diseases: an umbrella review of systematic reviews and meta-analyses. BMJ Open 2020;10:e038450. [PMID: 33380477 DOI: 10.1136/bmjopen-2020-038450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
431 Cabrera López C, Mascarós E, Azpeitia A, Villarrubia E. A Simplified Algorithm for the Diagnosis, Treatment, and Management of COPD in Routine Primary Care Practice. Int J Chron Obstruct Pulmon Dis 2020;15:3347-55. [PMID: 33364753 DOI: 10.2147/COPD.S281422] [Reference Citation Analysis]
432 Sivapalan P, Bonnesen B, Jensen JU. Novel Perspectives Regarding the Pathology, Inflammation, and Biomarkers of Acute Respiratory Distress Syndrome. Int J Mol Sci 2020;22:E205. [PMID: 33379178 DOI: 10.3390/ijms22010205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
433 Heo IR, Kim HC, Kim TH. Health-Related Quality of Life and Related Factors in Persons with Preserved Ratio Impaired Spirometry: Data from the Korea National Health and Nutrition Examination Surve. Medicina (Kaunas) 2020;57:4. [PMID: 33374629 DOI: 10.3390/medicina57010004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
434 Torén K, Schiöler L, Lindberg A, Andersson A, Behndig AF, Bergström G, Blomberg A, Caidahl K, Engvall JE, Eriksson MJ, Hamrefors V, Janson C, Kylhammar D, Lindberg E, Lindén A, Malinovschi A, Lennart Persson H, Sandelin M, Eriksson Ström J, Tanash H, Vikgren J, Johan Östgren C, Wollmer P, Sköld CM. The ratio FEV1 /FVC and its association to respiratory symptoms-A Swedish general population study. Clin Physiol Funct Imaging 2021;41:181-91. [PMID: 33284499 DOI: 10.1111/cpf.12684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
435 Mohebbichamkhorami M, Arbabi M, Mirzaei M, Ahmadi A, Hassanvand MS, Rouhi H. Ambient air particulate matter (PM10) satellite monitoring and respiratory health effects assessment. J Environ Health Sci Eng 2020;18:1247-58. [PMID: 33312639 DOI: 10.1007/s40201-020-00542-4] [Reference Citation Analysis]
436 Cortegiani A, Longhini F, Madotto F, Groff P, Scala R, Crimi C, Carlucci A, Bruni A, Garofalo E, Raineri SM, Tonelli R, Comellini V, Lupia E, Vetrugno L, Clini E, Giarratano A, Nava S, Navalesi P, Gregoretti C; H. F.-AECOPD study investigators. High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial. Crit Care 2020;24:692. [PMID: 33317579 DOI: 10.1186/s13054-020-03409-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
437 Eriksson Ström J, Pourazar J, Linder R, Blomberg A, Lindberg A, Bucht A, Behndig AF. Airway regulatory T cells are decreased in COPD with a rapid decline in lung function. Respir Res 2020;21:330. [PMID: 33317530 DOI: 10.1186/s12931-020-01593-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
438 Tripathi LP, Itoh MN, Takeda Y, Tsujino K, Kondo Y, Kumanogoh A, Mizuguchi K. Integrative Analysis Reveals Common and Unique Roles of Tetraspanins in Fibrosis and Emphysema. Front Genet 2020;11:585998. [PMID: 33424923 DOI: 10.3389/fgene.2020.585998] [Reference Citation Analysis]
439 Sicras-Mainar A, de Abajo FJ, Izquierdo-Alonso JL. Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study. Int J Chron Obstruct Pulmon Dis 2020;15:3291-302. [PMID: 33328730 DOI: 10.2147/COPD.S281333] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
440 Tashiro H, Kurihara Y, Takahashi K, Sadamatsu H, Haraguchi T, Tajiri R, Takamori A, Kimura S, Sueoka-Aragane N. Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease. BMC Pulm Med 2020;20:318. [PMID: 33287777 DOI: 10.1186/s12890-020-01362-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
441 Li T, Fanning KV, Nyunoya T, Chen Y, Zou C. Cigarette smoke extract induces airway epithelial cell death via repressing PRMT6/AKT signaling. Aging (Albany NY) 2020;12:24301-17. [PMID: 33260152 DOI: 10.18632/aging.202210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
442 Huang Y, Jiang B, Miao X, Ma J, Wang J, Ding K, Chen X, Hu Q, Fu F, Zeng T, Hu J, Hu B, Yang D, Zhang X. The Relationship of Lymphocyte to High-Density Lipoprotein Ratio with Pulmonary Function in COPD. Int J Chron Obstruct Pulmon Dis 2020;15:3159-69. [PMID: 33293805 DOI: 10.2147/COPD.S276372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
443 Şengören Dikiş Ö, Yildiz T, Us Dulger S, Yuksel Kacan C, Haberal MA, Cetin T. Does occupational air pollution threaten the lung health of indoor workers more than those of bus drivers?: a cross-sectional study. Aging Male 2020;23:934-40. [PMID: 31282830 DOI: 10.1080/13685538.2019.1635579] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
444 Moll M, Lutz SM, Ghosh AJ, Sakornsakolpat P, Hersh CP, Beaty TH, Dudbridge F, Tobin MD, Mittleman MA, Silverman EK, Hobbs BD, Cho MH. Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies. BMJ Open Respir Res 2020;7:e000755. [PMID: 33239407 DOI: 10.1136/bmjresp-2020-000755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
445 Li XY, Tang X, Wang R, Yuan X, Zhao Y, Wang L, Li HC, Chu HW, Li J, Mao WP, Wang YJ, Tian ZH, Liu JH, Luo Q, Sun B, Tong ZH. High-Flow Nasal Cannula for Chronic Obstructive Pulmonary Disease with Acute Compensated Hypercapnic Respiratory Failure: A Randomized, Controlled Trial. Int J Chron Obstruct Pulmon Dis 2020;15:3051-61. [PMID: 33262584 DOI: 10.2147/COPD.S283020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
446 Shin B, Kim SB, Kim CW, Park IH, Lee WY, Byun CS. Risk factors related to the recurrence of pneumothorax in patients with emphysema. J Thorac Dis 2020;12:5802-10. [PMID: 33209412 DOI: 10.21037/jtd-20-1557B] [Reference Citation Analysis]
447 Qin W, Yin J, Yang L, Yang S, Li Y, Li X, Hu W. The Relationship Between Chronic Obstructive Pulmonary Disease and Cerebral Small Vessel Disease Assessed by Magnetic Resonance Imaging: A Case-Control Study from a Single Center in Beijing, China. Med Sci Monit 2020;26:e925703. [PMID: 33214543 DOI: 10.12659/MSM.925703] [Reference Citation Analysis]
448 Gazourian L, Thedinger WB, Regis SM, Pagura EJ, Price LL, Gawlik M, Stefanescu CF, Lamb C, Rieger-Christ KM, Singh H, Casasola M, Walker AR, Rupal A, Patel AS, Come CE, Sanayei AM, Long WP, Rizzo GS, McKee AB, Washko GR, San Jose Estepar R, Wald C, McKee BJ, Thomson CC, Liesching TN. Qualitative emphysema and risk of COPD hospitalization in a multicenter CT lung cancer screening cohort study. Respir Med 2021;176:106245. [PMID: 33253972 DOI: 10.1016/j.rmed.2020.106245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
449 Lei Z, Guo H, Zou S, Jiang J, Kui Y, Song J. Long non-coding RNA maternally expressed gene regulates cigarette smoke extract induced lung inflammation and human bronchial epithelial apoptosis via miR-149-3p. Exp Ther Med 2021;21:60. [PMID: 33365060 DOI: 10.3892/etm.2020.9492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
450 Guo H, Su Y, Deng F. Effects of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Future Perspectives. Stem Cell Rev Rep 2021;17:440-58. [PMID: 33211245 DOI: 10.1007/s12015-020-10085-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
451 Saiphoklang N, Poachanukoon O, Soorapan S. Smoking characteristics and lung functions among university athletes. Sci Rep 2020;10:20118. [PMID: 33208923 DOI: 10.1038/s41598-020-77248-y] [Reference Citation Analysis]
452 Zannin E, Milesi I, Porta R, Cacciatore S, Barbano L, Trentin R, Fanfulla F, Vitacca M, Dellacà RL. Effect of nocturnal EPAP titration to abolish tidal expiratory flow limitation in COPD patients with chronic hypercapnia: a randomized, cross-over pilot study. Respir Res 2020;21:301. [PMID: 33208164 DOI: 10.1186/s12931-020-01567-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
453 Suissa S. Inhaled Corticosteroid Withdrawal in Chronic Obstructive Pulmonary Disease: Can IMPACT Help? Am J Respir Crit Care Med 2020;202:1202-4. [PMID: 32758097 DOI: 10.1164/rccm.202006-2600ED] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
454 Xie Z, Ossip DJ, Rahman I, Li D. Use of Electronic Cigarettes and Self-Reported Chronic Obstructive Pulmonary Disease Diagnosis in Adults. Nicotine Tob Res 2020;22:1155-61. [PMID: 31830263 DOI: 10.1093/ntr/ntz234] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
455 Zucchi JW, Franco EAT, Schreck T, Castro E Silva MH, Migliorini SRDS, Garcia T, Mota GAF, de Morais BEB, Machado LHS, Batista ANR, de Paiva SAR, de Godoy I, Tanni SE. Different Clusters in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Two-Center Study in Brazil. Int J Chron Obstruct Pulmon Dis 2020;15:2847-56. [PMID: 33192058 DOI: 10.2147/COPD.S268332] [Reference Citation Analysis]
456 Sigurgeirsdottir J, Halldorsdottir S, Arnardottir RH, Gudmundsson G, Bjornsson EH. Frustrated Caring: Family Members' Experience of Motivating COPD Patients Towards Self-Management. Int J Chron Obstruct Pulmon Dis 2020;15:2953-65. [PMID: 33235444 DOI: 10.2147/COPD.S273903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
457 Goffin JR, Pond GR, Puksa S, Tremblay A, Johnston M, Goss G, Nicholas G, Martel S, Bhatia R, Liu G, Schmidt H, Atkar-Khattra S, McWilliams A, Tsao MS, Tammemagi MC, Lam S. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population. BMC Pulm Med 2020;20:300. [PMID: 33198781 DOI: 10.1186/s12890-020-01344-y] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
458 Chen T, Zhong F, Yao C, Chen J, Xiang Y, Dong J, Yan Z, Ma Y. A Systematic Review on Traditional Uses, Sources, Phytochemistry, Pharmacology, Pharmacokinetics, and Toxicity of Fritillariae Cirrhosae Bulbus. Evid Based Complement Alternat Med 2020;2020:1536534. [PMID: 33273948 DOI: 10.1155/2020/1536534] [Reference Citation Analysis]
459 Ritchie AI, Brill SE, Vlies BH, Finney LJ, Allinson JP, Alves-Moreira L, Wiseman DJ, Walker PP, Baker E, Elkin SL, Mallia P, Law M, Donaldson GC, Calverley PMA, Wedzicha JA. Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial. Am J Respir Crit Care Med 2020;202:549-57. [PMID: 32267724 DOI: 10.1164/rccm.201910-2058OC] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
460 Ono M, Kobayashi S, Hanagama M, Ishida M, Sato H, Makiguchi T, Yanai M. Clinical characteristics of Japanese patients with chronic obstructive pulmonary disease (COPD) with comorbid interstitial lung abnormalities: A cross-sectional study. PLoS One 2020;15:e0239764. [PMID: 33170864 DOI: 10.1371/journal.pone.0239764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
461 Li L, Borland R, Cummings KM, McNeill A, Heckman BW, Fong GT, O'Connor RJ, Driezen P. Are health conditions and concerns about health effects of smoking predictive of quitting? Findings from the ITC 4CV Survey ( 2016-2018 ). Tob Prev Cessat 2020;6:60. [PMID: 33163706 DOI: 10.18332/tpc/127471] [Reference Citation Analysis]
462 Lundell S, Pesola UM, Nyberg A, Wadell K. Groping around in the dark for adequate COPD management: a qualitative study on experiences in long-term care. BMC Health Serv Res 2020;20:1025. [PMID: 33167968 DOI: 10.1186/s12913-020-05875-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
463 Veith M, Tüffers J, Peychev E, Klemmer A, Kotke V, Janciauskiene S, Wilhelm S, Bals R, Koczulla AR, Vogelmeier CF, Greulich T. The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis. Int J Chron Obstruct Pulmon Dis 2020;15:2827-36. [PMID: 33192056 DOI: 10.2147/COPD.S271810] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
464 Xia J, Sun L, Xu S, Xiang Q, Zhao J, Xiong W, Xu Y, Chu S. A Model Using Support Vector Machines Recursive Feature Elimination (SVM-RFE) Algorithm to Classify Whether COPD Patients Have Been Continuously Managed According to GOLD Guidelines. Int J Chron Obstruct Pulmon Dis 2020;15:2779-86. [PMID: 33177815 DOI: 10.2147/COPD.S271237] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
465 Conlon TM, John-Schuster G, Heide D, Pfister D, Lehmann M, Hu Y, Ertüz Z, Lopez MA, Ansari M, Strunz M, Mayr C, Angelidis I, Ciminieri C, Costa R, Kohlhepp MS, Guillot A, Günes G, Jeridi A, Funk MC, Beroshvili G, Prokosch S, Hetzer J, Verleden SE, Alsafadi H, Lindner M, Burgstaller G, Becker L, Irmler M, Dudek M, Janzen J, Goffin E, Gosens R, Knolle P, Pirotte B, Stoeger T, Beckers J, Wagner D, Singh I, Theis FJ, de Angelis MH, O'Connor T, Tacke F, Boutros M, Dejardin E, Eickelberg O, Schiller HB, Königshoff M, Heikenwalder M, Yildirim AÖ. Inhibition of LTβR signalling activates WNT-induced regeneration in lung. Nature 2020;588:151-6. [PMID: 33149305 DOI: 10.1038/s41586-020-2882-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
466 Huber MB, Kurz C, Kirsch F, Schwarzkopf L, Schramm A, Leidl R. The relationship between body mass index and health-related quality of life in COPD: real-world evidence based on claims and survey data. Respir Res 2020;21:291. [PMID: 33143706 DOI: 10.1186/s12931-020-01556-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
467 Calverley PMA. Defining Airflow Obstruction: More Data, Further Clarity. Am J Respir Crit Care Med 2020;202:649-50. [PMID: 32402208 DOI: 10.1164/rccm.202005-1551ED] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
468 Chen J, Li X, Huang C, Lin Y, Dai Q. Change of Serum Inflammatory Cytokines Levels in Patients With Chronic Obstructive Pulmonary Disease, Pneumonia and Lung Cancer. Technol Cancer Res Treat 2020;19:1533033820951807. [PMID: 33111646 DOI: 10.1177/1533033820951807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
469 Vestbo J. Editorial: Risk Prediction in Smokers. Chronic Obstr Pulm Dis 2020;7:297-9. [PMID: 33108108 DOI: 10.15326/jcopdf.7.4.2020.0174] [Reference Citation Analysis]
470 Hosoki K, Mikami Y, Urushiyama H, Souma K, Kawamura G, Uchida K, Nagase T, Jo T. Predictors of postoperative acute exacerbation of interstitial lung disease: a case-control study. BMJ Open Respir Res 2020;7:e000634. [PMID: 33115770 DOI: 10.1136/bmjresp-2020-000634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
471 Ritchie AI, Wedzicha JA. Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations. Clin Chest Med 2020;41:421-38. [PMID: 32800196 DOI: 10.1016/j.ccm.2020.06.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
472 Shirinbayan P, Salavati M, Soleimani F, Saeedi A, Vameghi R. Underlying pathway of factors leading to mental health in Iranian young adolescents: A structural equation modeling. J Res Med Sci 2020;25:75. [PMID: 33088312 DOI: 10.4103/jrms.JRMS_138_20] [Reference Citation Analysis]
473 Dong H, Hao Y, Li D, Su Z, Li W, Shi B, Gao P. Risk Factors for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Industrial Regions of China: A Multicenter Cross-Sectional Study. Int J Chron Obstruct Pulmon Dis 2020;15:2249-56. [PMID: 33061342 DOI: 10.2147/COPD.S270729] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
474 Watanabe Y, Tajiri K, Suzuki A, Nagata H, Kojima M. Influence of cigarette smoking on biventricular systolic function independent of respiratory function: a cross-sectional study. BMC Cardiovasc Disord 2020;20:451. [PMID: 33059582 DOI: 10.1186/s12872-020-01732-6] [Reference Citation Analysis]
475 Zhu J, Zhao Z, Wu B, Shi Z, Nie Q, Fu Z, Zeng Z, Hu W, Dong M, Xiong M, Hu K. Effect of Body Mass Index on Lung Function in Chinese Patients with Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study. Int J Chron Obstruct Pulmon Dis 2020;15:2477-86. [PMID: 33116464 DOI: 10.2147/COPD.S265676] [Reference Citation Analysis]
476 Stott-Miller M, Müllerová H, Miller B, Tabberer M, El Baou C, Keeley T, Martinez FJ, Han M, Dransfield M, Hansel NN, Cooper CB, Woodruff P, Ortega VE, Comellas AP, Paine Iii R, Kanner RE, Anderson W, Drummond MB, Kim V, Tal-Singer R, Lazaar AL. Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort. Int J Chron Obstruct Pulmon Dis 2020;15:2467-76. [PMID: 33116463 DOI: 10.2147/COPD.S267002] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
477 Carlier FM, Dupasquier S, Ambroise J, Detry B, Lecocq M, Biétry-Claudet C, Boukala Y, Gala JL, Bouzin C, Verleden SE, Hoton D, Gohy S, Bearzatto B, Pilette C. Canonical WNT pathway is activated in the airway epithelium in chronic obstructive pulmonary disease. EBioMedicine 2020;61:103034. [PMID: 33045470 DOI: 10.1016/j.ebiom.2020.103034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
478 Kirschner SK, Deutz NEP, Jonker R, Olde Damink SWM, Harrykissoon RI, Zachria AJ, Dasarathy S, Engelen MPKJ. Intestinal function is impaired in patients with Chronic Obstructive Pulmonary Disease. Clin Nutr 2021;40:2270-7. [PMID: 33873268 DOI: 10.1016/j.clnu.2020.10.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
479 Kermenli T, Azar C. Analysis of lung volume reduction surgery results with video-assisted thoracoscopic surgery in emphysematous lung patients. Kardiochir Torakochirurgia Pol 2020;17:127-31. [PMID: 33014087 DOI: 10.5114/kitp.2020.99075] [Reference Citation Analysis]
480 Sang L, Zhao Z, Yun PJ, Frerichs I, Möller K, Fu F, Liu X, Zhong N, Li Y. Qualitative and quantitative assessment of pendelluft: a simple method based on electrical impedance tomography. Ann Transl Med 2020;8:1216. [PMID: 33178748 DOI: 10.21037/atm-20-4182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
481 Takahashi K, Uchida M, Kato G, Takamori A, Kinoshita T, Yoshida M, Tajiri R, Kojima K, Inoue H, Kobayashi H, Sadamatsu H, Tashiro H, Tanaka M, Hayashi S, Kawaguchi A, Kimura S, Sueoka-Aragane N, Kawayama T; Saga-naïve COPD Physical Activity Evaluation (SCOPE) Study Investigator Group. First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2020;15:2115-26. [PMID: 32982204 DOI: 10.2147/COPD.S268905] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
482 Ruzycki CA, Murphy B, Nathoo H, Finlay WH, Martin AR. Combined in Vitro-in Silico Approach to Predict Deposition and Pharmacokinetics of Budesonide Dry Powder Inhalers. Pharm Res 2020;37:209. [PMID: 32995953 DOI: 10.1007/s11095-020-02924-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
483 Li J, Wang Q, Zhang Q, Wang Z, Wan X, Miao C, Zeng X. Higher Blood Vascular Cell Adhesion Molecule-1 is Related to the Increased Risk of Cardiovascular Events in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2020;15:2289-95. [PMID: 33061346 DOI: 10.2147/COPD.S264889] [Reference Citation Analysis]
484 Huang TM, Kuo KC, Wang YH, Wang CY, Lai CC, Wang HC, Chen L, Yu CJ; On the behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE). Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids. BMC Infect Dis 2020;20:706. [PMID: 32977747 DOI: 10.1186/s12879-020-05440-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
485 Bhatt SP, Bodduluri S, Raghav V, Bhakta NR, Wilson CG, Kim YI, Eberlein M, Sciurba FC, Han MK, Dransfield MT, Nakhmani A. The Peak Index: Spirometry Metric for Airflow Obstruction Severity and Heterogeneity. Ann Am Thorac Soc 2019;16:982-9. [PMID: 30865842 DOI: 10.1513/AnnalsATS.201811-812OC] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
486 Zhou A, Zhou Z, Deng D, Zhao Y, Duan J, Cheng W, Liu C, Chen P. The Value of FENO Measurement for Predicting Treatment Response in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2020;15:2257-66. [PMID: 33061343 DOI: 10.2147/COPD.S263673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
487 Singla E, Puri G, Dharwal V, Naura AS. Gallic acid ameliorates COPD-associated exacerbation in mice. Mol Cell Biochem 2021;476:293-302. [PMID: 32965595 DOI: 10.1007/s11010-020-03905-5] [Reference Citation Analysis]
488 Richmond BW, Mansouri S, Serezani A, Novitskiy S, Blackburn JB, Du RH, Fuseini H, Gutor S, Han W, Schaff J, Vasiukov G, Xin MK, Newcomb DC, Jin L, Blackwell TS, Polosukhin VV. Monocyte-derived dendritic cells link localized secretory IgA deficiency to adaptive immune activation in COPD. Mucosal Immunol 2021;14:431-42. [PMID: 32968197 DOI: 10.1038/s41385-020-00344-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
489 Hu W, Dong M, Xiong M, Zhao D, Zhao Y, Wang M, Wang T, Liu Z, Lu L, Hu K. Clinical Courses and Outcomes of Patients with Chronic Obstructive Pulmonary Disease During the COVID-19 Epidemic in Hubei, China. Int J Chron Obstruct Pulmon Dis 2020;15:2237-48. [PMID: 33061341 DOI: 10.2147/COPD.S265004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
490 Mega TA, Anbese ZK, Yoo SD. Mortality and its predictors among patients treated for acute exacerbations of chronic obstructive respiratory diseases in Jimma Medical Center; Jimma, Ethiopia: Prospective observational study. PLoS One 2020;15:e0239055. [PMID: 32966334 DOI: 10.1371/journal.pone.0239055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
491 Liu D, Meister M, Zhang S, Vong CI, Wang S, Fang R, Li L, Wang PG, Massion P, Ji X. Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease. Respir Res 2020;21:242. [PMID: 32957957 DOI: 10.1186/s12931-020-01507-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
492 Paudel KR, Dharwal V, Patel VK, Galvao I, Wadhwa R, Malyla V, Shen SS, Budden KF, Hansbro NG, Vaughan A, Yang IA, Kohonen-Corish MRJ, Bebawy M, Dua K, Hansbro PM. Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases. Front Med (Lausanne) 2020;7:554. [PMID: 33043031 DOI: 10.3389/fmed.2020.00554] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
493 Robinson SA, Wan ES, Shimada SL, Richardson CR, Moy ML. Age and Attitudes Towards an Internet-Mediated, Pedometer-Based Physical Activity Intervention for Chronic Obstructive Pulmonary Disease: Secondary Analysis. JMIR Aging 2020;3:e19527. [PMID: 32902390 DOI: 10.2196/19527] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
494 Fedele D, De Francesco A, Riso S, Collo A. Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: An overview.Nutrition. 2021;81:111016. [PMID: 33059127 DOI: 10.1016/j.nut.2020.111016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
495 Uno T, Homma T, Shigemura M, Fukuda Y, Kimura T, Onitsuka C, Kawahara T, Sato H, Akimoto K, Suganuma H, Kashima A, Yamamoto S, Ebato T, Matsunaga T, Kaneko K, Mikuni H, Sato H, Uchida Y, Fujiwara A, Kuwahara N, Manabe R, Ida H, Hirai K, Miyata Y, Jinno M, Ohta S, Kishino Y, Inoue H, Yamamoto M, Watanabe Y, Kusumoto S, Ando K, Suzuki S, Tanaka A, Ohmori T, Sagara H. Correlation of Arterial CO2 and Respiratory Impedance Values among Subjects with COPD. J Clin Med 2020;9:E2819. [PMID: 32878165 DOI: 10.3390/jcm9092819] [Reference Citation Analysis]
496 Yoon JK, Lee JK, Lee CH, Hwang YI, Kim H, Park D, Hwang KE, Kim SH, Jung KS, Yoo KH, Ra SW, Kim DK. The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients. Int J Chron Obstruct Pulmon Dis 2020;15:2061-70. [PMID: 32943859 DOI: 10.2147/COPD.S258353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
497 Mohammadtursun N, Li Q, Abuduwaki M, Jiang S, Zhang H, Sun J, Dong J. Loki zupa alleviates inflammatory and fibrotic responses in cigarette smoke induced rat model of chronic obstructive pulmonary disease. Chin Med 2020;15:92. [PMID: 32874197 DOI: 10.1186/s13020-020-00373-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
498 Chang YP, Lai CH, Lin CY, Chang YC, Lin MC, Chong IW, Sheu CC, Wei YF, Chu KA, Tsai JR, Lee CH, Chen YC. Mortality and vertebral fracture risk associated with long-term oral steroid use in patients with chronic obstructive pulmonary disease: A systemic review and meta-analysis. Chron Respir Dis 2019;16:1479973119838280. [PMID: 30939917 DOI: 10.1177/1479973119838280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
499 Tiew PY, Ko FWS, Pang SL, Matta SA, Sio YY, Poh ME, Lau KJX, Mac Aogáin M, Jaggi TK, Ivan FX, Gaultier NE, Uchida A, Drautz-Moses DI, Xu H, Koh MS, Hui DSC, Tee A, Abisheganaden JA, Schuster SC, Chew FT, Chotirmall SH. Environmental fungal sensitisation associates with poorer clinical outcomes in COPD. Eur Respir J 2020;56:2000418. [PMID: 32341102 DOI: 10.1183/13993003.00418-2020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
500 Burgel PR, Chotirmall SH. "Can't Stop the Feeling": Symptoms as the Key to Trial Success in Bronchiectasis? Am J Respir Crit Care Med 2020;201:1461-2. [PMID: 32209029 DOI: 10.1164/rccm.202003-0632ED] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
501 Zhang WZ. The Origins of Chronic Obstructive Pulmonary Disease: Sometimes the Journey Matters More than the Destination. Am J Respir Crit Care Med 2020;202:159-61. [PMID: 32391710 DOI: 10.1164/rccm.202004-0959ED] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
502 Cooper CB, Sirichana W, Arnold MT, Neufeld EV, Taylor M, Wang X, Dolezal BA. Remote Patient Monitoring for the Detection of COPD Exacerbations. Int J Chron Obstruct Pulmon Dis 2020;15:2005-13. [PMID: 33061338 DOI: 10.2147/COPD.S256907] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
503 Hu Y, Yao D, Ung COL, Hu H. Promoting Community Pharmacy Practice for Chronic Obstructive Pulmonary Disease (COPD) Management: A Systematic Review and Logic Model. Int J Chron Obstruct Pulmon Dis 2020;15:1863-75. [PMID: 32821091 DOI: 10.2147/COPD.S254477] [Reference Citation Analysis]
504 Amin Arefi SM, Tony Yang CW, Sin DD, Feng JJ. Simulation of nanoparticle transport and adsorption in a microfluidic lung-on-a-chip device. Biomicrofluidics 2020;14:044117. [PMID: 32849976 DOI: 10.1063/5.0011353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
505 Bond EG, Abrahamyan L, Khan MKA, Gershon A, Krahn M, Li P, Mian R, Mitsakakis N, Sadatsafavi M, To T, Pechlivanoglou P; Canadian Respiratory Research Network. Understanding resource utilization and mortality in COPD to support policy making: A microsimulation study. PLoS One 2020;15:e0236559. [PMID: 32817636 DOI: 10.1371/journal.pone.0236559] [Reference Citation Analysis]
506 Wageck B, Cox NS, Bondarenko J, Corbett M, Nichols A, Moore R, Holland AE. Early home-based pulmonary rehabilitation following acute exacerbation of COPD: A feasibility study using an action research approach. Chron Respir Dis 2020;17:1479973120949207. [PMID: 32815732 DOI: 10.1177/1479973120949207] [Reference Citation Analysis]
507 Syed N, Road JD, Ryerson CJ, Guenette JA. Evaluation of the Vibe Actigraph in Patients With Chronic Obstructive Pulmonary Disease: A Pilot Study. IEEE J Transl Eng Health Med 2020;8:2700708. [PMID: 32879810 DOI: 10.1109/JTEHM.2020.3018399] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
508 Rajnoveanu RM, Rajnoveanu AG, Ardelean AB, Todea DA, Pop CM, Antoniu SA, Motoc NS, Chis AF, Fildan AP, Man MA. Pulmonologists Adherence to the Chronic Obstructive Pulmonary Disease GOLD Guidelines: A Goal to Improve. Medicina (Kaunas) 2020;56:E422. [PMID: 32825456 DOI: 10.3390/medicina56090422] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
509 Leutz-Schmidt P, Wielpütz MO, Skornitzke S, Weinheimer O, Kauczor HU, Puderbach MU, Pahn G, Stiller W. Influence of acquisition settings and radiation exposure on CT lung densitometry-An anthropomorphic ex vivo phantom study. PLoS One 2020;15:e0237434. [PMID: 32797096 DOI: 10.1371/journal.pone.0237434] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
510 Ahmadi A, Eftekhari MH, Mazloom Z, Masoompour M, Fararooei M, Eskandari MH, Mehrabi S, Bedeltavana A, Famouri M, Zare M, Nasimi N, Sohrabi Z. Fortified whey beverage for improving muscle mass in chronic obstructive pulmonary disease: a single-blind, randomized clinical trial. Respir Res 2020;21:216. [PMID: 32807165 DOI: 10.1186/s12931-020-01466-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
511 Moll M, Sakornsakolpat P, Shrine N, Hobbs BD, DeMeo DL, John C, Guyatt AL, McGeachie MJ, Gharib SA, Obeidat M, Lahousse L, Wijnant SRA, Brusselle G, Meyers DA, Bleecker ER, Li X, Tal-Singer R, Manichaikul A, Rich SS, Won S, Kim WJ, Do AR, Washko GR, Barr RG, Psaty BM, Bartz TM, Hansel NN, Barnes K, Hokanson JE, Crapo JD, Lynch D, Bakke P, Gulsvik A, Hall IP, Wain L, Weiss ST, Silverman EK, Dudbridge F, Tobin MD, Cho MH; International COPD Genetics Consortium., SpiroMeta Consortium. Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts. Lancet Respir Med 2020;8:696-708. [PMID: 32649918 DOI: 10.1016/S2213-2600(20)30101-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
512 Andreas S, Bothner U, de la Hoz A, Kloer I, Trampisch M, Alter P. No Influence on Cardiac Arrhythmia or Heart Rate from Long-Term Treatment with Tiotropium/Olodaterol versus Monocomponents by Holter ECG Analysis in Patients with Moderate-to-Very-Severe COPD. Int J Chron Obstruct Pulmon Dis 2020;15:1945-53. [PMID: 32848380 DOI: 10.2147/COPD.S246350] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
513 Ancel J, Belgacemi R, Perotin JM, Diabasana Z, Dury S, Dewolf M, Bonnomet A, Lalun N, Birembaut P, Polette M, Deslée G, Dormoy V. Sonic hedgehog signalling as a potential endobronchial biomarker in COPD. Respir Res 2020;21:207. [PMID: 32767976 DOI: 10.1186/s12931-020-01478-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
514 Tan D, Walline JH, Ling B, Xu Y, Sun J, Wang B, Shan X, Wang Y, Cao P, Zhu Q, Geng P, Xu J. High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial. Crit Care 2020;24:489. [PMID: 32762701 DOI: 10.1186/s13054-020-03214-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
515 Sun T, Li X, Cheng W, Peng Y, Zhao Y, Liu C, Zeng Y, Chen Y, Cai S, Chen P. The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD. Int J Chron Obstruct Pulmon Dis 2020;15:1899-907. [PMID: 32848378 DOI: 10.2147/COPD.S255030] [Reference Citation Analysis]
516 Huang J, Reinhardt JD, Dai R, Wang P, Zhou M. Validation of the brief international classification of functioning, disability, and health core set for obstructive pulmonary disease in the Chinese context. Chron Respir Dis 2019;16:1479973119843648. [PMID: 31091985 DOI: 10.1177/1479973119843648] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
517 Gershon AS, Chung H, Porter J, Campitelli MA, Buchan SA, Schwartz KL, Crowcroft NS, Campigotto A, Gubbay JB, Karnauchow T, Katz K, McGeer AJ, McNally JD, Richardson DC, Richardson SE, Rosella LC, Simor AE, Smieja M, Zahariadis G, Kwong JC. Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease. J Infect Dis 2020;221:42-52. [PMID: 31549165 DOI: 10.1093/infdis/jiz419] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
518 Blanco I, Valeiro B, Torres-castro R, Barberán-garcía A, Torralba Y, Moisés J, Sebastián L, Osorio J, Rios J, Gimeno-santos E, Roca J, Barberà JA. Effects of Pulmonary Hypertension on Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease. Archivos de Bronconeumología (English Edition) 2020;56:499-505. [DOI: 10.1016/j.arbr.2019.10.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
519 Mansour W, El-shabrawy M, Khalil WA, Eldamanhory AS, Embarak S. Arterial stiffness can occur early in mild-to-moderate chronic obstructive pulmonary disease. Egypt J Bronchol 2020;14. [DOI: 10.1186/s43168-020-00014-1] [Reference Citation Analysis]
520 Kinjo T, Kitaguchi Y, Droma Y, Yasuo M, Wada Y, Ueno F, Ota M, Hanaoka M. The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients. Sci Rep 2020;10:12811. [PMID: 32732977 DOI: 10.1038/s41598-020-69184-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
521 Ferrer M, Torres A. Noninvasive Ventilation and High-Flow Nasal Therapy Administration in Chronic Obstructive Pulmonary Disease Exacerbations. Semin Respir Crit Care Med 2020;41:786-97. [PMID: 32725614 DOI: 10.1055/s-0040-1712101] [Reference Citation Analysis]
522 Remy KE, Verhoef PA, Malone JR, Ruppe MD, Kaselitz TB, Lodeserto F, Hirshberg EL, Slonim A, Dezfulian C. Caring for Critically Ill Adults With Coronavirus Disease 2019 in a PICU: Recommendations by Dual Trained Intensivists. Pediatr Crit Care Med 2020;21:607-19. [PMID: 32420720 DOI: 10.1097/PCC.0000000000002429] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
523 Gonzalez J, Rivera-Ortega P, Rodríguez-Fraile M, Restituto P, Colina I, Calleja MLD, Alcaide AB, Campo A, Bertó J, Seijo L, Pérez-Warnisher MT, Zulueta JJ, Varo N, de-Torres JP. Exploring the Association Between Emphysema Phenotypes and Low Bone Mineral Density in Smokers with and without COPD. Int J Chron Obstruct Pulmon Dis 2020;15:1823-9. [PMID: 32801680 DOI: 10.2147/COPD.S257918] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
524 Alwashmi MF, Fitzpatrick B, Farrell J, Gamble JM, Davis E, Nguyen HV, Farrell G, Hawboldt J. Perceptions of Patients Regarding Mobile Health Interventions for the Management of Chronic Obstructive Pulmonary Disease: Mixed Methods Study. JMIR Mhealth Uhealth 2020;8:e17409. [PMID: 32706697 DOI: 10.2196/17409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
525 Rangelov BA, Young AL, Jacob J, Cahn AP, Lee S, Wilson FJ, Hawkes DJ, Hurst JR. Thoracic Imaging at Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review. Int J Chron Obstruct Pulmon Dis 2020;15:1751-87. [PMID: 32801677 DOI: 10.2147/COPD.S250746] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
526 Rong B, Fu T, Rong C, Liu W, Li K, Liu H. Correlation between serum IL-32 concentration and clinical parameters of stable COPD: a retrospective clinical analysis. Sci Rep 2020;10:12092. [PMID: 32694699 DOI: 10.1038/s41598-020-69000-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
527 Wang J, Wan Z, Liu Q, Wang B, Wang L, Yang D, Wang L, Hong Y, Zhu R. Predictive Value of Red Blood Cell Distribution Width in Chronic Obstructive Pulmonary Disease Patients with Pulmonary Embolism. Anal Cell Pathol (Amst) 2020;2020:1935742. [PMID: 32775176 DOI: 10.1155/2020/1935742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
528 Ali L, Wallström S, Barenfeld E, Fors A, Fredholm E, Gyllensten H, Swedberg K, Ekman I. Person-centred care by a combined digital platform and structured telephone support for people with chronic obstructive pulmonary disease and/or chronic heart failure: study protocol for the PROTECT randomised controlled trial. BMJ Open 2020;10:e036356. [PMID: 32690519 DOI: 10.1136/bmjopen-2019-036356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
529 Jang YO, Lee SH, Choi JJ, Kim DH, Choi JM, Kang MJ, Oh YM, Park YJ, Shin Y, Lee SW. Fecal microbial transplantation and a high fiber diet attenuates emphysema development by suppressing inflammation and apoptosis. Exp Mol Med 2020;52:1128-39. [PMID: 32681029 DOI: 10.1038/s12276-020-0469-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
530 Berner K, Albertyn SCS, Dawnarain S, Hendricks LJ, Johnson J, Landman A, Burger M. The effectiveness of combined lower limb strengthening and whole-body vibration, compared to strengthening alone, for improving patient-centred outcomes in adults with COPD: A systematic review. S Afr J Physiother 2020;76:1412. [PMID: 32671277 DOI: 10.4102/sajp.v76i1.1412] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
531 Xiong H, Huang Q, Shuai T, Zhu L, Zhang C, Zhang M, Wang Y, Liu J. Assessment of comorbidities and prognosis in patients with COPD diagnosed with the fixed ratio and the lower limit of normal: a systematic review and meta-analysis. Respir Res 2020;21:189. [PMID: 32677946 DOI: 10.1186/s12931-020-01450-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
532 Wang Y, Bahar MA, Jansen AME, Kocks JWH, Alffenaar JC, Hak E, Wilffert B, Borgsteede SD. Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients. J Antimicrob Chemother 2019;74:2848-64. [PMID: 31127283 DOI: 10.1093/jac/dkz221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
533 Stapleton EM, Kizhakke Puliyakote A, Metwali N, Jeronimo M, Thornell IM, Manges RB, Bilas M, Kamal Batcha MA, Kumaravel MS, Durairaj K, Karuppusamy K, Kathiresan G, Rahim SA, Shanmugam K, Thorne PS, Peters TM, Hoffman EA, Comellas AP. Lung function of primary cooks using LPG or biomass and the effect of particulate matter on airway epithelial barrier integrity. Environ Res 2020;189:109888. [PMID: 32979995 DOI: 10.1016/j.envres.2020.109888] [Reference Citation Analysis]
534 Zhang WZ, Cloonan SM. To "Fe"ed or Not to "Fe"ed: Iron Depletion Exacerbates Emphysema Development in Murine Smoke Model. Am J Respir Cell Mol Biol 2020;62:541-2. [PMID: 31743655 DOI: 10.1165/rcmb.2019-0376ED] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
535 Zhao J, Pu J, Hao B, Huang L, Chen J, Hong W, Zhou Y, Li B, Ran P. LncRNA RP11-86H7.1 promotes airway inflammation induced by TRAPM2.5 by acting as a ceRNA of miRNA-9-5p to regulate NFKB1 in HBECS. Sci Rep 2020;10:11587. [PMID: 32665564 DOI: 10.1038/s41598-020-68327-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
536 Yoshimatsu Y, Tobino K, Nagami S, Yagi N, Oku Y. Breathing-Swallowing Discoordination and Inefficiency of an Airway Protective Mechanism Puts Patients at Risk of COPD Exacerbation. Int J Chron Obstruct Pulmon Dis 2020;15:1689-96. [PMID: 32764914 DOI: 10.2147/COPD.S257622] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
537 ButtÀ C, Tuttolomondo A, Casuccio A, DI Raimondo D, Miceli G, Cuttitta F, Zappulla V, Corpora F, Pinto A. Autonomic dysfunction in a group of lower extremities arterial disease outpatients. Minerva Cardiol Angiol 2021;69:28-35. [PMID: 32643892 DOI: 10.23736/S2724-5683.20.05094-X] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
538 Li Q, Tan L, Wang H, Kou Y, Shi X, Zhang S, Pan Y. Fusobacterium nucleatum Interaction with Pseudomonas aeruginosa Induces Biofilm-Associated Antibiotic Tolerance via Fusobacterium Adhesin A. ACS Infect Dis 2020;6:1686-96. [PMID: 32320601 DOI: 10.1021/acsinfecdis.9b00402] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
539 Adler D, Bailly S, Benmerad M, Joyeux-Faure M, Jullian-Desayes I, Soccal PM, Janssens JP, Sapène M, Grillet Y, Stach B, Tamisier R, Pépin JL. Clinical presentation and comorbidities of obstructive sleep apnea-COPD overlap syndrome. PLoS One 2020;15:e0235331. [PMID: 32645005 DOI: 10.1371/journal.pone.0235331] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
540 Bodduluri S, Nakhmani A, Reinhardt JM, Wilson CG, McDonald ML, Rudraraju R, Jaeger BC, Bhakta NR, Castaldi PJ, Sciurba FC, Zhang C, Bangalore PV, Bhatt SP. Deep neural network analyses of spirometry for structural phenotyping of chronic obstructive pulmonary disease. JCI Insight 2020;5:132781. [PMID: 32554922 DOI: 10.1172/jci.insight.132781] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
541 Szylińska A, Rotter I, Listewnik M, Lechowicz K, Brykczyński M, Dzidek S, Żukowski M, Kotfis K. Postoperative Delirium in Patients with Chronic Obstructive Pulmonary Disease after Coronary Artery Bypass Grafting. Medicina (Kaunas) 2020;56:E342. [PMID: 32660083 DOI: 10.3390/medicina56070342] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
542 Öztürk BÖ, Alpaydın AÖ, Özalevli S, Güler N, Cimilli C. Self-Management Training in Chronic Obstructive Lung Disease Improves the Quality of Life. Turk Thorac J 2020;21:266-73. [PMID: 32687788 DOI: 10.5152/TurkThoracJ.2019.19015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
543 Luyster FS, Wang J, Sciurba FC, Bon J. Longitudinal associations between sleep disturbance and disease severity in patients with COPD. Sleep Science Practice 2020;4. [DOI: 10.1186/s41606-020-00046-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
544 Soumagne T, Guillien A, Roche N, Annesi-Maesano I, Andujar P, Laurent L, Jouneau S, Botebol M, Laplante JJ, Dalphin JC, Degano B. In Patients with Mild-to-Moderate COPD, Tobacco Smoking, and Not COPD, Is Associated with a Higher Risk of Cardiovascular Comorbidity. Int J Chron Obstruct Pulmon Dis 2020;15:1545-55. [PMID: 32669840 DOI: 10.2147/COPD.S253417] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
545 Gao X, Coull B, Lin X, Vokonas P, Sparrow D, Hou L, DeMeo DL, Litonjua AA, Schwartz J, Baccarelli AA. Association of Neutrophil to Lymphocyte Ratio With Pulmonary Function in a 30-Year Longitudinal Study of US Veterans. JAMA Netw Open 2020;3:e2010350. [PMID: 32658288 DOI: 10.1001/jamanetworkopen.2020.10350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
546 Crossley D, Stockley J, Bolton CE, Hopkinson NS, Mahadeva R, Steiner M, Wilkinson T, Hurst JR, Gooptu B, Stockley RA. Relationship of CT densitometry to lung physiological parameters and health status in alpha-1 antitrypsin deficiency: initial report of a centralised database of the NIHR rare diseases translational research collaborative. BMJ Open 2020;10:e036045. [PMID: 32606060 DOI: 10.1136/bmjopen-2019-036045] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
547 Trudzinski FC, Jörres RA, Alter P, Kahnert K, Waschki B, Herr C, Kellerer C, Omlor A, Vogelmeier CF, Fähndrich S, Watz H, Welte T, Jany B, Söhler S, Biertz F, Herth F, Kauczor HU, Bals R; COSYCONET consortium. Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET. Sci Rep 2020;10:10544. [PMID: 32601330 DOI: 10.1038/s41598-020-67197-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
548 Zhang WZ, Oromendia C, Kikkers SA, Butler JJ, O'Beirne S, Kim K, O'Neal WK, Freeman CM, Christenson SA, Peters SP, Wells JM, Doerschuk C, Putcha N, Barjaktarevic I, Woodruff PG, Cooper CB, Bowler RP, Comellas AP, Criner GJ, Paine R 3rd, Hansel NN, Han MK, Crystal RG, Kaner RJ, Ballman KV, Curtis JL, Martinez FJ, Cloonan SM. Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS. Sci Rep 2020;10:10562. [PMID: 32601308 DOI: 10.1038/s41598-020-67047-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
549 Byun YM, Iida T, Yamada K, Abumi K, Kokabu T, Iwata A, Iwasaki N, Sudo H. Long-term pulmonary function after posterior spinal fusion in main thoracic adolescent idiopathic scoliosis. PLoS One 2020;15:e0235123. [PMID: 32584916 DOI: 10.1371/journal.pone.0235123] [Reference Citation Analysis]
550 Contoli M, Rogliani P, Di Marco F, Braido F, Corsico AG, Amici CA, Piro R, Sarzani R, Lessi P, Scognamillo C, Scichilone N, Santus P; SAT Study Group. Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study. Ther Adv Respir Dis 2019;13:1753466619888128. [PMID: 31760881 DOI: 10.1177/1753466619888128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
551 Cao X, Jin C, Tan T, Guo Y. Optimal threshold in low-dose CT quantification of emphysema. Eur J Radiol 2020;129:109094. [PMID: 32585442 DOI: 10.1016/j.ejrad.2020.109094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
552 Liu S, Liu M, Dong L. The clinical value of lncRNA MALAT1 and its targets miR-125b, miR-133, miR-146a, and miR-203 for predicting disease progression in chronic obstructive pulmonary disease patients. J Clin Lab Anal 2020;34:e23410. [PMID: 32583510 DOI: 10.1002/jcla.23410] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
553 Phillips R, Stanton H, Singh-Mehta A, Gillespie D, Bates J, Gal M, Thomas-Jones E, Lowe R, Hood K, Llor C, Melbye H, Cals J, White P, Butler C, Francis N. C-reactive protein-guided antibiotic prescribing for COPD exacerbations: a qualitative evaluation. Br J Gen Pract 2020;70:e505-13. [PMID: 32424045 DOI: 10.3399/bjgp20X709865] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
554 Veronesi G, Baldwin DR, Henschke CI, Ghislandi S, Iavicoli S, Oudkerk M, De Koning HJ, Shemesh J, Field JK, Zulueta JJ, Horgan D, Fiestas Navarrete L, Infante MV, Novellis P, Murray RL, Peled N, Rampinelli C, Rocco G, Rzyman W, Scagliotti GV, Tammemagi MC, Bertolaccini L, Triphuridet N, Yip R, Rossi A, Senan S, Ferrante G, Brain K, van der Aalst C, Bonomo L, Consonni D, Van Meerbeeck JP, Maisonneuve P, Novello S, Devaraj A, Saghir Z, Pelosi G. Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe. Cancers (Basel) 2020;12:E1672. [PMID: 32599792 DOI: 10.3390/cancers12061672] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
555 Niu H, Niu W, Yu T, Dong F, Huang K, Duan R, Qumu S, Lu M, Li Y, Yang T, Wang C. Association of RAGE gene multiple variants with the risk for COPD and asthma in northern Han Chinese. Aging (Albany NY) 2019;11:3220-37. [PMID: 31141790 DOI: 10.18632/aging.101975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
556 Synn AJ, Zhang C, Washko GR, Estépar RSJ, O'Connor GT, Li W, Mittleman MA, Rice MB. Cigarette Smoke Exposure and Radiographic Pulmonary Vascular Morphology in the Framingham Heart Study. Ann Am Thorac Soc 2019;16:698-706. [PMID: 30714821 DOI: 10.1513/AnnalsATS.201811-795OC] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
557 Bade BC, DeRycke EC, Ramsey C, Skanderson M, Crothers K, Haskell S, Bean-Mayberry B, Brandt C, Bastian LA, Akgün KM. Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation. Ann Am Thorac Soc 2019;16:707-14. [PMID: 30822098 DOI: 10.1513/AnnalsATS.201809-615OC] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
558 Zhang JB, Zhu JQ, Cao LX, Jin XH, Chen LL, Song YK, Zhou SF, Ma JH, Fu H, Xu JZ, Dong MP, Yan LC, Wu XD, Wang HP, Zhou JY, Wang YQ. Use of the modified Glasgow Coma Scale score to guide sequential invasive-noninvasive mechanical ventilation weaning in patients with AECOPD and respiratory failure. Exp Ther Med 2020;20:1441-6. [PMID: 32742377 DOI: 10.3892/etm.2020.8884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
559 Smith BM, Kirby M, Hoffman EA, Kronmal RA, Aaron SD, Allen NB, Bertoni A, Coxson HO, Cooper C, Couper DJ, Criner G, Dransfield MT, Han MK, Hansel NN, Jacobs DR Jr, Kaufman JD, Lin CL, Manichaikul A, Martinez FJ, Michos ED, Oelsner EC, Paine R 3rd, Watson KE, Benedetti A, Tan WC, Bourbeau J, Woodruff PG, Barr RG; MESA Lung, CanCOLD, and SPIROMICS Investigators. Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults. JAMA 2020;323:2268-80. [PMID: 32515814 DOI: 10.1001/jama.2020.6918] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 19.0] [Reference Citation Analysis]
560 Rodrigues A, Camillo CA, Furlanetto KC, Paes T, Morita AA, Spositon T, Donaria L, Ribeiro M, Probst VS, Hernandes NA, Pitta F. Cluster analysis identifying patients with COPD at high risk of 2-year all-cause mortality. Chron Respir Dis 2019;16:1479972318809452. [PMID: 30428721 DOI: 10.1177/1479972318809452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
561 Yang L, Wen M, Liu X, Wang K, Wang Y. Feikang granules ameliorate pulmonary inflammation in the rat model of chronic obstructive pulmonary disease via TLR2/4-mediated NF-κB pathway. BMC Complement Med Ther 2020;20:170. [PMID: 32493287 DOI: 10.1186/s12906-020-02964-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
562 Bao HR, Chen JL, Li F, Zeng XL, Liu XJ. Relationship between PI3K/mTOR/RhoA pathway-regulated cytoskeletal rearrangements and phagocytic capacity of macrophages. Braz J Med Biol Res 2020;53:e9207. [PMID: 32520207 DOI: 10.1590/1414-431X20209207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
563 Lundell S, Modig M, Holmner Å, Wadell K. Perceptions of Home Telemonitoring Use Among Patients With Chronic Obstructive Pulmonary Disease: Qualitative Study. JMIR Mhealth Uhealth 2020;8:e16343. [PMID: 32490844 DOI: 10.2196/16343] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
564 Zhang W, Sheridan SC, Birkhead GS, Croft DP, Brotzge JA, Justino JG, Stuart NA, Du Z, Romeiko XX, Ye B, Dong G, Hao Y, Lin S. Power Outage: An Ignored Risk Factor for COPD Exacerbations. Chest 2020;158:2346-57. [PMID: 32502591 DOI: 10.1016/j.chest.2020.05.555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
565 Wouters TJ, van Dam van Isselt EF, Achterberg WP. Information needs of older patients living with chronic obstructive pulmonary disease (COPD) indicated for a specific geriatric rehabilitation programme: a prospective cohort study. Int J Palliat Nurs 2020;26:238-45. [PMID: 32584692 DOI: 10.12968/ijpn.2020.26.5.238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
566 Te HS, Perlman DM, Shenoy C, Steinberger DJ, Cogswell RJ, Roukoz H, Peterson EJ, Zhang L, Allen TL, Bhargava M. Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts. BMC Pulm Med 2020;20:155. [PMID: 32487134 DOI: 10.1186/s12890-020-01191-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
567 Liang Z, Wang F, Zhang D, Long F, Yang Y, Gu W, Deng K, Xu J, Jian W, Zhou L, Shi W, Zheng J, Chen X, Chen R. Sputum and serum autoantibody profiles and their clinical correlation patterns in COPD patients with and without eosinophilic airway inflammation. J Thorac Dis 2020;12:3085-100. [PMID: 32642231 DOI: 10.21037/jtd-20-545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
568 Wu Q, Xie L, Li W, Xiang G, Hu W, Jiang H, Wu X, Wu X, Li S. Pulmonary Function Influences the Performance of Berlin Questionnaire, Modified Berlin Questionnaire, and STOP-Bang Score for Screening Obstructive Sleep Apnea in Subjects with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2020;15:1207-16. [PMID: 32581527 DOI: 10.2147/COPD.S248139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
569 Zhao K, Dong R, Yu Y, Tu C, Li Y, Cui Y, Bao L, Ling C. Cigarette smoke-induced lung inflammation in COPD mediated via CCR1/JAK/STAT /NF-κB pathway. Aging (Albany NY) 2020;12:9125-38. [PMID: 32463796 DOI: 10.18632/aging.103180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
570 Arnedillo A, Gonzalez-Montesinos JL, Fernandez-Santos JR, Vaz-Pardal C, España-Domínguez C, Ponce-González JG, Cuenca-García M. Effects of a Rehabilitation Programme with a Nasal Inspiratory Restriction Device on Exercise Capacity and Quality of Life in COPD. Int J Environ Res Public Health 2020;17:E3669. [PMID: 32456097 DOI: 10.3390/ijerph17103669] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
571 Ingebrigtsen TS, Marott JL, Lange P. Witnessed sleep apneas together with elevated plasma glucose are predictors of COPD exacerbations. Eur Clin Respir J 2020;7:1765543. [PMID: 33224452 DOI: 10.1080/20018525.2020.1765543] [Reference Citation Analysis]
572 Halpin DMG, Dransfield MT, Han MK, Jones CE, Kilbride S, Lange P, Lipson DA, Lomas DA, Martinez FJ, Pascoe S, Singh D, Wise R, Criner GJ. The effect of exacerbation history on outcomes in the IMPACT trial. Eur Respir J 2020;55:1901921. [PMID: 32299860 DOI: 10.1183/13993003.01921-2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
573 Zhang Y, Liang LR, Zhang S, Lu Y, Chen YY, Shi HZ, Lin YX. Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality. Int J Chron Obstruct Pulmon Dis 2020;15:1123-34. [PMID: 32547000 DOI: 10.2147/COPD.S245056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
574 Ortega VE, Li X, O'Neal WK, Lackey L, Ampleford E, Hawkins GA, Grayeski PJ, Laederach A, Barjaktarevic I, Barr RG, Cooper C, Couper D, Han MK, Kanner RE, Kleerup EC, Martinez FJ, Paine R 3rd, Peters SP, Pirozzi C, Rennard SI, Woodruff PG, Hoffman EA, Meyers DA, Bleecker ER; NHLBI Subpopulations and Intermediate Outcomes Measures in COPD Study (SPIROMICS). The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS. Am J Respir Crit Care Med 2020;201:540-54. [PMID: 31661293 DOI: 10.1164/rccm.201904-0769OC] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
575 Li T, Long C, Fanning KV, Zou C. Studying Effects of Cigarette Smoke on Pseudomonas Infection in Lung Epithelial Cells. J Vis Exp 2020. [PMID: 32449738 DOI: 10.3791/61163] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
576 Recio Iglesias J, Díez-Manglano J, López García F, Díaz Peromingo JA, Almagro P, Varela Aguilar JM. Management of the COPD Patient with Comorbidities: An Experts Recommendation Document. Int J Chron Obstruct Pulmon Dis 2020;15:1015-37. [PMID: 32440113 DOI: 10.2147/COPD.S242009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
577 Fernández-Jané C, Vilaró J, Fei Y, Wang C, Liu J, Huang N, Xia R, Tian X, Hu R, Wen L, Yu M, Gómara-Toldrà N, Solà-Madurell M, Sitjà-Rabert M. Acupuncture techniques for COPD: a systematic review. BMC Complement Med Ther 2020;20:138. [PMID: 32375775 DOI: 10.1186/s12906-020-02899-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
578 Stanford D, Kim H, Bodduluri S, LaFontaine J, Byzek SA, Schoeb TR, Harris ES, Nath HP, Bhatt SP, Raju SV, Rowe SM. Airway Remodeling in Ferrets with Cigarette Smoke Induced COPD using µCT Imaging. Am J Physiol Lung Cell Mol Physiol 2020. [PMID: 32374671 DOI: 10.1152/ajplung.00328.2019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
579 Lee EG, Rhee CK. The clinical efficacy of AG NPP709 (Synatura®) in patients with chronic bronchitis type stable chronic obstructive pulmonary disease. J Thorac Dis 2020;12:2435-42. [PMID: 32642149 DOI: 10.21037/jtd.2020.03.61] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
580 Calverley PMA. Guidance for the Better Care of Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2020;201:1022-3. [PMID: 32283943 DOI: 10.1164/rccm.202002-0459ED] [Reference Citation Analysis]
581 Fan L, Li L, Yu X, Liang Z, Cai T, Chen Y, Xu Y, Hu T, Wu L, Lin L. Jianpiyifei II Granules Suppress Apoptosis of Bronchial Epithelial Cells in Chronic Obstructive Pulmonary Disease via Inhibition of the Reactive Oxygen Species-Endoplasmic Reticulum Stress-Ca2+ Signaling Pathway. Front Pharmacol 2020;11:581. [PMID: 32425799 DOI: 10.3389/fphar.2020.00581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
582 Nenna R, Zhai J, Packard SE, Spangenberg A, Sherrill DL, Martinez FD, Halonen M, Guerra S. High cytomegalovirus serology and subsequent COPD-related mortality: a longitudinal study. ERJ Open Res 2020;6:00062-2020. [PMID: 32363208 DOI: 10.1183/23120541.00062-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
583 Poh TY, Ali NABM, Chan LLY, Tiew PY, Chotirmall SH. Evaluation of Droplet Digital Polymerase Chain Reaction (ddPCR) for the Absolute Quantification of Aspergillus species in the Human Airway. Int J Mol Sci 2020;21:E3043. [PMID: 32357408 DOI: 10.3390/ijms21093043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
584 Sánchez E, Mizab C, Sauret A, Barbé F, Martí R, López-Cano C, Hernández M, Gutiérrez-Carrasquilla L, Carmona P, González J, Dalmases M, Hernández C, Simó R, Lecube A. Effect of Subcutaneous Insulin on Spirometric Maneuvers in Patients with Type 1 Diabetes: A Case-Control Study. J Clin Med 2020;9:E1249. [PMID: 32344939 DOI: 10.3390/jcm9051249] [Reference Citation Analysis]
585 Wangsom A, Othaganont P, Ladores S. The Factors Predicting the Health-Related Quality of Life Among Persons with Chronic Obstructive Pulmonary Disease in Public Health Region 4, Thailand: A Mixed-Methods Study. TOPHJ 2020;13:105-13. [DOI: 10.2174/1874944502013010105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
586 Mackay AJ, Kostikas K, Roche N, Frent SM, Olsson P, Pfister P, Gupta P, Patalano F, Banerji D, Wedzicha JA. Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study. Respir Res 2020;21:93. [PMID: 32321518 DOI: 10.1186/s12931-020-01354-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
587 Baker S, Bakunina K, Duijm M, Hoogeman MS, Cornelissen R, Antonisse I, Praag J, Heemsbergen WD, Nuyttens JJ. Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer. Radiat Oncol 2020;15:89. [PMID: 32321553 DOI: 10.1186/s13014-020-01537-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
588 Wilshire CL, Fuller CC, Gilbert CR, Handy JR, Costas KE, Louie BE, Aye RW, Farivar AS, Vallières E, Gorden JA. Electronic Medical Record Inaccuracies: Multicenter Analysis of Challenges with Modified Lung Cancer Screening Criteria. Can Respir J 2020;2020:7142568. [PMID: 32300379 DOI: 10.1155/2020/7142568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
589 Ding Y, Yang Y, Li Q, Feng Q, Xu D, Wu C, Zhao J, Zhou X, Niu H, He P, Liu J, Yao H. The correlation between CYP4F2 variants and chronic obstructive pulmonary disease risk in Hainan Han population. Respir Res 2020;21:86. [PMID: 32295578 DOI: 10.1186/s12931-020-01348-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
590 Vaz Fragoso CA, Leo-Summers LS, Gill TM, McAvay GJ. Re-evaluation of the Uplift Clinical Trial Using Age-Appropriate Spirometric Criteria. Chest 2020;158:539-49. [PMID: 32278783 DOI: 10.1016/j.chest.2020.02.070] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
591 Aslani MR, Ghazaei Z, Ghobadi H. Correlation of serum fatty acid binding protein-4 and interleukin-6 with airflow limitation and quality of life in stable and acute exacerbation of COPD. Turk J Med Sci 2020;50:337-45. [PMID: 31905499 DOI: 10.3906/sag-1909-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
592 Liang GB, He ZH. Animal models of emphysema. Chin Med J (Engl) 2019;132:2465-75. [PMID: 31567388 DOI: 10.1097/CM9.0000000000000469] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
593 Xiong H, Huang Q, He C, Shuai T, Yan P, Zhu L, Yang K, Liu J. Prevalence of chronic obstructive pulmonary disease at high altitude: a systematic review and meta-analysis. PeerJ 2020;8:e8586. [PMID: 32280564 DOI: 10.7717/peerj.8586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
594 Szylińska A, Kotfis K, Listewnik M, Brykczyński M, Marra A, Rotter I. The burden of chronic obstructive pulmonary disease in open heart surgery-a retrospective cohort analysis of postoperative complications: STROBE compliant. Medicine (Baltimore) 2020;99:e19675. [PMID: 32221097 DOI: 10.1097/MD.0000000000019675] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
595 Oelsner EC, Ortega VE, Smith BM, Nguyen JN, Manichaikul AW, Hoffman EA, Guo X, Taylor KD, Woodruff PG, Couper DJ, Hansel NN, Martinez FJ, Paine R 3rd, Han MK, Cooper C, Dransfield MT, Criner G, Krishnan JA, Bowler R, Bleecker ER, Peters S, Rich SS, Meyers DA, Rotter JI, Barr RG. A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography. Am J Respir Crit Care Med 2019;200:721-31. [PMID: 30925230 DOI: 10.1164/rccm.201812-2355OC] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 8.5] [Reference Citation Analysis]
596 Balasubramanian A, Kolb TM, Damico RL, Hassoun PM, McCormack MC, Mathai SC. Diffusing Capacity Is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated With COPD. Chest 2020;158:722-34. [PMID: 32184109 DOI: 10.1016/j.chest.2020.02.047] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
597 Matsumura K, Kurachi T, Ishikawa S, Kitamura N, Ito S. Regional differences in airway susceptibility to cigarette smoke: An investigational case study of epithelial function and gene alterations in in vitro airway epithelial three-dimensional cultures. Toxicology Research and Application 2020;4:239784732091162. [DOI: 10.1177/2397847320911629] [Reference Citation Analysis]
598 Gao S, Chen J, Xie J, Wang J. The effects of BAFF on T lymphocytes in chronic obstructive pulmonary disease. Respir Res 2020;21:66. [PMID: 32160903 DOI: 10.1186/s12931-020-01333-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
599 Singla E, Dharwal V, Naura AS. Gallic acid protects against the COPD-linked lung inflammation and emphysema in mice. Inflamm Res 2020;69:423-34. [PMID: 32144443 DOI: 10.1007/s00011-020-01333-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
600 Yildiz F. The Efficacy of Lung Volume Reduction Coil Treatment in Patients with Severe Chronic Obstructive Pulmonary Disease (COPD) Type II Respiratory Failure. Int J Chron Obstruct Pulmon Dis 2020;15:479-86. [PMID: 32184585 DOI: 10.2147/COPD.S218785] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
601 Gong Y, Li C, Wang C, Li J, Ding M, Chen D, Lao M. Epidemiology and Mortality-Associated Factors of Invasive Fungal Disease in Elderly Patients: A 20-Year Retrospective Study from Southern China. Infect Drug Resist 2020;13:711-23. [PMID: 32184633 DOI: 10.2147/IDR.S242187] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
602 Shilian R, Abraham T, Wynbrandt J, Jhaveri D, Hostoffer RW, Peppers BP. Daily Integrated Care Conferences to Reduce Length of Hospital Stay for Patients With Chronic Obstructive Pulmonary Disease. J Am Osteopath Assoc 2020;120:144-52. [PMID: 32091558 DOI: 10.7556/jaoa.2020.027] [Reference Citation Analysis]
603 Li XX, Du XW, Song W, Lu C, Hao WN. Effect of continuous nursing care based on the IKAP theory on the quality of life of patients with chronic obstructive pulmonary disease: A randomized controlled study. Medicine (Baltimore). 2020;99:e19543. [PMID: 32176107 DOI: 10.1097/md.0000000000019543] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
604 Arimura-Omori M, Kiyohara C, Yanagihara T, Yamamoto Y, Ogata-Suetsugu S, Harada E, Hamada N, Tsuda T, Takata S, Shimabukuro I, Nagata N, Yatera K, Torii R, Okamoto M, Fujita M, Nakanishi Y. Association between Telomere-Related Polymorphisms and the Risk of IPF and COPD as a Precursor Lesion of Lung Cancer: Findings from the Fukuoka Tobacco-Related Lung Disease (FOLD) Registry. Asian Pac J Cancer Prev 2020;21:667-73. [PMID: 32212792 DOI: 10.31557/APJCP.2020.21.3.667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
605 Aissa S, Knaz A, Maatoug J, Khedher A, Benzarti W, Abdelghani A, Garrouche A, Hayouni A, Benzarti M, Gargouri I, Ben Saad H. Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD). Biomed Res Int 2020;2020:1031845. [PMID: 32190644 DOI: 10.1155/2020/1031845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
606 Cho J, Lee CH, Kim DK, Hwang HG, Kim YI, Choi HS, Park JW, Yoo KH, Jung KS, Lee SD; KOLD and KOCOSS Investigators. Impact of gender on chronic obstructive pulmonary disease outcomes: a propensity score-matched analysis of a prospective cohort study. Korean J Intern Med 2020;35:1154-63. [PMID: 32098456 DOI: 10.3904/kjim.2019.111] [Reference Citation Analysis]
607 Wu Y, Qin J, He J, Shen Y, Wang H, Li Y, Zeng Q, Dong J, An Y, Xiong S, Feng M, Wen F. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation. Int J Chron Obstruct Pulmon Dis 2020;15:397-407. [PMID: 32158205 DOI: 10.2147/COPD.S234760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
608 Reddy AT, Lakshmi SP, Banno A, Jadhav SK, Pulikkal Kadamberi I, Kim SC, Reddy RC. Cigarette smoke downregulates Nur77 to exacerbate inflammation in chronic obstructive pulmonary disease (COPD). PLoS One 2020;15:e0229256. [PMID: 32084204 DOI: 10.1371/journal.pone.0229256] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
609 Peng J, Chen C, Zhou M, Xie X, Zhou Y, Luo CH. A Machine-learning Approach to Forecast Aggravation Risk in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Clinical Indicators. Sci Rep 2020;10:3118. [PMID: 32080330 DOI: 10.1038/s41598-020-60042-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
610 Ye L, Mao S, Fang S, Zhang J, Tan Y, Gu W. Increased Serum Romo1 Was Correlated with Lung Function, Inflammation, and Oxidative Stress in Chronic Obstructive Pulmonary Disease. Inflammation 2019;42:1555-60. [PMID: 31049771 DOI: 10.1007/s10753-019-01017-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
611 Li CL, Lin MH, Chen PS, Tsai YC, Shen LS, Kuo HC, Liu SF. Using the BODE Index and Comorbidities to Predict Health Utilization Resources in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2020;15:389-95. [PMID: 32110007 DOI: 10.2147/COPD.S234363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
612 Özdemir T, Candemir I, Ergün P, Türkkani MH, Koç O. Patients with COPD who underwent pulmonary rehabilitation in Turkey: prevalence, distribution, and mortality. Turk J Med Sci 2020;50:141-7. [PMID: 31769642 DOI: 10.3906/sag-1901-224] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
613 Yao RQ, Ren C, Xia ZF, Yao YM. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles. Autophagy 2021;17:385-401. [PMID: 32048886 DOI: 10.1080/15548627.2020.1725377] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
614 Xiong J, Tian J, Zhou L, Le Y, Sun Y. Interleukin-17A Deficiency Attenuated Emphysema and Bone Loss in Mice Exposed to Cigarette Smoke. Int J Chron Obstruct Pulmon Dis 2020;15:301-10. [PMID: 32103929 DOI: 10.2147/COPD.S235384] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
615 Lin CM, Yang TM, Yang YH, Tsai YH, Lee CP, Chen PC, Chen WC, Hsieh MJ. Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations. Int J Chron Obstruct Pulmon Dis 2020;15:289-99. [PMID: 32103928 DOI: 10.2147/COPD.S229047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
616 Tam A, Tanabe N, Churg A, Wright JL, Hogg JC, Sin DD. Sex differences in lymphoid follicles in COPD airways. Respir Res 2020;21:46. [PMID: 32033623 DOI: 10.1186/s12931-020-1311-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
617 Lin SY, Xue H, Deng Y, Chukmaitov A. Multi-morbidities are Not a Driving Factor for an Increase of COPD-Related 30-Day Readmission Risk. Int J Chron Obstruct Pulmon Dis 2020;15:143-54. [PMID: 32021153 DOI: 10.2147/COPD.S230072] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
618 Zuo H, Trombetta-Lima M, Heijink IH, van der Veen CHTJ, Hesse L, Faber KN, Poppinga WJ, Maarsingh H, Nikolaev VO, Schmidt AM. A-Kinase Anchoring Proteins Diminish TGF-β1/Cigarette Smoke-Induced Epithelial-To-Mesenchymal Transition. Cells 2020;9:E356. [PMID: 32028718 DOI: 10.3390/cells9020356] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
619 Choate R, Pasquale CB, Parada NA, Prieto-Centurion V, Mularski RA, Yawn BP. The Burden of Cough and Phlegm in People With COPD: A COPD Patient-Powered Research Network Study. Chronic Obstr Pulm Dis 2020;7:49-59. [PMID: 31999902 DOI: 10.15326/jcopdf.7.1.2019.0146] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
620 Gao N, Xu W, Ji J, Yang Y, Wang ST, Wang J, Chen X, Meng S, Tian X, Xu KF. Lung function and systemic inflammation associated with short-term air pollution exposure in chronic obstructive pulmonary disease patients in Beijing, China. Environ Health 2020;19:12. [PMID: 32000783 DOI: 10.1186/s12940-020-0568-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 28] [Article Influence: 8.5] [Reference Citation Analysis]
621 Sjöström R, Söderström L, Klockmo C, Patrician A, Sandström T, Björklund G, Hanstock H, Stenfors N. Qualitative identification and characterisation of self-reported symptoms arising in humans during experimental exposure to cold air. Int J Circumpolar Health 2019;78:1583528. [PMID: 30821652 DOI: 10.1080/22423982.2019.1583528] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
622 Ma A, Wen L, Yin J, Hu Y, Yue X, Li J, Dong X, Gupta Y, Ludwig RJ, Krauss-Etschmann S, Riemekasten G, Petersen F, Yu X. Serum Levels of Autoantibodies Against Extracellular Antigens and Neutrophil Granule Proteins Increase in Patients with COPD Compared to Non-COPD Smokers. Int J Chron Obstruct Pulmon Dis 2020;15:189-200. [PMID: 32099344 DOI: 10.2147/COPD.S235903] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
623 Schwarz D, Dhungana S, Kumar A, Acharya B, Agrawal P, Aryal A, Baum A, Choudhury N, Citrin D, Dangal B, Dhimal M, Gauchan B, Gupta T, Halliday S, Karmacharya B, Kishore S, Koirala B, Kshatriya U, Levine E, Maru S, Rimal P, Sapkota S, Schwarz R, Shrestha A, Thapa A, Maru D. An integrated intervention for chronic care management in rural Nepal: protocol of a type 2 hybrid effectiveness-implementation study. Trials 2020;21:119. [PMID: 31996250 DOI: 10.1186/s13063-020-4063-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
624 Engelen MPKJ, Jonker R, Thaden JJ, Ten Have GAM, Jeon MS, Dasarathy S, Deutz NEP. Comprehensive metabolic flux analysis to explain skeletal muscle weakness in COPD. Clin Nutr 2020;39:3056-65. [PMID: 32035752 DOI: 10.1016/j.clnu.2020.01.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
625 Tanno A, Fujino N, Yamada M, Sugiura H, Hirano T, Tanaka R, Sano H, Suzuki S, Okada Y, Ichinose M. Decreased expression of a phagocytic receptor Siglec-1 on alveolar macrophages in chronic obstructive pulmonary disease. Respir Res 2020;21:30. [PMID: 31992280 DOI: 10.1186/s12931-020-1297-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
626 Refaee T, Wu G, Ibrahim A, Halilaj I, Leijenaar RTH, Rogers W, Gietema HA, Hendriks LEL, Lambin P, Woodruff HC. The Emerging Role of Radiomics in COPD and Lung Cancer. Respiration 2020;99:99-107. [PMID: 31991420 DOI: 10.1159/000505429] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
627 Konietzke P, Wielpütz MO, Wagner WL, Wuennemann F, Kauczor HU, Heussel CP, Eichinger M, Eberhardt R, Gompelmann D, Weinheimer O. Quantitative CT detects progression in COPD patients with severe emphysema in a 3-month interval. Eur Radiol 2020;30:2502-12. [PMID: 31965260 DOI: 10.1007/s00330-019-06577-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
628 Ponce-Gallegos MA, Pérez-Rubio G, Ambrocio-Ortiz E, Partida-Zavala N, Hernández-Zenteno R, Flores-Trujillo F, García-Gómez L, Hernández-Pérez A, Ramírez-Venegas A, Falfán-Valencia R. Genetic variants in IL17A and serum levels of IL-17A are associated with COPD related to tobacco smoking and biomass burning. Sci Rep 2020;10:784. [PMID: 31964947 DOI: 10.1038/s41598-020-57606-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
629 Bai S, Ye R, Wang C, Sun P, Zhao L. Comparative analysis of pathophysiological parameters between emphysematous smokers and emphysematous patients with COPD. Sci Rep 2020;10:420. [PMID: 31942006 DOI: 10.1038/s41598-019-57354-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
630 Reddy AT, Lakshmi SP, Banno A, Reddy RC. Glucocorticoid Receptor α Mediates Roflumilast's Ability to Restore Dexamethasone Sensitivity in COPD. Int J Chron Obstruct Pulmon Dis 2020;15:125-34. [PMID: 32021151 DOI: 10.2147/COPD.S230188] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
631 Yoon S, Kim TE, Kim TH, Na JO, Shin KC, Rhee CK, Jung SS, Choe KH, Yoo KH. Clinical Role of the Chronic Obstructive Pulmonary Disease Assessment Test in Prediction of the Response to Treatment for Exacerbations. J Korean Med Sci 2020;35:e10. [PMID: 31920016 DOI: 10.3346/jkms.2020.35.e10] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
632 Maynard-Paquette AC, Poirier C, Chartrand-Lefebvre C, Dubé BP. Ultrasound Evaluation of the Quadriceps Muscle Contractile Index in Patients with Stable Chronic Obstructive Pulmonary Disease: Relationships with Clinical Symptoms, Disease Severity and Diaphragm Contractility. Int J Chron Obstruct Pulmon Dis 2020;15:79-88. [PMID: 32021146 DOI: 10.2147/COPD.S222945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
633 Chin AT, Rylance J, Makumbirofa S, Meffert S, Vu T, Clayton J, Mason P, Woodruff P, Metcalfe J. Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study. Int J Tuberc Lung Dis 2019;23:203-11. [PMID: 30808453 DOI: 10.5588/ijtld.18.0313] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
634 Huang C, Liu Y, Shi G. A systematic review with meta-analysis of gastroesophageal reflux disease and exacerbations of chronic obstructive pulmonary disease. BMC Pulm Med 2020;20:2. [PMID: 31914979 DOI: 10.1186/s12890-019-1027-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
635 Koo HJ, Lee SM, Seo JB, Lee SM, Kim N, Oh SY, Lee JS, Oh YM. Prediction of Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease: Correlation with Quantitative CT Parameters. Korean J Radiol 2019;20:683-92. [PMID: 30887750 DOI: 10.3348/kjr.2018.0391] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
636 Zhao M, Huang Y, Li L, Zhou L, Wu Z, Liu Y, Zhang H, Hu C. Enhanced External Counterpulsation Efficacy on Exercise Endurance in COPD Patients and Healthy Subjects: A Pilot Randomized Clinical Trial. Int J Chron Obstruct Pulmon Dis 2020;15:25-31. [PMID: 32021141 DOI: 10.2147/COPD.S225566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
637 Makhinova T, Walker BL, Gukert M, Kalvi L, Guirguis LM. Checking Inhaler Technique in the Community Pharmacy: Predictors of Critical Errors. Pharmacy (Basel) 2020;8:E6. [PMID: 31935995 DOI: 10.3390/pharmacy8010006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
638 Friedlander HM, Ford JA, Zaccardelli A, Terrio AV, Cho MH, Sparks JA. Obstructive lung diseases and risk of rheumatoid arthritis. Expert Rev Clin Immunol 2020;16:37-50. [PMID: 31774329 DOI: 10.1080/1744666X.2019.1698293] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
639 Xu J, Gaddis NC, Bartz TM, Hou R, Manichaikul AW, Pankratz N, Smith AV, Sun F, Terzikhan N, Markunas CA, Patchen BK, Schu M, Beydoun MA, Brusselle GG, Eiriksdottir G, Zhou X, Wood AC, Graff M, Harris TB, Ikram MA, Jacobs DR Jr, Launer LJ, Lemaitre RN, O'Connor GT, Oelsner EC, Psaty BM, Vasan RS, Rohde RR, Rich SS, Rotter JI, Seshadri S, Smith LJ, Tiemeier H, Tsai MY, Uitterlinden AG, Voruganti VS, Xu H, Zilhão NR, Fornage M, Zillikens MC, London SJ, Barr RG, Dupuis J, Gharib SA, Gudnason V, Lahousse L, North KE, Steffen LM, Cassano PA, Hancock DB. Omega-3 Fatty Acids and Genome-Wide Interaction Analyses Reveal DPP10-Pulmonary Function Association. Am J Respir Crit Care Med 2019;199:631-42. [PMID: 30199657 DOI: 10.1164/rccm.201802-0304OC] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
640 Park S, Oh EJ, Han S, Shin B, Shin SH, Im Y, Son YH, Park HY. Intraoperative Anesthetic Management of Patients with Chronic Obstructive Pulmonary Disease to Decrease the Risk of Postoperative Pulmonary Complications after Abdominal Surgery. J Clin Med 2020;9:E150. [PMID: 31935888 DOI: 10.3390/jcm9010150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
641 Sanjay HS, Hiremath BV, Prithvi BS, Dinesh PA. Machine learning based assessment of auditory threshold perception in human beings. SN Appl Sci 2020;2. [DOI: 10.1007/s42452-019-1929-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 4.5] [Reference Citation Analysis]
642 Huang TH, Chen CZ, Kuo HI, Er HP, Lin SH. Enhanced risk of traumatic brain injury in patients with chronic obstructive pulmonary disease. J Investig Med 2020;68:846-55. [PMID: 31892639 DOI: 10.1136/jim-2019-001207] [Reference Citation Analysis]
643 Moll M, Regan EA, Hokanson JE, Lutz SM, Silverman EK, Crapo JD, Make BJ, DeMeo DL. The Association of Multiparity with Lung Function and Chronic Obstructive Pulmonary Disease-Related Phenotypes. Chronic Obstr Pulm Dis 2020;7:86-98. [PMID: 32324980 DOI: 10.15326/jcopdf.7.2.2019.0166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
644 Han MK, Ye W, Kim DY, Woodruff P; Pulmonary Trials Cooperative Investigators. Design of the Redefining Therapy in Early COPD Study. Chronic Obstr Pulm Dis 2020;7:382-9. [PMID: 32989941 DOI: 10.15326/jcopdf.7.4.2020.0157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
645 Wang Q, Wang H, Wang L, Yu F. Diagnosis of Chronic Obstructive Pulmonary Disease Based on Transfer Learning. IEEE Access 2020;8:47370-83. [DOI: 10.1109/access.2020.2979218] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
646 Giang NT, Ngoc TN, Nam NV, Nhung NV, Thang TB, Hung DK, Bac ND, Toi CD, Hung PN. Lung Volume Reduction Surgery in Patients with Heterogenous Emphysema: Selecting Perspective. Open Access Maced J Med Sci 2019;7:4389-92. [PMID: 32215100 DOI: 10.3889/oamjms.2019.841] [Reference Citation Analysis]
647 Sakornsakolpat P, McCormack M, Bakke P, Gulsvik A, Make BJ, Crapo JD, Cho MH, Silverman EK. Genome-Wide Association Analysis of Single-Breath DlCO. Am J Respir Cell Mol Biol 2019;60:523-31. [PMID: 30694715 DOI: 10.1165/rcmb.2018-0384OC] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
648 Lor KL, Liu CP, Chang YC, Yu CJ, Wang CY, Chung MJ, Lin FY, Chen CM. Predictive Modelling of Lung Function using Emphysematous Density Distribution. Sci Rep 2019;9:19763. [PMID: 31875053 DOI: 10.1038/s41598-019-56351-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
649 Wei Y, Wang S, Wang D, Liu C. Expression and clinical significance of serum amyloid A and interleukin-6 in patients with acute exacerbation of chronic obstructive pulmonary disease. Exp Ther Med 2020;19:2089-94. [PMID: 32104270 DOI: 10.3892/etm.2019.8366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
650 Donohue JF, Mahler DA, Sethi S. Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD. Int J Chron Obstruct Pulmon Dis 2019;14:2947-58. [PMID: 31908443 DOI: 10.2147/COPD.S157654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
651 Elnemr R, Sweed RA, Shafiek H. Diaphragmatic motor cortex hyperexcitability in patients with chronic obstructive pulmonary disease. PLoS One 2019;14:e0217886. [PMID: 31851669 DOI: 10.1371/journal.pone.0217886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
652 Tamire M, Addissie A, Kumie A, Husmark E, Skovbjerg S, Andersson R, Lärstad M. Respiratory Symptoms and Lung Function among Ethiopian Women in Relation to Household Fuel Use. Int J Environ Res Public Health 2019;17:E41. [PMID: 31861594 DOI: 10.3390/ijerph17010041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
653 Ernst P, Dahl M, Chateau D, Daneman N, Quail J, Sketris IS, Fisher A, Zhang J, Bugden S; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study. Int J Chron Obstruct Pulmon Dis 2019;14:2939-46. [PMID: 31908442 DOI: 10.2147/COPD.S226324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
654 Nishimura K, Kusunose M, Sanda R, Tsuji Y, Hasegawa Y, Oga T. Comparison between electronic and paper versions of patient-reported outcome measures in subjects with chronic obstructive pulmonary disease: an observational study with a cross-over administration. BMJ Open 2019;9:e032767. [PMID: 31857313 DOI: 10.1136/bmjopen-2019-032767] [Reference Citation Analysis]
655 Bachmann MO, Bateman ED, Stelmach R, Cruz AA, Pacheco de Andrade M, Zonta R, Zepeda J, Natal S, Cornick RV, Wattrus C, Anderson L, Georgeu-Pepper D, Lombard C, Fairall LR. Effects of PACK guide training on the management of asthma and chronic obstructive pulmonary disease by primary care clinicians: a pragmatic cluster randomised controlled trial in Florianópolis, Brazil. BMJ Glob Health 2019;4:e001921. [PMID: 31908865 DOI: 10.1136/bmjgh-2019-001921] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
656 Coquart JB, Heutte N, Terce G, Grosbois JM. Convergent Validity and Minimal Clinically Important Difference of the Maugeri Foundation Respiratory Failure Questionnaire (MRF-28) and the Chronic Obstructive Pulmonary Disease-Specific Health-Related Quality of Life questionnaire (VQ11). Int J Chron Obstruct Pulmon Dis 2019;14:2895-903. [PMID: 31853177 DOI: 10.2147/COPD.S222165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
657 Sharifov OF, Denney TS Jr, Wells JM, Payne GA, Gulati S, Gupta H, Dransfield MT, Lloyd SG. Velocity Transfer Function In The Right Pulmonary Artery And Impaired Cardiopulmonary Reserve In COPD. Int J Chron Obstruct Pulmon Dis 2019;14:2753-7. [PMID: 31819407 DOI: 10.2147/COPD.S220868] [Reference Citation Analysis]
658 Micheletto C, Sparacino A. Triple Therapy in COPD. CRMR 2019;15:102-11. [DOI: 10.2174/1573398x15666190314151921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
659 Blervaque L, Passerieux E, Pomiès P, Catteau M, Héraud N, Blaquière M, Bughin F, Ayoub B, Molinari N, Cristol JP, Perez-Martin A, Mercier J, Hayot M, Gouzi F. Impaired training-induced angiogenesis process with loss of pericyte-endothelium interactions is associated with an abnormal capillary remodelling in the skeletal muscle of COPD patients. Respir Res 2019;20:278. [PMID: 31806021 DOI: 10.1186/s12931-019-1240-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
660 Yoshimatsu Y, Tobino K, Sueyasu T, Nishizawa S, Ko Y, Yasuda M, Ide H, Tsuruno K, Miyajima H. Repetitive Saliva Swallowing Test Predicts COPD Exacerbation. Int J Chron Obstruct Pulmon Dis 2019;14:2777-85. [PMID: 31824143 DOI: 10.2147/COPD.S226268] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
661 Calverley PM, Page C, Dal Negro RW, Fontana G, Cazzola M, Cicero AF, Pozzi E, Wedzicha JA. Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation. Int J Chron Obstruct Pulmon Dis 2019;14:2733-44. [PMID: 31819405 DOI: 10.2147/COPD.S221852] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
662 Boixeda R, Díez-manglano J, Gómez-antúnez M, López-garcía F, Recio J, Almagro P. Consensus for managing patients with chronic obstructive pulmonary disease according to the CODEX index. Revista Clínica Española (English Edition) 2019;219:494-504. [DOI: 10.1016/j.rceng.2019.03.022] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
663 Tang S, Ma T, Zhang H, Zhang J, Zhong X, Tan C, Qiu Y, Zeng W, Feng X. Erythromycin Prevents Elastin Peptide-Induced Emphysema and Modulates CD4+T Cell Responses in Mice. Int J Chron Obstruct Pulmon Dis 2019;14:2697-709. [PMID: 31819402 DOI: 10.2147/COPD.S222195] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
664 Lee JK, Rhee CK, Kim K, Ra SW, Lee JH, Jung KS, Yoo KH, Kim YI, Kim DK. Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2019;14:2639-47. [PMID: 31819397 DOI: 10.2147/COPD.S216326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
665 Janssen R, Wouters EF, Janssens W, Daamen WF, Hagedoorn P, de Wit HA, Serré J, Gayan-Ramirez G, Franssen FM, Reynaert NL, von der Thüsen JH, Frijlink HW. Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale. Int J Chron Obstruct Pulmon Dis 2019;14:2587-602. [PMID: 32063701 DOI: 10.2147/COPD.S228411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
666 Jang JG, Kim JS, Chung JH, Shin KC, Ahn JH, Lee MS, Bang SH, Park DY, Nam MJ, Jin HJ, Lee KH. Comprehensive Effects of Organized Education for Patients with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2019;14:2603-9. [PMID: 31819396 DOI: 10.2147/COPD.S221673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
667 Biondi NL, Samiratedu MM, Highsmith E, Rosenblum A, McGrady K, Knepper S, Bowers R. The Impact of Interprofessional Monitoring and Education on the Usage of Systemic Glucocorticoids in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective, Medication Use Review. Cureus 2019;11:e6224. [PMID: 31777703 DOI: 10.7759/cureus.6224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
668 Labaki WW, Han MK. Improving Detection of Early Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc 2018;15:S243-8. [PMID: 30759006 DOI: 10.1513/AnnalsATS.201808-529MG] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
669 Oelsner EC, Balte PP, Grams ME, Cassano PA, Jacobs DR, Barr RG, Burkart KM, Kalhan R, Kronmal R, Loehr LR, O'Connor GT, Schwartz JE, Shlipak M, Tracy RP, Tsai MY, White W, Yende S. Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study. Am J Respir Crit Care Med 2019;199:321-32. [PMID: 30261735 DOI: 10.1164/rccm.201803-0402OC] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
670 Rennard SI. Advancing Chronic Obstructive Pulmonary Disease Therapy: Opportunities, Challenges, and Excitement. Am J Respir Cell Mol Biol 2019;60:1-2. [PMID: 30562048 DOI: 10.1165/rcmb.2018-0288ED] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
671 Parekh TM, Bhatia S, Cherrington A, Kim YI, Lambert A, Iyer A, Regan EA, DeMeo DL, Han M, Dransfield MT. Factors influencing decline in quality of life in smokers without airflow obstruction: The COPDGene study. Respir Med 2020;161:105820. [PMID: 31759270 DOI: 10.1016/j.rmed.2019.105820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
672 Barr RG. Rethinking Chronic Obstructive Pulmonary Disease. Chronic Pulmonary Insufficiency and Combined Cardiopulmonary Insufficiency. Ann Am Thorac Soc 2018;15:S30-4. [PMID: 29461894 DOI: 10.1513/AnnalsATS.201708-667KV] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
673 von Siemens SM, Perneczky R, Vogelmeier CF, Behr J, Kauffmann-Guerrero D, Alter P, Trudzinski FC, Bals R, Grohé C, Söhler S, Waschki B, Lutter JI, Welte T, Jörres RA, Kahnert K; COSYCONET study group. The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort. Respir Res 2019;20:257. [PMID: 31727165 DOI: 10.1186/s12931-019-1217-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
674 Wells JM, Xing D, Viera L, Burkes RM, Wu Y, Bhatt SP, Dransfield MT, Couper DJ, O'Neal W, Hoffman EA, Gaggar A, Barjaktarevic I, Curtis JL, Labaki WW, Han MLK, Freeman CM, Putcha N, Schlange T, Blalock JE; SPIROMICS Investigators,. The matrikine acetyl-proline-glycine-proline and clinical features of COPD: findings from SPIROMICS. Respir Res 2019;20:254. [PMID: 31718676 DOI: 10.1186/s12931-019-1230-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
675 Kovelis D, Gomes ARS, Mazzarin C, de Miranda A, Valderramas S. Association Between the Results of the Timed Up-and-Go Test Adjusted for Disease Severity and Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease: a Pilot Study. Clinics (Sao Paulo) 2019;74:e930. [PMID: 31721937 DOI: 10.6061/clinics/2019/e930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
676 Ferrari M, Piccinno E, Marcon A, Marchetti P, Cazzoletti L, Pirina P, Battaglia S, Grosso A, Squillacioti G, Antonicelli L, Verlato G, Pesce G. Chronic bronchitis without airflow obstruction, asthma and rhinitis are differently associated with cardiovascular risk factors and diseases. PLoS One 2019;14:e0224999. [PMID: 31697758 DOI: 10.1371/journal.pone.0224999] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
677 Trevisan C, Rizzuto D, Maggi S, Sergi G, Welmer AK, Vetrano DL. Cross-Sectional and Longitudinal Associations between Peak Expiratory Flow and Frailty in Older Adults. J Clin Med 2019;8:E1901. [PMID: 31703301 DOI: 10.3390/jcm8111901] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
678 Sandelowsky H, Krakau I, Modin S, Ställberg B, Nager A. COPD patients need more information about self-management: a cross-sectional study in Swedish primary care. Scand J Prim Health Care 2019;37:459-67. [PMID: 31694439 DOI: 10.1080/02813432.2019.1684015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
679 Sulku J, Janson C, Melhus H, Malinovschi A, Ställberg B, Bröms K, Högman M, Lisspers K, Hammarlund-Udenaes M, Nielsen EI. A Cross-Sectional Study Assessing Appropriateness Of Inhaled Corticosteroid Treatment In Primary And Secondary Care Patients With COPD In Sweden. Int J Chron Obstruct Pulmon Dis 2019;14:2451-60. [PMID: 31806954 DOI: 10.2147/COPD.S218747] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
680 Mokari-Yamchi A, Jabbari M, Sharifi A, Barati M, Kheirouri S. Low FEV1 Is Associated With Increased Risk Of Cachexia In COPD Patients. Int J Chron Obstruct Pulmon Dis 2019;14:2433-40. [PMID: 31802861 DOI: 10.2147/COPD.S221466] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
681 Kruapanich C, Tantisuwat A, Thaveeratitham P, Lertmaharit S, Ubolnuar N, Mathiyakom W. Effects of Different Modes of Upper Limb Training in Individuals With Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Ann Rehabil Med 2019;43:592-614. [PMID: 31693849 DOI: 10.5535/arm.2019.43.5.592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
682 Vaz Fragoso CA, Van Ness PH, McAvay GJ. FEV1 as a Standalone Spirometric Predictor and the Attributable Fraction for Death in Older Persons. Respir Care 2020;65:217-26. [PMID: 31662447 DOI: 10.4187/respcare.07012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
683 Oelsner EC, Smith BM, Hoffman EA, Kalhan R, Donohue KM, Kaufman JD, Nguyen JN, Manichaikul AW, Rotter JI, Michos ED, Jacobs DR Jr, Burke GL, Folsom AR, Schwartz JE, Watson K, Barr RG. Prognostic Significance of Large Airway Dimensions on Computed Tomography in the General Population. The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. Ann Am Thorac Soc 2018;15:718-27. [PMID: 29529382 DOI: 10.1513/AnnalsATS.201710-820OC] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
684 Price DB, Voorham J, Brusselle G, Clemens A, Kostikas K, Stephens JW, Park HY, Roche N, Fogel R. Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study. NPJ Prim Care Respir Med 2019;29:38. [PMID: 31659161 DOI: 10.1038/s41533-019-0150-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
685 Hosseini M, Almasi-Hashiani A, Sepidarkish M, Maroufizadeh S. Global prevalence of asthma-COPD overlap (ACO) in the general population: a systematic review and meta-analysis. Respir Res 2019;20:229. [PMID: 31647021 DOI: 10.1186/s12931-019-1198-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
686 Chen J, Kaye L, Tuffli M, Barrett MA, Jones-Ford S, Shenouda T, Gondalia R, Henderson K, Combs V, Van Sickle D, Stempel DA. Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis. JMIR Form Res 2019;3:e13286. [PMID: 31647471 DOI: 10.2196/13286] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
687 Rittayamai N, Phuangchoei P, Tscheikuna J, Praphruetkit N, Brochard L. Effects of high-flow nasal cannula and non-invasive ventilation on inspiratory effort in hypercapnic patients with chronic obstructive pulmonary disease: a preliminary study. Ann Intensive Care 2019;9:122. [PMID: 31641959 DOI: 10.1186/s13613-019-0597-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
688 Hepworth ML, Passey SL, Seow HJ, Vlahos R. Losartan does not inhibit cigarette smoke-induced lung inflammation in mice. Sci Rep 2019;9:15053. [PMID: 31636311 DOI: 10.1038/s41598-019-51504-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
689 Bak SH, Kwon SO, Han SS, Kim WJ. Computed tomography-derived area and density of pectoralis muscle associated disease severity and longitudinal changes in chronic obstructive pulmonary disease: a case control study. Respir Res 2019;20:226. [PMID: 31638996 DOI: 10.1186/s12931-019-1191-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
690 Dransfield MT, Voelker H, Bhatt SP, Brenner K, Casaburi R, Come CE, Cooper JAD, Criner GJ, Curtis JL, Han MK, Hatipoğlu U, Helgeson ES, Jain VV, Kalhan R, Kaminsky D, Kaner R, Kunisaki KM, Lambert AA, Lammi MR, Lindberg S, Make BJ, Martinez FJ, McEvoy C, Panos RJ, Reed RM, Scanlon PD, Sciurba FC, Smith A, Sriram PS, Stringer WW, Weingarten JA, Wells JM, Westfall E, Lazarus SC, Connett JE; BLOCK COPD Trial Group. Metoprolol for the Prevention of Acute Exacerbations of COPD. N Engl J Med 2019;381:2304-14. [PMID: 31633896 DOI: 10.1056/NEJMoa1908142] [Cited by in Crossref: 52] [Cited by in F6Publishing: 16] [Article Influence: 17.3] [Reference Citation Analysis]
691 Frent SM, Chapman KR, Larbig M, Mackay A, Fogel R, Gutzwiller FS, Shen S, Patalano F, Banerji D, Kostikas K, Wedzicha JA. Capturing Exacerbations of Chronic Obstructive Pulmonary Disease with EXACT. A Subanalysis of FLAME. Am J Respir Crit Care Med 2019;199:43-51. [PMID: 30019939 DOI: 10.1164/rccm.201801-0038OC] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
692 Montón C, Prina E, Pomares X, Cugat JR, Casabella A, Oliva JC, Gallego M, Monsó E. Nebulized Colistin And Continuous Cyclic Azithromycin In Severe COPD Patients With Chronic Bronchial Infection Due To Pseudomonas aeruginosa: A Retrospective Cohort Study. Int J Chron Obstruct Pulmon Dis 2019;14:2365-73. [PMID: 31802860 DOI: 10.2147/COPD.S209513] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
693 Fanjul F, Campins A, Asensio J, Sampériz G, Yañez A, Romaguera D, Fiol M, Riera M. Interatrial blocks prevalence and risk factors for human immunodeficiency virus-infected persons. PLoS One 2019;14:e0223777. [PMID: 31622385 DOI: 10.1371/journal.pone.0223777] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
694 Wang W, Zha G, Zou JJ, Wang X, Li CN, Wu XJ. Berberine Attenuates Cigarette Smoke Extract-induced Airway Inflammation in Mice: Involvement of TGF-β1/Smads Signaling Pathway. Curr Med Sci 2019;39:748-53. [PMID: 31612392 DOI: 10.1007/s11596-019-2101-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
695 Oelsner EC, Balte PP, Bhatt SP, Cassano PA, Couper D, Folsom AR, Freedman ND, Jacobs DR Jr, Kalhan R, Mathew AR, Kronmal RA, Loehr LR, London SJ, Newman AB, O'Connor GT, Schwartz JE, Smith LJ, White WB, Yende S. Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study. Lancet Respir Med 2020;8:34-44. [PMID: 31606435 DOI: 10.1016/S2213-2600(19)30276-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 9.3] [Reference Citation Analysis]
696 Ozretić P, da Silva Filho MI, Catalano C, Sokolović I, Vukić-Dugac A, Šutić M, Kurtović M, Bubanović G, Popović-Grle S, Skrinjarić-Cincar S, Vugrek O, Jukić I, Rumora L, Bosnar M, Samaržija M, Bals R, Jakopović M, Försti A, Knežević J. Association of NLRP1 Coding Polymorphism with Lung Function and Serum IL-1β Concentration in Patients Diagnosed with Chronic Obstructive Pulmonary Disease (COPD). Genes (Basel) 2019;10:E783. [PMID: 31601004 DOI: 10.3390/genes10100783] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
697 Stenlund T, Nyberg A, Lundell S, Wadell K. Web-based support for self-management strategies versus usual care for people with COPD in primary healthcare: a protocol for a randomised, 12-month, parallel-group pragmatic trial. BMJ Open 2019;9:e030788. [PMID: 31594889 DOI: 10.1136/bmjopen-2019-030788] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
698 Spilling CA, Jones PW, Dodd JW, Barrick TR. Disruption of white matter connectivity in chronic obstructive pulmonary disease. PLoS One 2019;14:e0223297. [PMID: 31581226 DOI: 10.1371/journal.pone.0223297] [Reference Citation Analysis]
699 Vlahos R. Lipids in Chronic Obstructive Pulmonary Disease: A Target for Future Therapy? Am J Respir Cell Mol Biol 2020;62:273-4. [PMID: 31577908 DOI: 10.1165/rcmb.2019-0338ED] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
700 Tran DT, Akpinar I, Mayers I, Makhinova T, Jacobs P. Temporal Trends Of Pharmacologic Therapies For Patients With Chronic Obstructive Pulmonary Disease In Alberta, Canada. Int J Chron Obstruct Pulmon Dis 2019;14:2245-56. [PMID: 31576120 DOI: 10.2147/COPD.S214191] [Reference Citation Analysis]
701 Dumas O, Varraso R, Boggs KM, Quinot C, Zock JP, Henneberger PK, Speizer FE, Le Moual N, Camargo CA Jr. Association of Occupational Exposure to Disinfectants With Incidence of Chronic Obstructive Pulmonary Disease Among US Female Nurses. JAMA Netw Open 2019;2:e1913563. [PMID: 31626315 DOI: 10.1001/jamanetworkopen.2019.13563] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 10.3] [Reference Citation Analysis]
702 O'Farrell HE, Yang IA. Extracellular vesicles in chronic obstructive pulmonary disease (COPD). J Thorac Dis 2019;11:S2141-54. [PMID: 31737342 DOI: 10.21037/jtd.2019.10.16] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
703 Rehman AU, Hassali MAA, Muhammad SA, Harun SN, Shah S, Abbas S. The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature. Eur J Health Econ 2020;21:181-94. [PMID: 31564007 DOI: 10.1007/s10198-019-01119-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
704 Lim HI, Jun SJ, Lee SW. Glomerular hyperfiltration may be a novel risk factor of restrictive spirometry pattern: Analysis of the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2015. PLoS One 2019;14:e0223050. [PMID: 31553782 DOI: 10.1371/journal.pone.0223050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
705 Rinne ST, Wiener RS, Chen Y, Rise P, Udris E, Feemster LC, Au DH. Impact of Guideline Changes on Indications for Inhaled Corticosteroids among Veterans with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2018;198:1226-8. [PMID: 29969041 DOI: 10.1164/rccm.201803-0554LE] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
706 Micheletto C, Braido F, Contoli M, Di Marco F, Santus P. A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management. Int J Chron Obstruct Pulmon Dis 2019;14:2185-93. [PMID: 31576115 DOI: 10.2147/COPD.S216059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
707 O'Beirne SL, Shenoy SA, Salit J, Strulovici-Barel Y, Kaner RJ, Visvanathan S, Fine JS, Mezey JG, Crystal RG. Ambient Pollution-related Reprogramming of the Human Small Airway Epithelial Transcriptome. Am J Respir Crit Care Med 2018;198:1413-22. [PMID: 29897792 DOI: 10.1164/rccm.201712-2526OC] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
708 Alter P, Mayerhofer BA, Kahnert K, Watz H, Waschki B, Andreas S, Biertz F, Bals R, Vogelmeier CF, Jörres RA. Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort. Int J Chron Obstruct Pulmon Dis 2019;14:2163-72. [PMID: 31571852 DOI: 10.2147/COPD.S209343] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
709 Tanner L, Single AB. Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance. J Innate Immun 2020;12:203-25. [PMID: 31527372 DOI: 10.1159/000502489] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
710 Wu AC, Kiley JP, Noel PJ, Amur S, Burchard EG, Clancy JP, Galanter J, Inada M, Jones TK, Kropski JA, Loyd JE, Nogee LM, Raby BA, Rogers AJ, Schwartz DA, Sin DD, Spira A, Weiss ST, Young LR, Himes BE. Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement. Am J Respir Crit Care Med 2018;198:e116-36. [PMID: 30640517 DOI: 10.1164/rccm.201810-1895ST] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 9.7] [Reference Citation Analysis]
711 Synn AJ, Li W, San José Estépar R, Zhang C, Washko GR, O'Connor GT, Araki T, Hatabu H, Bankier AA, Mittleman MA, Rice MB. Radiographic pulmonary vessel volume, lung function and airways disease in the Framingham Heart Study. Eur Respir J 2019;54:1900408. [PMID: 31248956 DOI: 10.1183/13993003.00408-2019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
712 Singanayagam A, Loo SL, Calderazzo M, Finney LJ, Trujillo Torralbo MB, Bakhsoliani E, Girkin J, Veerati P, Pathinayake PS, Nichol KS, Reid A, Footitt J, Wark PAB, Grainge CL, Johnston SL, Bartlett NW, Mallia P. Antiviral immunity is impaired in COPD patients with frequent exacerbations. Am J Physiol Lung Cell Mol Physiol 2019;317:L893-903. [PMID: 31513433 DOI: 10.1152/ajplung.00253.2019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
713 Simonÿ C, Riber C, Bodtger U, Birkelund R. Striving for Confidence and Satisfaction in Everyday Life with Chronic Obstructive Pulmonary Disease: Rationale and Content of the Tele-Rehabilitation Programme >C☺PD-Life>>. Int J Environ Res Public Health 2019;16:E3320. [PMID: 31505861 DOI: 10.3390/ijerph16183320] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
714 Bewley MA, Budd RC, Ryan E, Cole J, Collini P, Marshall J, Kolsum U, Beech G, Emes RD, Tcherniaeva I, Berbers GAM, Walmsley SR, Donaldson G, Wedzicha JA, Kilty I, Rumsey W, Sanchez Y, Brightling CE, Donnelly LE, Barnes PJ, Singh D, Whyte MKB, Dockrell DH; COPDMAP. Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists. Am J Respir Crit Care Med 2018;198:739-50. [PMID: 29547002 DOI: 10.1164/rccm.201705-0903OC] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
715 Burkart KM, Sofer T, London SJ, Manichaikul A, Hartwig FP, Yan Q, Soler Artigas M, Avila L, Chen W, Davis Thomas S, Diaz AA, Hall IP, Horta BL, Kaplan RC, Laurie CC, Menezes AM, Morrison JV, Oelsner EC, Rastogi D, Rich SS, Soto-Quiros M, Stilp AM, Tobin MD, Wain LV, Celedón JC, Barr RG. A Genome-Wide Association Study in Hispanics/Latinos Identifies Novel Signals for Lung Function. The Hispanic Community Health Study/Study of Latinos. Am J Respir Crit Care Med 2018;198:208-19. [PMID: 29394082 DOI: 10.1164/rccm.201707-1493OC] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 7.7] [Reference Citation Analysis]
716 Ding Y, Li Q, Feng Q, Xu D, Wu C, Zhao J, Zhou X, Yang Y, Niu H, He P, Xing L. CYP2B6 genetic polymorphisms influence chronic obstructive pulmonary disease susceptibility in the Hainan population. Int J Chron Obstruct Pulmon Dis 2019;14:2103-15. [PMID: 31564857 DOI: 10.2147/COPD.S214961] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
717 Pehlivan E, Yazar E, Balcı A, Kılıç L. Comparison of Compliance Rates and Treatment Efficiency in Home-Based with Hospital-Based Pulmonary Rehabilitation in COPD. Turk Thorac J 2019;20:192-7. [PMID: 31479415 DOI: 10.5152/TurkThoracJ.2019.18060] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
718 Russell DW, Gaggar A. ADAM9: A Damaging Player in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2018;198:1465-6. [PMID: 29986153 DOI: 10.1164/rccm.201805-1012ED] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
719 Diao W, Labaki WW, Han MK, Yeomans L, Sun Y, Smiley Z, Kim JH, McHugh C, Xiang P, Shen N, Sun X, Guo C, Lu M, Standiford TJ, He B, Stringer KA. Disruption of histidine and energy homeostasis in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2019;14:2015-25. [PMID: 31564849 DOI: 10.2147/COPD.S210598] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
720 Kalhan R, Dransfield MT, Colangelo LA, Cuttica MJ, Jacobs DR Jr, Thyagarajan B, Estepar RSJ, Harmouche R, Onieva JO, Ash SY, Okajima Y, Iribarren C, Sidney S, Lewis CE, Mannino DM, Liu K, Smith LJ, Washko GR. Respiratory Symptoms in Young Adults and Future Lung Disease. The CARDIA Lung Study. Am J Respir Crit Care Med 2018;197:1616-24. [PMID: 29369684 DOI: 10.1164/rccm.201710-2108OC] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
721 Zhang WZ, Gomi K, Mahjour SB, Martinez FJ, Shaykhiev R. Update in Chronic Obstructive Pulmonary Disease 2017. Am J Respir Crit Care Med 2018;197:1534-9. [PMID: 29688027 DOI: 10.1164/rccm.201801-0113UP] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
722 Martinez FJ, Han MK, Allinson JP, Barr RG, Boucher RC, Calverley PMA, Celli BR, Christenson SA, Crystal RG, Fagerås M, Freeman CM, Groenke L, Hoffman EA, Kesimer M, Kostikas K, Paine R 3rd, Rafii S, Rennard SI, Segal LN, Shaykhiev R, Stevenson C, Tal-Singer R, Vestbo J, Woodruff PG, Curtis JL, Wedzicha JA. At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2018;197:1540-51. [PMID: 29406779 DOI: 10.1164/rccm.201710-2028PP] [Cited by in Crossref: 83] [Cited by in F6Publishing: 48] [Article Influence: 27.7] [Reference Citation Analysis]
723 Sánchez E, Gutiérrez-Carrasquilla L, Barbé F, Betriu À, López-Cano C, Gaeta AM, Purroy F, Pamplona R, Ortega M, Fernández E, Hernández C, Lecube A, Simó R; ILERVAS Project. Lung function measurements in the prediabetes stage: data from the ILERVAS Project. Acta Diabetol 2019;56:1005-12. [PMID: 30989377 DOI: 10.1007/s00592-019-01333-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
724 Barnett T, Jenkins A, Bouldin A, Crumby M, Morgan AK, Warren ML. Assessing Quality of Pharmacist-Led Education for Patients with COPD Using the Lung Information Needs Questionnaire: A Pilot Study. Innov Pharm 2019;10. [PMID: 34007545 DOI: 10.24926/iip.v10i2.1515] [Reference Citation Analysis]
725 Sheng W, Huang Y, Deng Z, Ma H. Investigation of the Prevalence and Diagnosis of Chronic Obstructive Pulmonary Disease in a Group of Elderly Individuals Residing in an Island Area of Ningbo. Can Respir J 2019;2019:6918340. [PMID: 31467620 DOI: 10.1155/2019/6918340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
726 Singh AP, Biswas A, Shukla A, Maiti P. Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal Transduct Target Ther 2019;4:33. [PMID: 31637012 DOI: 10.1038/s41392-019-0068-3] [Cited by in Crossref: 114] [Cited by in F6Publishing: 157] [Article Influence: 38.0] [Reference Citation Analysis]
727 Li D, Wu Y, Guo S, Qin J, Feng M, An Y, Zhang J, Li Y, Xiong S, Zhou H, Zeng Q, Chen L, Wen F. Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD. Int J Chron Obstruct Pulmon Dis 2019;14:1933-41. [PMID: 31695352 DOI: 10.2147/COPD.S207855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
728 Sargis RM, Simmons RA. Environmental neglect: endocrine disruptors as underappreciated but potentially modifiable diabetes risk factors. Diabetologia. 2019;62:1811-1822. [PMID: 31451869 DOI: 10.1007/s00125-019-4940-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
729 Gantzhorn EK, Prior TS, Hilberg O. Long-term non-invasive ventilation for stable chronic hypercapnic COPD. Eur Clin Respir J 2019;6:1644893. [PMID: 31448069 DOI: 10.1080/20018525.2019.1644893] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
730 Lopez Varela MV, Montes de Oca M, Wehrmeister FC, Rodriguez C, Ramirez L, Menezes A. External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population. Int J Chron Obstruct Pulmon Dis 2019;14:1901-11. [PMID: 31692595 DOI: 10.2147/COPD.S206250] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
731 Andersson E, Sällsten G, Lohman S, Neitzel R, Torén K. Lung function and paper dust exposure among workers in a soft tissue paper mill. Int Arch Occup Environ Health 2020;93:105-10. [PMID: 31451924 DOI: 10.1007/s00420-019-01469-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
732 Hao W, Li M, Zhang Y, Zhang C, Wang P. Comparative Study of Cytokine Levels in Different Respiratory Samples in Mild-to-Moderate AECOPD Patients. Lung 2019;197:565-72. [PMID: 31451927 DOI: 10.1007/s00408-019-00263-y] [Reference Citation Analysis]
733 Teopompi E, Risé P, Pisi R, Buccellati C, Aiello M, Pisi G, Tripodi C, Fainardi V, Clini E, Chetta A, Rovati GE, Sala A. Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation. Front Pharmacol 2019;10:938. [PMID: 31507425 DOI: 10.3389/fphar.2019.00938] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
734 Suzuki Y, Inui N, Karayama M, Imokawa S, Yamada T, Yokomura K, Asada K, Kusagaya H, Kaida Y, Matsuda H, Koshimizu N, Toyoshima M, Masuda M, Hayakawa H, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Suda T. Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD. Int J Chron Obstruct Pulmon Dis 2019;14:1867-77. [PMID: 31686799 DOI: 10.2147/COPD.S214610] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
735 Andreas S, Röver C, Heinz J, Straube S, Watz H, Friede T. Decline of COPD exacerbations in clinical trials over two decades - a systematic review and meta-regression. Respir Res 2019;20:186. [PMID: 31420040 DOI: 10.1186/s12931-019-1163-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
736 Wang M, Aaron CP, Madrigano J, Hoffman EA, Angelini E, Yang J, Laine A, Vetterli TM, Kinney PL, Sampson PD, Sheppard LE, Szpiro AA, Adar SD, Kirwa K, Smith B, Lederer DJ, Diez-Roux AV, Vedal S, Kaufman JD, Barr RG. Association Between Long-term Exposure to Ambient Air Pollution and Change in Quantitatively Assessed Emphysema and Lung Function. JAMA 2019;322:546-56. [PMID: 31408135 DOI: 10.1001/jama.2019.10255] [Cited by in Crossref: 130] [Cited by in F6Publishing: 107] [Article Influence: 43.3] [Reference Citation Analysis]
737 Lemay AM, Courtemanche O, Couttas TA, Jamsari G, Gagné A, Bossé Y, Joubert P, Don AS, Marsolais D. High FA2H and UGT8 transcript levels predict hydroxylated hexosylceramide accumulation in lung adenocarcinoma. J Lipid Res 2019;60:1776-86. [PMID: 31409741 DOI: 10.1194/jlr.M093955] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
738 Huang S, He X, Doyle TJ, Zaccardelli A, Marshall AA, Friedlander HM, Blaustein RB, Smith EA, Cui J, Iannaccone CK, Mahmoud TG, Weinblatt ME, Dellaripa PF, Shadick NA, Sparks JA. Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry. Clin Rheumatol 2019;38:3401-12. [PMID: 31410660 DOI: 10.1007/s10067-019-04733-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
739 Labaki WW, Gu T, Murray S, Curtis JL, Yeomans L, Bowler RP, Barr RG, Comellas AP, Hansel NN, Cooper CB, Barjaktarevic I, Kanner RE, Paine R 3rd, McDonald MN, Krishnan JA, Peters SP, Woodruff PG, O'Neal WK, Diao W, He B, Martinez FJ, Standiford TJ, Stringer KA, Han MK. Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study. Sci Rep 2019;9:11367. [PMID: 31388056 DOI: 10.1038/s41598-019-47761-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
740 Segal LN, Martinez FJ. Chronic obstructive pulmonary disease subpopulations and phenotyping. J Allergy Clin Immunol 2018;141:1961-71. [PMID: 29884286 DOI: 10.1016/j.jaci.2018.02.035] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
741 Rasooly D, Ioannidis JPA, Khoury MJ, Patel CJ. Family History-Wide Association Study to Identify Clinical and Environmental Risk Factors for Common Chronic Diseases. Am J Epidemiol 2019;188:1563-8. [PMID: 31172187 DOI: 10.1093/aje/kwz125] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
742 Eapen MS, Hansbro PM, Larsson-Callerfelt AK, Jolly MK, Myers S, Sharma P, Jones B, Rahman MA, Markos J, Chia C, Larby J, Haug G, Hardikar A, Weber HC, Mabeza G, Cavalheri V, Khor YH, McDonald CF, Sohal SS. Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities. Drugs 2018;78:1717-40. [PMID: 30392114 DOI: 10.1007/s40265-018-1001-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
743 Piscaer I, van den Ouweland JMW, Vermeersch K, Reynaert NL, Franssen FME, Keene S, Wouters EFM, Janssens W, Vermeer C, Janssen R. Low Vitamin K Status Is Associated with Increased Elastin Degradation in Chronic Obstructive Pulmonary Disease. J Clin Med 2019;8:E1116. [PMID: 31357639 DOI: 10.3390/jcm8081116] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
744 González J, Henschke CI, Yankelevitz DF, Seijo LM, Reeves AP, Yip R, Xie Y, Chung M, Sánchez-Salcedo P, Alcaide AB, Campo A, Bertó J, Del Mar Ocón M, Pueyo J, Bastarrika G, de-Torres JP, Zulueta JJ. Emphysema phenotypes and lung cancer risk. PLoS One 2019;14:e0219187. [PMID: 31344121 DOI: 10.1371/journal.pone.0219187] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
745 Balasubramanian A, MacIntyre NR, Henderson RJ, Jensen RL, Kinney G, Stringer WW, Hersh CP, Bowler RP, Casaburi R, Han MK, Porszasz J, Barr RG, Make BJ, Wise RA, McCormack MC. Diffusing Capacity of Carbon Monoxide in Assessment of COPD. Chest 2019;156:1111-9. [PMID: 31352035 DOI: 10.1016/j.chest.2019.06.035] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
746 Halpin DMG, de Jong HJI, Carter V, Skinner D, Price D. Distribution, Temporal Stability and Appropriateness of Therapy of Patients With COPD in the UK in Relation to GOLD 2019. EClinicalMedicine 2019;14:32-41. [PMID: 31709400 DOI: 10.1016/j.eclinm.2019.07.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
747 Nishimura K, Oga T, Nakayasu K, Ogasawara M, Hasegawa Y, Mitsuma S. How different are COPD-specific patient reported outcomes, health status, dyspnoea and respiratory symptoms? An observational study in a working population. BMJ Open 2019;9:e025132. [PMID: 31345963 DOI: 10.1136/bmjopen-2018-025132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
748 Rahman O, Markl M, Balte P, Berhane H, Blanken C, Suwa K, Dashnaw S, Wieben O, Bluemke DA, Prince MR, Lima J, Michos E, Ambale-Venkatesh B, Hoffman EA, Gomes AS, Watson K, Sun Y, Carr J, Barr RG. Reproducibility and Changes in Vena Caval Blood Flow by Using 4D Flow MRI in Pulmonary Emphysema and Chronic Obstructive Pulmonary Disease (COPD): The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Substudy. Radiology 2019;292:585-94. [PMID: 31335282 DOI: 10.1148/radiol.2019182143] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
749 Richmond BW, Du RH, Han W, Benjamin JT, van der Meer R, Gleaves L, Guo M, McKissack A, Zhang Y, Cheng DS, Polosukhin VV, Blackwell TS. Bacterial-derived Neutrophilic Inflammation Drives Lung Remodeling in a Mouse Model of Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol 2018;58:736-44. [PMID: 29314863 DOI: 10.1165/rcmb.2017-0329OC] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
750 Ayora AF, Soler LM, Gasch AC. Analysis of two questionnaires on quality of life of Chronic Obstructive Pulmonary Disease patients. Rev Lat Am Enfermagem 2019;27:e3148. [PMID: 31340341 DOI: 10.1590/1518-8345.2624.3148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
751 Starkey MR, Plank MW, Casolari P, Papi A, Pavlidis S, Guo Y, Cameron GJM, Haw TJ, Tam A, Obiedat M, Donovan C, Hansbro NG, Nguyen DH, Nair PM, Kim RY, Horvat JC, Kaiko GE, Durum SK, Wark PA, Sin DD, Caramori G, Adcock IM, Foster PS, Hansbro PM. IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis. Eur Respir J 2019;54:1800174. [PMID: 31196943 DOI: 10.1183/13993003.00174-2018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
752 Paneroni M, Vogiatzis I, Belli S, Savio G, Visca D, Zampogna E, Aliani M, Carolis V, Maniscalco M, Simonelli C, Vitacca M. Is Two Better Than One? The Impact of Doubling Training Volume in Severe COPD: A Randomized Controlled Study. J Clin Med 2019;8:E1052. [PMID: 31323895 DOI: 10.3390/jcm8071052] [Reference Citation Analysis]
753 Yang L, Zhu Y, Huang JA, Jin J, Zhang X. A Low Lean-to-Fat Ratio Reduces the Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Patients with a Normal or Low Body Mass Index. Med Sci Monit 2019;25:5229-36. [PMID: 31302663 DOI: 10.12659/MSM.914783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
754 Yasuo M, Droma Y, Kitaguchi Y, Ito M, Imamura H, Kawakubo M, Hanaoka M. The relationship between acrolein and oxidative stress in COPD: in systemic plasma and in local lung tissue. Int J Chron Obstruct Pulmon Dis 2019;14:1527-37. [PMID: 31371938 DOI: 10.2147/COPD.S208633] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
755 Cruz T, López-Giraldo A, Noell G, Casas-Recasens S, Garcia T, Molins L, Juan M, Fernandez MA, Agustí A, Faner R. Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD). Respir Res 2019;20:152. [PMID: 31299954 DOI: 10.1186/s12931-019-1105-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
756 Yang J, Liu C, Li L, Tu X, Lu Z. Red Blood Cell Distribution Width Predicts Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease. Can Respir J 2019;2019:3853454. [PMID: 31379981 DOI: 10.1155/2019/3853454] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
757 Lai CC, Chen CH, Lin CYH, Wang CY, Wang YH. The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials. Int J Chron Obstruct Pulmon Dis 2019;14:1539-48. [PMID: 31371939 DOI: 10.2147/COPD.S200846] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
758 Najafinobar N, Venkatesan S, von Sydow L, Klarqvist M, Olsson H, Zhou XH, Cloonan SM, Malmberg P. ToF-SIMS mediated analysis of human lung tissue reveals increased iron deposition in COPD (GOLD IV) patients. Sci Rep 2019;9:10060. [PMID: 31296897 DOI: 10.1038/s41598-019-46471-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
759 Franssen FM, Alter P, Bar N, Benedikter BJ, Iurato S, Maier D, Maxheim M, Roessler FK, Spruit MA, Vogelmeier CF, Wouters EF, Schmeck B. Personalized medicine for patients with COPD: where are we? Int J Chron Obstruct Pulmon Dis 2019;14:1465-84. [PMID: 31371934 DOI: 10.2147/COPD.S175706] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 8.3] [Reference Citation Analysis]
760 Fujino N, Brand OJ, Morgan DJ, Fujimori T, Grabiec AM, Jagger CP, Maciewicz RA, Yamada M, Itakura K, Sugiura H, Ichinose M, Hussell T. Sensing of apoptotic cells through Axl causes lung basal cell proliferation in inflammatory diseases. J Exp Med 2019;216:2184-201. [PMID: 31289116 DOI: 10.1084/jem.20171978] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
761 Halper-Stromberg E, Yun JH, Parker MM, Singer RT, Gaggar A, Silverman EK, Leach S, Bowler RP, Castaldi PJ. Systemic Markers of Adaptive and Innate Immunity Are Associated with Chronic Obstructive Pulmonary Disease Severity and Spirometric Disease Progression. Am J Respir Cell Mol Biol 2018;58:500-9. [PMID: 29206476 DOI: 10.1165/rcmb.2017-0373OC] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
762 Abdulai RM, Jensen TJ, Patel NR, Polkey MI, Jansson P, Celli BR, Rennard SI. Deterioration of Limb Muscle Function during Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2018;197:433-49. [PMID: 29064260 DOI: 10.1164/rccm.201703-0615CI] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 9.3] [Reference Citation Analysis]
763 Aridgides DS, Mellinger DL, Armstrong DA, Hazlett HF, Dessaint JA, Hampton TH, Atkins GT, Carroll JL, Ashare A. Functional and metabolic impairment in cigarette smoke-exposed macrophages is tied to oxidative stress. Sci Rep 2019;9:9624. [PMID: 31270372 DOI: 10.1038/s41598-019-46045-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
764 Saferali A, Yun JH, Parker MM, Sakornsakolpat P, Chase RP, Lamb A, Hobbs BD, Boezen MH, Dai X, de Jong K, Beaty TH, Wei W, Zhou X, Silverman EK, Cho MH, Castaldi PJ, Hersh CP; COPDGene Investigators., International COPD Genetics Consortium Investigators. Analysis of genetically driven alternative splicing identifies FBXO38 as a novel COPD susceptibility gene. PLoS Genet 2019;15:e1008229. [PMID: 31269066 DOI: 10.1371/journal.pgen.1008229] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
765 Barnes PJ. Inflammatory endotypes in COPD. Allergy 2019;74:1249-56. [PMID: 30834543 DOI: 10.1111/all.13760] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 13.7] [Reference Citation Analysis]
766 Kim J, Kim DY, Heo HR, Choi SS, Hong SH, Kim WJ. Role of miRNA-181a-2-3p in cadmium-induced inflammatory responses of human bronchial epithelial cells. J Thorac Dis 2019;11:3055-69. [PMID: 31463135 DOI: 10.21037/jtd.2019.07.55] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
767 Yoon HY, Park SY, Lee CH, Byun MK, Na JO, Lee JS, Lee WY, Yoo KH, Jung KS, Lee JH. Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis. Int J Chron Obstruct Pulmon Dis 2019;14:1389-97. [PMID: 31388298 DOI: 10.2147/COPD.S205517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
768 Bhatt SP, Balte PP, Schwartz JE, Cassano PA, Couper D, Jacobs DR Jr, Kalhan R, O'Connor GT, Yende S, Sanders JL, Umans JG, Dransfield MT, Chaves PH, White WB, Oelsner EC. Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality. JAMA 2019;321:2438-47. [PMID: 31237643 DOI: 10.1001/jama.2019.7233] [Cited by in Crossref: 72] [Cited by in F6Publishing: 54] [Article Influence: 24.0] [Reference Citation Analysis]
769 Finney LJ, Padmanaban V, Todd S, Ahmed N, Elkin SL, Mallia P. Validity of the diagnosis of pneumonia in hospitalised patients with COPD. ERJ Open Res 2019;5:00031-2019. [PMID: 31249841 DOI: 10.1183/23120541.00031-2019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
770 Zakowska I, Kosiek K, Kowalczyk A, Grabowski J, Godycki-Cwirko M. Community determinants of COPD exacerbations in elderly patients in Poland: protocol for a retrospective Big Data observational cohort study. BMJ Open 2019;9:e030524. [PMID: 31230036 DOI: 10.1136/bmjopen-2019-030524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
771 Kwan HY, Maddocks M, Nolan CM, Jones SE, Patel S, Barker RE, Kon SSC, Polkey MI, Cullinan P, Man WD. The prognostic significance of weight loss in chronic obstructive pulmonary disease-related cachexia: a prospective cohort study. J Cachexia Sarcopenia Muscle 2019;10:1330-8. [PMID: 31207189 DOI: 10.1002/jcsm.12463] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
772 Veil-Picard M, Soumagne T, Vongthilath R, Annesi-Maesano I, Guillien A, Laurent L, Andujar P, Roche N, Jouneau S, Cypriani B, Laplante JJ, Degano B, Dalphin JC. Is atopy a risk indicator of chronic obstructive pulmonary disease in dairy farmers? Respir Res 2019;20:124. [PMID: 31208466 DOI: 10.1186/s12931-019-1082-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
773 Lan YW, Yang JC, Yen CC, Huang TT, Chen YC, Chen HL, Chong KY, Chen CM. Predifferentiated amniotic fluid mesenchymal stem cells enhance lung alveolar epithelium regeneration and reverse elastase-induced pulmonary emphysema. Stem Cell Res Ther 2019;10:163. [PMID: 31196196 DOI: 10.1186/s13287-019-1282-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
774 Magnus MC, Henderson J, Tilling K, Howe LD, Fraser A. Independent and combined associations of maternal and own smoking with adult lung function and COPD. Int J Epidemiol 2018;47:1855-64. [PMID: 30339246 DOI: 10.1093/ije/dyy221] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
775 Yang SN, Ko HK, Hsiao YH,